Diet
UltraSound
Diabetes

Cancer & Biopsy
Germanium
Heart Disease
Free Radicals
IV Chelation Therapy

Vibrant Life Home Web
Family Of Three Chelation Formulas
MSM
Other VL Products
The Wednesday Letter
Frequently Asked Questions
Testimonials
Karl Loren Web


Shopping Cart

Separate Search Page
or search below


Navigation Help

Oral Chelation Therapy
Other

Ingredients
Technical
Write To Karl Loren Table Of Contents

Metastasis

Write To Karl Loren About This Page

Cancer & Biopsy

 


Metastasis is the action of a cancer that has been relatively inactive in a relatively fixed location, for some reason, usually suddenly, starting to spread throughout the body.  The most common reason for Metastasis would be surgery which cuts into the cancer, usually in an effort to cut it all out, where the result is that some part of the cancer was NOT cut out and now that the protective wall around the formerly inactive, or slow-growing cancer is disrupted, cancer cells enter into the blood stream, are carried to other parts of the body, and then start growing as new cancers in those locations.
Results for your query in Medline on July 11, 2000:
Search all fields for: metastasis And biopsy And spread
Published in 1966 through 1999
Only select references with abstracts available
Show references published in English only

Documents: 1 to 100 of 243


Top Of Menu

1 Sinner WN, et al; Implantation metastasis after percutaneous transthoracic needle aspiration biopsy. (Acta Radiol [Diagn] (Stockh), 1976 Jul, Abstract available) [MEDLINE]
2 Meyers DS, et al; Aspiration cytology for diagnosis of head and neck masses. (Otolaryngology, 1978 Jul, Abstract available) [MEDLINE]
3 Torrington KG, et al; Diagnosis of lymphangitic carcinomatosis by transbronchial lung biopsy. (South Med J, 1978 Dec, Abstract available) [MEDLINE]
4 Hoover HC Jr, et al; Techniques for inhibiting tumor metastases. (Cancer, 1975 Jan, Abstract available) [MEDLINE]
5 Exelby PR, et al; Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey--1974. (J Pediatr Surg, 1975 Jun, Abstract available) [MEDLINE]
6 Cohen MH, et al; Staging laparotomy in the treatment of metastatic melanoma of the lower extremities. (Ann Surg, 1975 Dec, Abstract available) [MEDLINE]
7 Cole WH; Dissemination of cancer: the need for stimulation of the immune process during the immunosuppression produced by major operations. (South Med J, 1982 Dec, Abstract available) [MEDLINE]
8 Healy TM, et al; Lung cancer diagnosis: evaluation of diagnostic techniques. (N Z Med J, 1975 May, Abstract available) [MEDLINE]
9 Mohs FE; Chemosurgery for skin cancer: fixed tissue and fresh tissue techniques. (Arch Dermatol, 1976 Feb, Abstract available) [MEDLINE]
10 Castrow FF 2d, et al; Scalpel excision of primary cutaneous malignant melanomas without metastasis. (J Dermatol Surg Oncol, 1979 Feb, Abstract available) [MEDLINE]

Menu Position #10

11 Larsson SE, et al; Primary liposarcoma of bone. (Acta Orthop Scand, 1975 Dec, Abstract available) [MEDLINE]
12 Foucar E, et al; Well-differentiated peripheral cholangiocarcinoma with an unusual clinical course. (Gastroenterology, 1979 Aug, Abstract available) [MEDLINE]
13 Nelson RS; Gastrointestinal carcinoma: diagnosis, staging, and follow-up. (Geriatrics, 1976 Sep, Abstract available) [MEDLINE]
14 Berman CG, et al; Diagnostic imaging in cancer. (Prim Care, 1992 Dec, Abstract available) [MEDLINE]
15 Hald T, et al; Extraperitoneal pelvioscopy: a new aid in staging of lower urinary tract tumors. A preliminary report. (J Urol, 1980 Aug, Abstract available) [MEDLINE]
16 Frisch B, et al; Scope and value of bone marrow biopsies in metastatic cancer. (Invasion Metastasis, 1984, Abstract available) [MEDLINE]
17 Plainfosse MC, et al; 165 renal carcinomas: accuracy of imaging for diagnosis and spread--cost efficiency. (Eur J Radiol, 1983 May, Abstract available) [MEDLINE]
18 Burkhardt R, et al; Detection of haematologic and nonhaematologic cancer by bone biopsy. (Cancer Detect Prev, 1981, Abstract available) [MEDLINE]
19 Kaspar HG, et al; Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix. (Obstet Gynecol, 1993 Feb, Abstract available) [MEDLINE]
20 Rao AR, et al; Management of gastrointestinal lymphoma. (Am J Clin Oncol, 1984 Jun, Abstract available) [MEDLINE]

Menu Position #20

21 Adolphs HD, et al; Significance of supraclavicular lymph node biopsy for staging, therapy and prognosis of testicular tumors. (Eur Urol, 1980, Abstract available) [MEDLINE]
22 Utz JP, et al; The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma. (Chest, 1993 Oct, Abstract available) [MEDLINE]
23 Pilepich MV, et al; Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group. (Prostate, 1984, Abstract available) [MEDLINE]
24 Ravi R, et al; Inguinal pick in invasive penile carcinoma: can it stage node negative patients? (Arch Esp Urol, 1991 Nov, Abstract available) [MEDLINE]
25 Burke TW, et al; Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma. (Gynecol Oncol, 1987 Nov, Abstract available) [MEDLINE]
26 Veroux G, et al; Radioimmunoguided surgery. (Hepatogastroenterology, 1999 Nov, Abstract available) [MEDLINE]
27 Robertson WW Jr, et al; Passive movement of radioactive microspheres from bone and soft tissue in an extremity. (J Orthop Res, 1985, Abstract available) [MEDLINE]
28 Feussner H, et al; Pretherapeutic laparoscopic staging in advanced gastric carcinoma [see comments] (Endoscopy, 1999 Jun, Abstract available) [MEDLINE]
29 McQuone SJ, et al; Occult tonsillar carcinoma in the unknown primary. (Laryngoscope, 1998 Nov, Abstract available) [MEDLINE]
30 Barendregt WB, et al; The value of parasternal mediastinoscopy in staging bronchial carcinoma. (Eur J Cardiothorac Surg, 1995, Abstract available) [MEDLINE]

Menu Position #30

31 Schwickert G, et al; Correlation of high lactate levels in human cervical cancer with incidence of metastasis. (Cancer Res, 1995 Nov, Abstract available) [MEDLINE]
32 Parker LA, et al; Evaluation of T1N0M0 lung cancer with CT. (J Comput Assist Tomogr, 1991 Nov, Abstract available) [MEDLINE]
33 Schwickert G, et al; Mapping and quantification of biomolecules in tumor biopsies using bioluminescence. (Experientia, 1996 May, Abstract available) [MEDLINE]
34 Susini T, et al; Preoperative evaluation of tumor ploidy in endometrial carcinoma: An accurate tool to identify patients at risk for extrauterine disease and recurrence. (Cancer, 1999 Sep, Abstract available) [MEDLINE]
35 Rassekh CH, et al; Accuracy of intraoperative staging of the NO neck in squamous cell carcinoma. (Laryngoscope, 1995 Dec, Abstract available) [MEDLINE]
36 Vansteenkiste J, et al; Transcarinal needle aspiration biopsy in the staging of lung cancer. (Eur Respir J, 1994 Feb, Abstract available) [MEDLINE]
37 Kaspar HG, et al; Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix. (Obstet Gynecol, 1993 Feb, Abstract available) [MEDLINE]
38 de Visscher JG, et al; Relationship of tumor thickness in punch biopsy and subsequent surgical specimens in stage I squamous cell carcinoma of the lower lip. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1999 Aug, Abstract available) [MEDLINE]
39 Dommann SN, et al; Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas. (Am J Dermatopathol, 1997 Aug, Abstract available) [MEDLINE]
40 Utz JP, et al; The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma. (Chest, 1993 Oct, Abstract available) [MEDLINE]

Menu Position #40

41 Fortner JG; Inadvertent spread of cancer at surgery. (J Surg Oncol, 1993 Jul, Abstract available) [MEDLINE]
42 Zoubek A, et al; Mobilization of tumour cells during biopsy in an infant with Ewing sarcoma. (Eur J Pediatr, 1996 May, Abstract available) [MEDLINE]
43 Fend F, et al; Occult papillary carcinoma of the thyroid with pulmonary lymphangitic spread diagnosed by lung biopsy. (Klin Wochenschr, 1989 Jul, Abstract available) [MEDLINE]
44 Peters JH, et al; Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography. (Arch Surg, 1994 May, Abstract available) [MEDLINE]
45 Malata CM, et al; Metastatic tumours of the parotid gland. (Br J Oral Maxillofac Surg, 1998 Jun, Abstract available) [MEDLINE]
46 Scappini P, et al; Penile cancer. Aspiration biopsy cytology for staging. (Cancer, 1986 Oct, Abstract available) [MEDLINE]
47 Collins HS, et al; Widespread lymph node metastases in a patient with microinvasive cervical carcinoma. (Gynecol Oncol, 1989 Aug, Abstract available) [MEDLINE]
48 Kassis ES, et al; Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques. (JSLS, 1998 Oct, Abstract available) [MEDLINE]
49 Criel A, et al; Small B cell NHL and their leukemic counterpart: differences in subtyping and assessment of leukemic spread. (Leukemia, 1996 May, Abstract available) [MEDLINE]
50 Renshaw AA, et al; Subtypes of renal cell carcinoma. Different onset and sites of metastatic disease. (Am J Clin Pathol, 1999 Apr, Abstract available) [MEDLINE]

Menu Position #50

51 Piscioli F, et al; Aspiration cytology in the staging of urologic cancer. (Cancer, 1985 Sep, Abstract available) [MEDLINE]
52 Krasna MJ; Role of thoracoscopic lymph node staging for lung and esophageal cancer. (Oncology (Huntingt), 1996 Jun, Abstract available) [MEDLINE]
53 Krasna MJ; Minimally invasive staging for esophageal cancer. (Chest, 1997 Oct, Abstract available) [MEDLINE]
54 Dean PJ, et al; Malignant epithelioid hemangioendothelioma of the liver in young women. Relationship to oral contraceptive use. (Am J Surg Pathol, 1985 Oct, Abstract available) [MEDLINE]
55 Cottingham T, et al; Sentinel node dissection in the treatment of melanoma. Report of three cases and review of the literature. (Dermatol Surg, 1997 Feb, Abstract available) [MEDLINE]
56 Karnofsky DA; Determining the extent of the cancer and clinical planning for cure. (Cancer, 1968 Oct, Abstract available) [MEDLINE]
57 Ekfors TO, et al; An analysis of 38 malignant fibrous histiocytomas in the extremities. (Acta Pathol Microbiol Scand [A], 1978 Jan, Abstract available) [MEDLINE]
58 Alsabti EA; Serum immunoglobulins in breast cancer. (J Surg Oncol, 1979, Abstract available) [MEDLINE]
59 Chan RC, et al; Parameningeal rhabdomyosarcoma. (Radiology, 1979 Apr, Abstract available) [MEDLINE]
60 Hodge SJ, et al; Zosteriform inflammatory metastatic carcinoma. (Int J Dermatol, 1979 Mar, Abstract available) [MEDLINE]

Menu Position #60

61 Bunn PA Jr, et al; Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination. (Ann Intern Med, 1980 Aug, Abstract available) [MEDLINE]
62 Brenner J, et al; Malignant mesothelioma of the pleura: review of 123 patients. (Cancer, 1982 Jun, Abstract available) [MEDLINE]
63 Horenblas S, et al; Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. (J Urol, 1993 Mar, Abstract available) [MEDLINE]
64 Beahrs OH; Staging of cancer of the breast as a guide to therapy. (Cancer, 1984 Feb, Abstract available) [MEDLINE]
65 Rubsamen PE, et al; Merkel cell carcinoma of the eyelid and periocular tissues. (Am J Ophthalmol, 1992 Jun, Abstract available) [MEDLINE]
66 Zaunbauer W, et al; Computed tomography in carcinoma of the rectum. (Gastrointest Radiol, 1981 Jan, Abstract available) [MEDLINE]
67 Russell WG, et al; Sebaceous carcinoma of meibomian gland origin. The diagnostic importance of pagetoid spread of neoplastic cells. (Am J Clin Pathol, 1980 Apr, Abstract available) [MEDLINE]
68 Chen SS, et al; Prognostic significance of morphology of tumor and retroperitoneal lymph nodes in epithelial carcinoma of the ovary. I. Correlation with lymph node metastasis. (Gynecol Oncol, 1984 May, Abstract available) [MEDLINE]
69 Valente M, et al; Post-thoracotomy diagnostic and staging conversion rates of clinically staged I lung cancer. (Tumori, 1981 May, Abstract available) [MEDLINE]
70 Hashizume T, et al; Preoperative prediction of nodal state in gastric cancer by nuclear DNA content. (Eur J Surg, 1991 Apr, Abstract available) [MEDLINE]

Menu Position #70

71 Kopelson G, et al; Infratentorial glioblastoma: the role of neuraxis irradiation. (Int J Radiat Oncol Biol Phys, 1982 Jun, Abstract available) [MEDLINE]
72 Papachristou DN, et al; Adenocarcinoma of the gastric cardia. The choice of gastrectomy. (Ann Surg, 1980 Jul, Abstract available) [MEDLINE]
73 Muss HB, et al; Bone marrow evaluation in small cell lung cancer. (Am J Clin Oncol, 1984 Feb, Abstract available) [MEDLINE]
74 Collier BD, et al; Current imaging strategies for colorectal cancer. (J Nucl Med, 1993 Mar, Abstract available) [MEDLINE]
75 Daly BD, et al; Thoracic metastases from carcinoma of the nasopharynx: high frequency of hilar and mediastinal lymphadenopathy. (AJR Am J Roentgenol, 1993 Feb, Abstract available) [MEDLINE]
76 Yamamura K, et al; Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis [see comments] (Semin Cancer Biol, 1993 Aug, Abstract available) [MEDLINE]
77 Krasna MJ, et al; Thoracoscopic lymph node staging for esophageal cancer. (Ann Thorac Surg, 1993 Sep, Abstract available) [MEDLINE]
78 Kanda S, et al; Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity. (Int J Cancer, 1992 Nov, Abstract available) [MEDLINE]
79 Colcher D, et al; Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma [published erratum appears in Cancer Res 1987 Nov 15;47(22):6161] (Cancer Res, 1987 Aug, Abstract available) [MEDLINE]
80 Eilber FR, et al; Progress in the recognition and treatment of soft tissue sarcomas. (Cancer, 1990 Feb, Abstract available) [MEDLINE]

Menu Position #80

81 Horenblas S, et al; Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. (J Urol, 1993 Mar, Abstract available) [MEDLINE]
82 Sian KU, et al; Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma. (Ann Plast Surg, 1999 Jun, Abstract available) [MEDLINE]
83 Chariyalertsak S, et al; Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer. (Tumour Biol, 1994, Abstract available) [MEDLINE]
84 Visonneau S, et al; Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice. (Am J Pathol, 1998 May, Abstract available) [MEDLINE]
85 Rau B, et al; Laparoscopic lymph node assessment in pretherapeutic staging of gastric and esophageal cancer. (Recent Results Cancer Res, 1996, Abstract available) [MEDLINE]
86 Chuang L, et al; Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. (Gynecol Oncol, 1995 Aug, Abstract available) [MEDLINE]
87 Kuban DA, et al; Mortality in prostatic carcinoma. (Urology, 1989 Jan, Abstract available) [MEDLINE]
88 Chen SS; Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus. (Gynecol Oncol, 1989 Feb, Abstract available) [MEDLINE]
89 Böttger T, et al; Preoperative diagnostics in pancreatic carcinoma: would less be better? (Langenbecks Arch Surg, 1998 Aug, Abstract available) [MEDLINE]
90 Kubota K, et al; A case of malignant pleural mesothelioma with metastasis to the orbit. (Jpn J Clin Oncol, 1996 Dec, Abstract available) [MEDLINE]

Menu Position #90

91 Leminen A, et al; Spread of ovarian cancer after laparoscopic surgery: report of eight cases. (Gynecol Oncol, 1999 Dec, Abstract available) [MEDLINE]
92 Herr HW; Routine CT scan in cystectomy patients: does it change management? [published erratum appears in Urology 1996 May;47(5):785] (Urology, 1996 Mar, Abstract available) [MEDLINE]
93 Biesterfeld S, et al; Absence of epidermal growth factor receptor expression in squamous cell carcinoma of the uterine cervix is an indicator of limited tumor disease. (Oncol Rep, 1999 Jan, Abstract available) [MEDLINE]
94 Tsuda H, et al; Prognostic value of p53 protein accumulation in cancer cell nuclei in adenocarcinoma of the uterine cervix. (Jpn J Cancer Res, 1995 Nov, Abstract available) [MEDLINE]
95 Barbu V, et al; Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study. (Hepatology, 1997 Nov, Abstract available) [MEDLINE]
96 Collier BD, et al; Current imaging strategies for colorectal cancer. (J Nucl Med, 1993 Mar, Abstract available) [MEDLINE]
97 Daly BD, et al; Thoracic metastases from carcinoma of the nasopharynx: high frequency of hilar and mediastinal lymphadenopathy. (AJR Am J Roentgenol, 1993 Feb, Abstract available) [MEDLINE]
98 Best LA, et al; Surgery in the management of mediastinal carcinoid. (J Cardiovasc Surg (Torino), 1994 Dec, Abstract available) [MEDLINE]
99 Leitha T, et al; Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion. (J Nucl Med, 1998 Jul, Abstract available) [MEDLINE]
100 Sgouros S, et al; Spinal ependymomas--the value of postoperative radiotherapy for residual disease control. (Br J Neurosurg, 1996 Dec, Abstract available) [MEDLINE]

Menu Position #100


Click here for more information!

Clinical | Non-clinical | Boston University | Physician's World | HealthStream | Reuters Medical | Newswire | Doody's Book Review | Software Reviews | Blackwell Science | Munksgaard | Your Health | Your Lifestyle | Your Research | MedGate Member Login


We subscribe to the HONcode principles
of the Health On the Net Foundation

Send comments to support@healthgate.com
Copyright © 2000 HealthGate® Data Corp.

-------------- -------------- -------------- -------------- --------------

Return To Top

Continuing Medical Education


NLM database Documents


Record 1 from database: MEDLINE
Return To Top

Title
Implantation metastasis after percutaneous transthoracic needle aspiration biopsy.
Author
Sinner WN; Zajicek J
Address
 
Source
Acta Radiol [Diagn] (Stockh), 1976 Jul, 17:4, 473-80
Abstract
The risk of tumour spread at aspiration biopsy of pulmonary tumours through the needle track has been analyzed by reviewing the case histories of 1 264 patients with a malignant tumour demonstrated by needle biopsy. Only in one case did metastatic tumour growth develop at the site of the biopsy. The history of this case is presented and the available literature on the subject discussed.
Language of Publication
English
Unique Identifier
77018915

Return To Top


MeSH Heading (Major)
Biopsy, Needle|*AE; Carcinoma, Squamous Cell|*/PA/RA; Lung Neoplasms|*/PA/RA; Neoplasm Seeding|*
MeSH Heading
Aged; Case Report; Follow-Up Studies; Human; Lung|PA; Male; Neoplasm Metastasis

Publication Type
JOURNAL ARTICLE
ISSN
0567-8056
Country of Publication
SWEDEN

Record 2 from database: MEDLINE
Return To Top

Title
Aspiration cytology for diagnosis of head and neck masses.
Author
Meyers DS; Templer J; Davis WE; Balch JA
Address
 
Source
Otolaryngology, 1978 Jul, 86:4 Pt 1, ORL-650-5
Abstract
Most American clinicans have been relectant to utilize aspiration biopsy due to poor interpretive skills by the pathologists in the past and a fear of tumor spread by the needle. Voluminous European series and recent American series have proved aspiration to be safe and reliable. In our series of 78 cases, both thin-needle aspiration and conventional tissue biopsies were made. The diagnoses were compared and the overall agreement rate was 90%.
Language of Publication
English
Unique Identifier
79245956

Return To Top


MeSH Heading (Major)
Biopsy|*MT; Biopsy, Needle|*MT; Head and Neck Neoplasms|*PA
MeSH Heading
Carcinoma, Squamous Cell|PA; Comparative Study; Diagnostic Errors; Human; Neoplasm Metastasis

Publication Type
JOURNAL ARTICLE
ISSN
0161-6439
Country of Publication
UNITED STATES

Record 3 from database: MEDLINE
Return To Top

Title
Diagnosis of lymphangitic carcinomatosis by transbronchial lung biopsy.
Author
Torrington KG; Hooper RG
Address
 
Source
South Med J, 1978 Dec, 71:12, 1487-8
Abstract
The records of patients who had transbronchial lung biopsy at Walter Reed Army Medical Center between January 1974 and September 1977 were retrospectively reviewed. Nine patients were found whose clinical and radiographic presentations were compatible with lymphangitic carcinomatosis. In five patients in lymphangitic spread of carcinoma was diagnosed from transbronchial lung biopsy specimens. A single patient had a false-negative biopsy, proven at autopsy three weeks later. The other three patients with negative biopsies are alive and receiving chemotherapy 12 months later (two patients) or are lost to follow-up (one patient). Transbronchial lung biopsy is an accurate procedure for diagnosing lymphangitic carcinomatosis. In addition, aggressive chemotherapy should not be used in these patients without a tissue diagnosis.
Language of Publication
English
Unique Identifier
79076778

Return To Top


MeSH Heading (Major)
Carcinoma|*PA; Lung|*PA; Lung Neoplasms|*PA; Lymphangitis|*PA
MeSH Heading
Biopsy|MT; Bronchoscopy; Fiber Optics; Human; Neoplasm Metastasis; Retrospective Studies

Publication Type
JOURNAL ARTICLE
ISSN
0038-4348
Country of Publication
UNITED STATES

Record 4 from database: MEDLINE
Return To Top

Title
Techniques for inhibiting tumor metastases.
Author
Hoover HC Jr; Ketcham AS
Address
 
Source
Cancer, 1975 Jan, 35:1, 5-14
Abstract
Of the four major biological mechanisms of cancer spread, hematogenous dissemination is perhaps the most significant, as it usually heralds a fatal outcome for the patient. Recent experimental approaches have shown ways of altering the metastatic process and even totally inhibiting it in some animal models. It appears that these models may be applicable to certain human cancers. To prevent hematogenous metastasis formation the process must be inhibited at any one of four levels: 1) growth of the primary; 2) invasion of vessel walls; 3) release of viable tumor cells; or 4) entrapment and growth in distant organs. Judicious handling of the primary can decrease metastasis by minimizing the shedding of tumor cells. New experimental agents prevent the release of tumor cells from the primary by normalizing the blood vessels of the tumor. Warfarin, heparin, and fibrinolytic agents inhibit the entrapment of circulating tumor cells, presumably by their effect on coagulative mechanisms. A better understanding of the benefits of combined approaches to cancer using chemotherapy, irradiation, and immunotherapy, alone and as adjuncts to surgery, offers new opportunity to study methods of controlling metastatic disease.
Language of Publication
English
Unique Identifier
75074060

Return To Top


MeSH Heading (Major)
Neoplasm Circulating Cells|*PC; Neoplasm Metastasis|*; Neoplasms|RT/*TH
MeSH Heading
Animal; Antineoplastic Agents|TU; Biopsy; Cell Adhesion; Cell Movement; Detergents|TU; Formaldehyde|AA/TU; Heparin|TU; Human; Immunotherapy; Mice; Mice, Inbred Strains; Neoplasms, Experimental|SU/TH; Pharmaceutic Aids; Piperazines|TU; Polyethylene Glycols|TU; Propane|AA/TU; Rats; Rats, Inbred Strains; Warfarin|TU

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0008-543X
Country of Publication
UNITED STATES

Record 5 from database: MEDLINE
Return To Top

Title
Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey--1974.
Author
Exelby PR; Filler RM; Grosfeld JL
Address
 
Source
J Pediatr Surg, 1975 Jun, 10:3, 329-37
Abstract
A review of 227 cases of hepatoblastoma, hepatic cell carcinoma in children seen in the United States over a 10-yr period is presented. Both tumors were seen most commonly in infancy, but the hepatocellular carcinoma shows a second peak of incidence around puberty. Males predominated in both diseases more so in hepatoblastoma. Presenting symptoms in both diseases were very similar, most commonly an upper abdominal mass or abdominal enlargement associated with anorexia and weight loss. In the preoperative evaluation the presence of alpha-feto protein was one of the most helpful diagnostic tests. Disturbances of liver function were usually mild but were more marked in those children with hepatocellular carcinoma. Preoperative x-rays were abnormal in a large percentage of cases with the hepatic arteriogram and vena cavagram being the most useful diagnostic x-rays for liver tumors. Liver scans were positive for liver tumor in 95% of the children when this test was carried out. The follow-up for these patients ranged from 2 to 10 yr. The size of the primary tumor did not appear to correlate with survival but bilateral location of the tumor, 33% in hepatoblastoma and 45% in hepatocellular carcinoma, made many of these tumors inoperable. Multicentric tumors were also found in a large number of patients, being more common in hepatocellular carcinoma. There was a high rate of local recurrence or local extension after operation in both diseases, and metastatic spread was similar being most common to the lungs and abdomen. A wide variety of surgical procedures were carried out in these patients from biopsy only to extended hepatic lobectomy. When incomplete excision or biopsy only was carried out no patient survived in either group. Among the hepatoblastoma patients, 45 of 78 patients who had complete excision are surviving. In the hepatocellular carcinoma patients where the operability rate was much lower 12 of 33 patients are surviving when tumor was completely excised. Complications were frequent, the most common being excessive blood loss at operation. There were eight operative deaths and 17 postoperative deaths in the combined group. There was no evidence that radiation therapy or chemotherapy controlled disease which could not be completely excised surgically. The only direct evidence of a favorable effect of radiation and chemotherapy were three cases of hepatoblastoma in which the tumor changed from inoperable to operable by a combination of radiation therapy and multiple drug chemotherapy. Both tumors are highly malignant, and 90% of the children who died of hepatoblastoma died within 12 mo of diagnosis. In the hepatocellular carcinoma 80% of the deaths occurred within 1 yr of diagnosis. At this time it seems that operative excision offers the only chance of cure in children with these tumors and cure rates of 60% can be expected with hepatoblastoma and 33% in hepatocellular carcinoma if the tumor can be completely excised.
Language of Publication
English
Unique Identifier
75191344

Return To Top


MeSH Heading (Major)
Carcinoma, Hepatocellular|*/PA/TH; Liver Neoplasms|*/PA/TH
MeSH Heading
alpha-Fetoproteins|AN; Adolescence; Angiography; Biopsy; Child; Child, Preschool; Female; Human; Infant; Infant, Newborn; Liver|PA/RA/SU; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Postoperative Complications; Radionuclide Imaging

Publication Type
JOURNAL ARTICLE
ISSN
0022-3468
Country of Publication
UNITED STATES

Record 6 from database: MEDLINE
Return To Top

Title
Staging laparotomy in the treatment of metastatic melanoma of the lower extremities.
Author
Cohen MH; Schour L; Felix EL; Bernstein AD; Chretien PB; Rosenberg SA; Ketcham AS
Address
 
Source
Ann Surg, 1975 Dec, 182:6, 710-4
Abstract
Twenty-six consecutive patients with melanoma of the lower extremities metastatic to the superficial inguinal lymph nodes were subjected to laparotomy. No patient had preoperative evidence of tumor dissemination past the superficial inguinal nodes. However three patients (12%) had metastases to the liver or para-aortic lymph nodes documented at laparotomy and were not subjected to iliac and obturator lymph node dissection. One of these patients had concomitant local recurrence of melanoma at the ankle. The other two patients had superficial inguinal lymph nodes at least 5 cm in diameter, although two other such patients with similar 5 cm lymph nodes did not have positive intra-abdominal findings. The remaining 23 of the 26 patients underwent ipsilateral iliac and obturator lymph node dissection, which proved positive in 3/23 patients (13%). Of these 23 patients undergoing iliac and obturator node dissection, 18 had clinically positive (and microscopically positive) superficial inguinal nodes prior to their dissection, while the remaining 5 patients had clinically negative (but microscopically positive) superficial inguinal nodes. The three cases of positive dissected iliac and obturator nodes occurred among the 18 patients with clinically positive superficial inguinal nodes (17%). Among the 5 patients with clinically negative, microscopically positive superficial groin nodes, there was no detectable deep inguinal nodal spread (or hepatic or para-aortic involvement).
Language of Publication
English
Unique Identifier
76060602

Return To Top


MeSH Heading (Major)
Leg|*; Lymph Nodes|*PA; Melanoma|*PA/SU
MeSH Heading
Adolescence; Adult; Aged; Biopsy; Case Report; Child; Female; Human; Laparotomy; Liver Neoplasms|PA/SU; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Age; Neoplasm Metastasis

Publication Type
JOURNAL ARTICLE
ISSN
0003-4932
Country of Publication
UNITED STATES

Record 7 from database: MEDLINE
Return To Top

Title
Dissemination of cancer: the need for stimulation of the immune process during the immunosuppression produced by major operations.
Author
Cole WH
Address
 
Source
South Med J, 1982 Dec, 75:12, 1479-86
Abstract
There are four mechanisms of the dissemination of cancer: direct extension by tissue planes, by lymphatics, by the vascular system, and by implantation. Implantation may be either spontaneous or iatrogenic, and the unique cases of spontaneous implantation reported by Beahrs, in which carcinoma of the colon had seeded a fresh hemorrhoidectomy wound, illustrate how hardy cancer cells can be. The factors affecting the spread of cancer appear even more important than the mechanisms themselves. Immunologic factors (including stimulation), immunosuppression, tumor enhancement, tumor inhibition, and contrasting features are important. Stimulation of the immune process is becoming important because so many chemicals or processes are immunosuppressive, and it is now evident that all, or practically all, major operations are immunosuppressive. Accordingly, at the time of operation for cancer the patient should be given something to stimulate his immune system during the three or four weeks it is being suppressed by the operation.
Language of Publication
English
Unique Identifier
83067685

Return To Top


MeSH Heading (Major)
Immune Tolerance|*; Immunization|*; Neoplasm Invasiveness|*/DI; Neoplasm Metastasis|*; Neoplasms|IM/*SU
MeSH Heading
Antineoplastic Agents|AE; Biopsy|AE; Biopsy, Needle|AE; Colonic Neoplasms|SU; Female; Human; Lymphatic Metastasis|PC; Neoplasm Circulating Cells; Neoplasm Seeding

Publication Type
JOURNAL ARTICLE
ISSN
0038-4348
Country of Publication
UNITED STATES

Record 8 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Lung cancer diagnosis: evaluation of diagnostic techniques.
Author
Healy TM; Borrie J
Address
 
Source
N Z Med J, 1975 May, 81:539, 423-4
Abstract
In 200 patients with histologically proven lung cancer, retrospective analysis of the relative diagnostic value of sputum cytology, bronchial washings cytology, bronchial biopsy, scalene node biopsy, mediastinoscopy and thoracotomy was undertaken. Bronchial biopsy proved positive in 80 percent of patients with central tumours (those lying between the origin of a main brochus and the origins of lobar segmental bronchi) against 35 percent of patients with peripheral tumours (those lying distal to the origins of the lobar segmental bronchi). Sputum cytology was positive in 27 percent of patients so investigated and bronchial washings cytology in 14 percent--both techniques being more effective with central tumours. Thoracotomy, as the sole method of obtaining histological confirmation of the clinical diagnosis, accounted for 20.5 percent of all cases, being used more often in patients with peripheral tumours. In 15 percent the first histologically positive result came from distal spread. The relative indications for needle biopsy and endobronchial fibroscopy are discussed.
Language of Publication
English
Unique Identifier
76011247

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Lung Neoplasms|*DI/SU
MeSH Heading
Biopsy; Bronchi|PA; Bronchoscopy; Comparative Study; Cytodiagnosis; Evaluation Studies; Female; Human; Lymph Nodes|PA; Male; Mediastinoscopy; Neoplasm Metastasis; Pleural Effusion|CY; Retrospective Studies; Sputum|CY; Thoracic Surgery; Thorax|SU

Publication Type
JOURNAL ARTICLE
ISSN
0028-8446
Country of Publication
NEW ZEALAND

Record 9 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Chemosurgery for skin cancer: fixed tissue and fresh tissue techniques.
Author
Mohs FE
Address
 
Source
Arch Dermatol, 1976 Feb, 112:2, 211-5
Abstract
Complete microscopical control of the excision of cancer of the skin is achieved by removing tissues layer by layer and examining the undersurface of each layer by means of frozen sections. If the cancer is extensive and complicated or if it is of a type readily spread over an excisional surface, the tissues are fixed in situ with zinc chloride prior to excision (chemosurgery, fixed tissue technique). If the cancer is not too extensive or complicated, the tissues are excised in the fresh, unfixed state (chemosurgery, fresh tissue technique). Both techniques are highly reliable; for example, in two consecutive series of basal cell carcinomas treated chemosurgically, the five-year rate of cure was 99.3% for the 9,351 lesions removed by the fixed tissue technique and 97% for the 127 lesions removed by the fresh tissue technique.
Language of Publication
English
Unique Identifier
76276623

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Carcinoma, Basal Cell|PA/*SU; Ear Neoplasms|*SU; Facial Neoplasms|*SU; Skin Neoplasms|PA/*SU
MeSH Heading
Biopsy; Ear, External|SU; Eyelid Neoplasms|PA/SU; Eyelids|PA; Histocytochemistry; Human; Neoplasm Metastasis; Neoplasm Recurrence, Local|SU; Staining

Publication Type
JOURNAL ARTICLE
ISSN
0003-987X
Country of Publication
UNITED STATES

Record 10 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Scalpel excision of primary cutaneous malignant melanomas without metastasis.
Author
Castrow FF 2d; Chernosky ME
Address
 
Source
J Dermatol Surg Oncol, 1979 Feb, 5:2, 109-11
Abstract
Views and opinions about surgical treatment of primary malignant melanomas that are without local spread or metastasis are presented. An attempt is made to determine the limitations of office-based dermatologists in the treatment of malignant melanomas of this stage. Using accepted criteria for clinical recognition of malignant melanomas early, it is suggested that surgical excisions of small malignant melanomas that are judged to be complete obviate preliminary biopsies and furnish surgical specimens that can be read histopathologically for confirmation of clinical diagnosis and adequacy of excision.
Language of Publication
English
Unique Identifier
79110131

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Melanoma|CL/PA/*SU; Skin Neoplasms|CL/PA/*SU
MeSH Heading
Biopsy; Follow-Up Studies; Human; Neoplasm Metastasis

Publication Type
JOURNAL ARTICLE
Country of Publication
UNITED STATES

Record 11 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Primary liposarcoma of bone.
Author
Larsson SE; Lorentzon R; Boquist L
Address
 
Source
Acta Orthop Scand, 1975 Dec, 46:6, 869-76
Abstract
A case is presented of a rare primary liposarcoma of bone localized to the major trochanter of the left femur of a 52-year-old female. Despite combined treatment with curettage and irradiation with a total dose of 4,500 rad the neoplasm showed rapid invasive growth with destruction of the bone, spread to the iliac fossa and outgrowth through the operation wound. Approximately 5 months after admission the patient succumbed due to widespread metastases in the lungs, liver and left kidney. The histopathology, clinical course and treatment of this rare neoplasm of the bone are discussed.
Language of Publication
English
Unique Identifier
76108497

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Femoral Neoplasms|*/PA/RA; Liposarcoma|*/PA/RA
MeSH Heading
Biopsy; Case Report; Female; Femur|PA; Human; Lung Neoplasms; Middle Age; Neoplasm Metastasis

Publication Type
JOURNAL ARTICLE
ISSN
0001-6470
Country of Publication
DENMARK

Record 12 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Well-differentiated peripheral cholangiocarcinoma with an unusual clinical course.
Author
Foucar E; Kaplan LR; Gold JH; Kiang DT; Sibley RK; Bosl G
Address
 
Source
Gastroenterology, 1979 Aug, 77:2, 347-53
Abstract
A patient with an unresectable well-differentiated bile duct tumor who survived for 15 yr after biopsy diagnosis is presented. Histologic examination of the tumor revealed bland features of bile duct adenoma despite extensive spread within the liver. Over its subsequent course, the tumor progressively replaced the liver, achieving huge size, although there was no evidence of metastases until shortly before the patient's death. This clinical course was very unusual for either bile duct adenoma or cholangiocarcinoma, but would be more characteristic of another tumor of intrahepatic bile duct origin, the biliary cystadenoma. However, this latter diagnosis was excluded with both gross and microscopic pathologic criteria. Evidence is presented to support classification of this tumor as an unusual varient of peripheral cholangiocarcinoma which requires correlation of the clinical and pathologic findings for correst diagnosis.
Language of Publication
English
Unique Identifier
79192471

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Adenoma, Bile Duct|*DI/PA/UL; Bile Duct Neoplasms|*DI/PA/UL
MeSH Heading
Adult; Anemia|ET; Basement Membrane|UL; Biopsy; Case Report; Desmosomes|UL; Epithelium|UL; Female; Gallbladder|PA; Human; Laparoscopy; Laparotomy; Liver|PA; Lung Neoplasms; Microvilli|UL; Neoplasm Metastasis; Pain; Palpation; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0016-5085
Country of Publication
UNITED STATES

Record 13 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Gastrointestinal carcinoma: diagnosis, staging, and follow-up.
Author
Nelson RS
Address
 
Source
Geriatrics, 1976 Sep, 31:9, 83-5
Abstract
When cancer of the gastrointestinal tract is suspected, thorough studies should be made to determine the presence, type, and severity of the primary tumor and whether it has spread. Besides routine x-ray studies, angiography, scanning, and sonography may furnish valuable information. Endoscopy, which has revolutionized diagnosis of these tumors, not only makes it possible to obtain a specimen for histologic analysis without laparotomy but also reveals gross involvement as a guide to surgery. Staging of the lesion helps the physician select which patients would benefit from surgery and which instead should be treated with palliative chemotherapy or irradiation, or both. The patient's quality of life during treatment also must be considered. The side effects of multiple-agent chemotherapy, for example, may take too great a toll on the patient's ability to function. Continuous, long-term follow-up is essential. Metastases may develop after three to five years in particularly indolent tumors, and new primary lesions are far from rare.
Language of Publication
English
Unique Identifier
76258593

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Gastrointestinal Neoplasms|*DI/PA/SU
MeSH Heading
Biopsy; Follow-Up Studies; Human; Neoplasm Metastasis; Prognosis

Publication Type
JOURNAL ARTICLE
ISSN
0016-867X
Country of Publication
UNITED STATES

Record 14 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Diagnostic imaging in cancer.
Author
Berman CG; Clark RA
Address
Department of Radiology, University of South Florida, Tampa.
Source
Prim Care, 1992 Dec, 19:4, 677-713
Abstract
Screening chest radiographs do not reduce mortality from lung cancer. Should an incidental noncalcified pulmonary parenchymal nodule be discovered, chest CT will demonstrate one third of such patients to, in fact, have the multiple nodules of metastatic disease. CT is very helpful to guide fine needle aspiration biopsy of lung lesions and to assist in evaluation for resectability. MR can be helpful in special circumstances, including the definition of the extent of paravertebral, superior sulcus, and diaphragmatic lesions. Endorectal ultrasound is not sensitive enough to function as a screening tool for prostate cancer but is used routinely to guide biopsies. CT and MR are rarely helpful in staging this disease. Given the highly characteristic trait of bone metastasis in prostate cancer, a bone scan is mandatory in all patients. Double contrast barium enema can be used as an adjunct or alternative to sigmoidoscopy for colorectal cancer screening, in the preoperative evaluation of patients, and in postoperative surveillance. CT and MR can detect macroscopic adenopathy and liver metastases; CT is generally the preferred study. Screening mammography can have a major impact in reducing breast cancer mortality. It is recommended that a baseline study be obtained at age 35. Annual or biannual examinations should commence at age 40. Any palpable lesion, whether or not it is demonstrated mammographically, must be subjected to biopsy. Ultrasound is the most useful initial imaging study for evaluating pelvic masses. MR will, on occasion, identify the origin of a mass not determinable from ultrasound scan. MR is particularly valuable to identify parametrial spread (inoperability) of cervical cancer, and has been underused for this purpose. Surgery remains the mainstay for the staging of ovarian and endometrial cancer, although CT can be helpful to identify macroscopic relapse, ascites, or liver metastases. Bone scan and liver CT remain the standard procedures for detecting metastases in these respective organ systems. MR can be invaluable in the imaging of epidural metastasis and spinal cord compression in patients with vertebral metastatic disease. Contrast-enhanced MR is more sensitive than contrast-enhanced CT for detecting brain metastases, but the latter remains a useful tool. Chest CT can improve the detection of pulmonary metastases when this is of crucial importance.
Language of Publication
English
Unique Identifier
93101764

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Diagnostic Imaging|*MT; Lung Neoplasms|*DI/PA/TH; Neoplasm Metastasis|*DI/PA
MeSH Heading
Biopsy, Needle|MT; Breast Neoplasms|DI/PA; Colorectal Neoplasms|DI/SU; Human; Male; Neoplasm Staging; Prostatic Neoplasms|DI/EP/MO; Tomography, X-Ray Computed; United States

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, ACADEMIC
ISSN
0095-4543
Country of Publication
UNITED STATES

Record 15 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Extraperitoneal pelvioscopy: a new aid in staging of lower urinary tract tumors. A preliminary report.
Author
Hald T; Rasmussen F
Address
 
Source
J Urol, 1980 Aug, 124:2, 245-8
Abstract
A new technique to obtain biopsy specimens from the pelvic lymph nodes is presented. A mediastinoscope introduced through a small incision in the abdominal wall allows the identification of the pelvic nodes. A series of 12 patients with prostatic or bladder carcinoma is presented and the feasibility of the method is documented. There was no morbidity associated with the endoscopic node biopsy. Suggestions for modification of the instrument are made. The method is now under further scrutiny to establish its place among other available methods to study lymphogenous spread of pelvic malignancies.
Language of Publication
English
Unique Identifier
80251874

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Bladder Neoplasms|*PA; Neoplasm Staging|IS/*MT
MeSH Heading
Aged; Biopsy|IS; Female; Human; Lymph Nodes|PA; Lymphatic Metastasis|PA; Male; Middle Age

Publication Type
JOURNAL ARTICLE
ISSN
0022-5347
Country of Publication
UNITED STATES

Record 16 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Scope and value of bone marrow biopsies in metastatic cancer.
Author
Frisch B; Bartl R; Mahl G; Burkhardt R
Address
 
Source
Invasion Metastasis, 1984, 4 Suppl 1:, 12-30
Abstract
The results of examination of 1,810 bone marrow biopsies of 1,725 patients with known or suspected carcinomas are presented. The frequency of positive biopsies was 72% for unknown primaries, 42% for mammary, 32% for prostatic, 14% for pulmonary and 19% for other cancers; the overall rate of detection of metastases was 35%. The mode of spread, the grade of tumour cell differentiation and the host response to the presence of the metastases were investigated by light and electron microscopic studies and by means of antibody reactions on fresh-frozen sections. The results are presented and their relevance to the fundamental understanding of the metastatic process is outlined. Implications for clinical oncology and patient management are discussed.
Language of Publication
English
Unique Identifier
85181957

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Bone Marrow|*PA; Bone Neoplasms|IM/PA/*SC; Neoplasm Metastasis|*PA
MeSH Heading
Biopsy; Cell Differentiation; Human; Neoplasm Staging; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0251-1789
Country of Publication
SWITZERLAND

Record 17 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
165 renal carcinomas: accuracy of imaging for diagnosis and spread--cost efficiency.
Author
Plainfosse MC; Delecoeullerie G; Vital JL; Paty E; Merran S
Address
 
Source
Eur J Radiol, 1983 May, 3:2, 132-7
Abstract
Based on a study of 165 cases of renal carcinoma, we compare the relative diagnosis efficiency of different methods: intravenous urography (IVU), ultrasound (U.S.), arteriography and computed tomography (C.T.). Our evidence enables us to assert the excellent diagnostic accuracy of ultrasound and the superiority of computed tomography for good staging of renal carcinoma. The cost efficient methods for the evaluation of this tumour are intravenous urography (to show and localize the renal mass), ultrasound (to assert the echogenic structure) and computed tomography (to establish the diagnosis of carcinoma and judge its spread).
Language of Publication
English
Unique Identifier
83261902

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Kidney Neoplasms|*DI/EC/PA
MeSH Heading
Angiography; Biopsy, Needle; Comparative Study; Cost-Benefit Analysis; Diagnostic Errors; Human; Neoplasm Metastasis; Neoplasm Staging; Tomography, X-Ray; Tomography, X-Ray Computed; Ultrasonics|DU; Urography

Publication Type
JOURNAL ARTICLE
ISSN
0720-048X
Country of Publication
GERMANY, WEST

Record 18 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Detection of haematologic and nonhaematologic cancer by bone biopsy.
Author
Burkhardt R; Frisch B; Bartl R; Kettner G; Schlag R; Hill W
Address
 
Source
Cancer Detect Prev, 1981, 4:1-4, 619-27
Abstract
A retrospective study was carried out to test the efficacy of routine bone marrow biopsies for the diagnosis, classification, and prognosis of different forms of neoplastic involvement. Trephine and needle biopsies of the iliac crest of 3,626 patients with haematologic and 838 patients with nonhaematologic neoplasias were embedded without prior decalcification. 43 histologic variables were evaluated in 3-millimicrons sections of each biopsy, stained by five different techniques. The incidence of bone marrow involvement, in decreasing order of frequency, was as follows: plasmacytoma 55% and 95% of 428 cases, malignant lymphoma 37% and 79% of 1.112 cases, metastatic carcinoma 20% and 63% of 838 cases, and Hodgkin disease 3% and 28% of 772 cases each without and with manifest systemic dissemination. In the group of the metastatic carcinomas, there was a striking incidence of bone marrow involvement--82%--due to occult primary tumours. From a comparison of these figures with those reported in the literature, it is concluded that the large variations in positive and negative results are due to 1) differences in the size and the preparation of the specimens, 2) extent of the neoplastic dissemination at the time of the biopsy, and 3) the incidence of bone marrow involvement characteristic for a particular type of neoplasia. In addition, a subclassification of the chronic myeloproliferative disorders is proposed; it is based on histologic criteria whose prognostic relevance was tested and demonstrated by statistical analysis of the survival rates. The high incidence of detection reported in this study in patients without other evidence of systemic spread, or even in patients with occult neoplasias, provides a strong justification for the use of bone marrow biopsy as a primary diagnostic tool as well as a staging procedure, in both haematologic and nonhaematologic cancer.
Language of Publication
English
Unique Identifier
83155514

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Biopsy|*; Bone Marrow|*PA; Neoplasms|*DI
MeSH Heading
Bone Marrow Diseases|DI; Human; Myeloproliferative Disorders|PA; Neoplasm Metastasis; Retrospective Studies; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0361-090X
Country of Publication
UNITED STATES

Record 19 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix.
Author
Kaspar HG; Dinh TV; Doherty MG; Hannigan EV; Kumar D
Address
Department of Pathology, University of Texas Medical Branch, Galveston.
Source
Obstet Gynecol, 1993 Feb, 81:2, 296-300
Abstract
OBJECTIVE: To evaluate the prognostic significance of three-dimensional determination of tumor size in stage I cervical adenocarcinoma. METHODS: Tumor volume was measured using hematoxylin and eosin-stained sections of cone biopsy and hysterectomy specimens from 36 patients with stage I adenocarcinoma of the cervix. The volume was then correlated with pelvic lymphatic spread and clinical outcome. RESULTS: The subjects were followed for a mean (+/- SEM) of 63 +/- 8 months. No recurrence or lymphatic seeding was encountered in the 22 tumors measuring no more than 500 mm3. Two of 25 tumors (8%) having up to 5 mm depth of stromal invasion had lymph node metastasis, one of which was 1.5 mm, compared with four of 11 (36%) in the group with deeper than 5 mm invasion (P < .02). The depth of stromal invasion predicted recurrence less significantly. Among the 25 tumors with up to 5 mm stromal invasion, two recurred, compared with three of 11 with more than 5 mm invasion (P < .1). Two women who had tumor volumes below 500 mm3 and depths of stromal invasion up to 8.5 mm were disease-free at 52 and 96 months of follow-up. On the other hand, tumors with 2.6 and 3.8 mm stromal invasion, but with volumes exceeding 500 mm3, recurred. CONCLUSION: Tumor volume is a better predictor of pelvic lymph node metastasis and recurrence than is the depth of stromal invasion in stage I cervical adenocarcinoma.
Language of Publication
English
Unique Identifier
93141184

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Adenocarcinoma|EP/*PA; Cervix Neoplasms|EP/*PA; Cervix Uteri|*PA
MeSH Heading
Biopsy; Female; Follow-Up Studies; Human; Lymphatic Metastasis; Middle Age; Neoplasm Invasiveness; Neoplasm Recurrence, Local|EP; Neoplasm Staging; Prognosis; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0029-7844
Country of Publication
UNITED STATES

Record 20 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Management of gastrointestinal lymphoma.
Author
Rao AR; Kagan AR; Potyk D; Nussbaum H; Chan P; Hintz BL; Wollin M; Ryoo MC
Address
 
Source
Am J Clin Oncol, 1984 Jun, 7:3, 213-9
Abstract
A study was made of 65 patients with primary gastrointestinal (GI) lymphoma. The occurrence was 40 (62%) in stomach, 15 (23%) in the small intestine, and 10 (15%) in colorectum. The majority of patients had their histology classified according to Rappaport's classification. Diffuse histiocytic type had the worst prognosis (median survival 13.8 months), and nodular histology had the best prognosis. A modified staging system proposed by Blackledge et al. was used. Patients who had their disease confined to one viscus (Stage I) or with spread to regional lymph nodes (Stage II) had an excellent prognosis, with a 5-year survival of 87 and 67%, respectively. However, those who had distant nodal involvement (Stage III, e.g., para-aortic nodes) or spread to adjacent organs within the abdomen (Stage IV) had worse prognosis, with 5-year survival of 40 and 13%, respectively. In Stage I, radiotherapy alone was as effective as surgical resection. None of the 11 patients treated by radiotherapy alone had perforation or bleeding. The 5-year disease-free survival was 51%.
Language of Publication
English
Unique Identifier
84228327

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Gastrointestinal Neoplasms|PA/*TH; Lymphoma|PA/*TH
MeSH Heading
Adolescence; Adult; Age Factors; Aged; Antineoplastic Agents, Combined|TU; Biopsy; Child; Combined Modality Therapy; Female; Follow-Up Studies; Human; Lymphatic Metastasis; Male; Middle Age; Neoplasm Staging; Neoplasms, Multiple Primary; Prognosis; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0277-3732
Country of Publication
UNITED STATES

Record 21 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Significance of supraclavicular lymph node biopsy for staging, therapy and prognosis of testicular tumors.
Author
Adolphs HD; Weissbach L; Distelmaier W
Address
 
Source
Eur Urol, 1980, 6:6, 339-43
Abstract
Supraclavicular lymph node biopsies were performed in 40 patients with germinal testicular tumors. The radiologic visualization of both the thoracic ducts and the supraclavicular lymph nodes was reviewed and no relation to retroperitoneal lymph node involvement was found. In 5 patients with retroperitoneal but without distant metastases, supraclavicular lymph nodes revealed tumor metastases, two of which had been clinically suspected. Depending on the staging system applied, the tumor stage had to be changed in 1 or 3 patients, respectively. For comparison, in 4 patients with distant metastases no metastatic involvement of the supraclavicular nodes was demonstrable. It is concluded that supraclavicular tumor spread is not indicative of distant metastasis and incurability. Therefore, in these cases primary radical surgery should not be considered contraindicated.
Language of Publication
English
Unique Identifier
81114299

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Lymph Nodes|*PA; Testicular Neoplasms|*DI/RA/TH
MeSH Heading
Biopsy; Human; Lymphatic Metastasis; Male; Neoplasm Staging; Prognosis

Publication Type
JOURNAL ARTICLE
ISSN
0302-2838
Country of Publication
SWITZERLAND

Record 22 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma.
Author
Utz JP; Patel AM; Edell ES
Address
Division of Thoracic Diseases and Internal Medicine, Mayo Medical Center, Rochester, Minn. 55905.
Source
Chest, 1993 Oct, 104:4, 1012-6
Abstract
Metastatic spread to subcarinal lymph nodes in patients with bronchogenic carcinoma generally indicates unresectability. Transcarinal needle aspiration of the main carina (TCNA) has been used to obviate the need for more invasive procedures, particularly thoracic surgery. Of 510 transbronchial needle aspirations performed at our institution from 1983 to 1991, 88 (17 percent) were from the main carina in patients with bronchogenic carcinoma. We reviewed these 88 TCNA procedures to assess our experience with TCNA in the staging of lung cancer. The TCNA results were positive in 32 of 88 (36 percent) patients (20 non-small-cell cancers, 12 small-cell lung cancers). Following bronchoscopy, TCNA was the only evidence of unresectability in all 20 patients with non-small-cell lung cancer and was the only mode of diagnosis in 5 of 12 (42 percent) patients with small-cell lung cancer. Thirteen patients with non-small-cell lung cancer and positive TCNA also had positive bronchial secretion cytologic studies. Five of these patients had further subcarinal sampling and in all cases metastatic involvement was confirmed. TCNA was positive in 29 of 67 (43 percent) patients with radiographic evidence of mediastinal adenopathy. Of the remaining 38 patients with radiographic evidence of mediastinal adenopathy and negative TCNA results, 23 patients had further mediastinal sampling with mediastinoscopy or thoracotomy and in all cases mediastinal spread of cancer was established. Nineteen of 58 (33 percent) patients with an endoscopically normal-appearing main carina had a positive TCNA, while 13 of 30 (43 percent) patients with broadening or widening of the main carina had positive TCNA results. There were no complications. We conclude that TCNA is often a safe and useful staging modality in patients with bronchogenic carcinoma.
Language of Publication
English
Unique Identifier
94008088

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Carcinoma, Bronchogenic|EP/*PA/SC; Lung|*PA; Lung Neoplasms|EP/*PA
MeSH Heading
Biopsy, Needle|MT; Human; Lymphatic Metastasis; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies

Publication Type
JOURNAL ARTICLE
ISSN
0012-3692
Country of Publication
UNITED STATES

Record 23 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.
Author
Pilepich MV; Asbell SO; Mulholland GS; Pajak T
Address
 
Source
Prostate, 1984, 5:5, 471-6
Abstract
One hundred thirty-six patients with carcinoma of the prostate entered on phase III RTOG studies (RTOG 75-06 and RTOG 77-06) between 1976 and the end of 1980 underwent staging lymphadenectomy prior to irradiation. The operative reports and histological findings have been reviewed in order to determine the patterns of intrapelvic tumor spread and to correlate the type of surgical procedure and the extent of lymphatic dissection with the incidence and type of postirradiation complications (primarily genital and lower extremity lymphedema). The surgical procedures were classified into three categories according to extent: 1) biopsy only, 2) limited (diagnostic) dissection, and 3) complete (therapeutic) dissection. The incidence of postirradiation lymphedema was found to be strongly dependent upon the extent of dissection. Patients undergoing limited (diagnostic) dissection followed by pelvic irradiation have a 25-30% risk of developing this debilitating complication. In patients undergoing complete (therapeutic) dissection followed by pelvic irradiation lymphedema has been observed in 66% of cases.
Language of Publication
English
Unique Identifier
85014495

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Carcinoma|*PA/RT/SU; Prostatic Neoplasms|*PA/RT/SU
MeSH Heading
Biopsy; Follow-Up Studies; Human; Lymph Node Excision; Lymph Nodes|PA; Lymphatic Metastasis; Lymphedema|EP; Male; Neoplasm Staging; Radiotherapy Dosage; Random Allocation

Publication Type
JOURNAL ARTICLE
ISSN
0270-4137
Country of Publication
UNITED STATES

Record 24 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Inguinal pick in invasive penile carcinoma: can it stage node negative patients?
Author
Ravi R; Shrivastava BR; Mallikarjuna VS
Address
Department of Genitourinary Surgery, Cancer Institute (WIA), Madras, India.
Source
Arch Esp Urol, 1991 Nov, 44:9, 1123-6
Abstract
In node negative patients of invasive penile carcinoma, prophylactic lymphadenectomy is associated with considerable morbidity, while a "wait and watch" policy is associated with up to 20% cancer related mortality in many series. In between, selective node biopsies, including sentinel node biopsies, have been suggested to stage these patients. However, these procedures are unreliable and associated with high false negative rates. The inguinal pick procedure was devised by us to stage these patients more accurately. It is more elaborate that the previously described selective biopsies and includes biopsy of all identifiable nodes in the inguinal region, including the sentinel node area. In our experience of the procedure in 52 patients with invasive penile carcinoma, it was positive in 5 patients (9.6%). However, 7 of the 47 patients with negative result developed inguinal recurrences and 3 other patients developed distant metastases on follow up. The 5-year disease free survival of inguinal pick positive and negative patients was 100% and 82.9%, respectively. The sensitivity of the procedure in detecting regional spread in these patients was only 72%. Thus, the inguinal pick, though associated with no morbidity, can be meaningful only if it is positive and a negative result does not guarantee absence of regional metastases in node negative patients of invasive penile carcinoma.
Language of Publication
English
Unique Identifier
92222329

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Carcinoma|EP/*PA/SC; Lymph Node Excision|*/AE; Lymph Nodes|*PA; Neoplasm Staging|*MT; Penile Neoplasms|EP/*PA/SU
MeSH Heading
Biopsy; Evaluation Studies; False Negative Reactions; Frozen Sections; Human; Incidence; India|EP; Inguinal Canal; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local|EP; Sensitivity and Specificity

Publication Type
JOURNAL ARTICLE
ISSN
0004-0614
Country of Publication
SPAIN

Record 25 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Evaluation of the scalene lymph nodes in primary and recurrent cervical carcinoma.
Author
Burke TW; Heller PB; Hoskins WJ; Weiser EB; Nash JD; Park RC
Address
Department of Obstetrics and Gynecology, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.
Source
Gynecol Oncol, 1987 Nov, 28:3, 312-7
Abstract
Open biopsy of the left scalene lymph nodes has been utilized to identify distant spread of cervical carcinoma in selected groups of patients who do not have other clinical evidence of disseminated disease. Twenty-one patients with primary cervical carcinoma and histologically proven para-aortic lymph node metastases and 10 patients with centrally recurrent tumors underwent scalene lymph node biopsy at Walter Reed Army Medical Center or the Naval Hospital, Bethesda, Maryland, between July 1, 1979 and June 30, 1985. All patients undergoing scalene node biopsy had clinically negative physical examinations. There were no surgical complications. All 31 biopsies were negative for metastatic tumor. Combined with previously reported data from this institution, 3 of 28 patients (11%) with primary cervical carcinoma and involved para-aortic nodes, and 6 of 35 patients (17%) with centrally recurrent disease had subclinical scalene node metastases. Patients with clinically suspicious scalene lymphadenopathy had fine needle aspiration cytology performed to document metastatic disease. The success of this technique has eliminated the need for open biopsy in these patients. Scalene node biopsy provides valuable prognostic information in patients with cervical cancer who have positive para-aortic lymph nodes. It also obviates surgical exploration in some patients felt to have resectable recurrent disease who actually have subclinical distant spread.
Language of Publication
English
Unique Identifier
88056535

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Adenocarcinoma|DI/PA/*SC; Biopsy|*; Carcinoma, Squamous Cell|DI/PA/*SC; Cervix Neoplasms|*/PA; Lymphatic Metastasis|*DI/PA; Neoplasm Recurrence, Local|*
MeSH Heading
Adult; Female; Human; Lymph Nodes|PA; Neoplasm Staging

Publication Type
JOURNAL ARTICLE
ISSN
0090-8258
Country of Publication
UNITED STATES

Record 26 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Radioimmunoguided surgery.
Author
Veroux G; Nicosia AS; Veroux P; Cardillo P; Veroux M; Amodeo C
Address
Institute of Surgical Pathology-University of Catania, Italy.
Source
Hepatogastroenterology, 1999 Nov, 46:30, 3099-108
Abstract
Although clinical staging of neoplastic diseases has long remained the only approach to prognosis and treatment, parameters for stage determination, such as tumor size (T) and lymph-node involvement (N), do not always provide effective indication of optimal treatment. Molecular medicine has also provided useful indications as to an alternative and/or integration to clinical staging. Despite the numerous possibilities afforded by pre-operative staging techniques, failures in defining the real spread of neoplasias into surrounding structures have remained a very important diagnostic problem. The labeling of monoclonal antibodies binding with neoplastic target cells by way of radioactive isotopes introduced the techniques known as immunoscintigraphy and SPECT, which then evolved into radioimmunoguided surgery. Fourty patients suffering from colorectal cancer whose age ranged between 42-82 years were singled out for this study. Before undergoing surgery, they were administered pancoloscopy and macrobiopsies, AP-LL chest x-rays, hepatobiliary ECT, echoendoscopy, abdomen and pelvis CT with nephrostographic phase, and total body bone scintigraphy. They were treated with 125I-B72.3 and 125I-FO23C5 (5% and 95% of patients, respectively). Thyrosuppression was achieved by Lugol solution (15 drops x 3/die) from the 6th day before infusion and until the day of surgical operation. Radioimmunoguided surgery (RIGS) has also been tested on staging and second-look of ovarian tumors. Five years after surgical operation the survival rate of Dukes A patients (15%) was confirmed to amount to 100%, whereas for Dukes B patients (50%) having undergone RIGS-guided exeresis on single unrecognized metastases (2 patients) and on unrecognized n+ (5 patients) the survival rate was found to be 85% after 5 years; 2 patients deceased due to relapse; 1 patient deceased due to e.p.a. Finally, for Dukes C patients; (35%) having undergone RIGS-guided exeresis on unrecognized liver micrometastases (1 patient), on single isolated metastases (2 patients) and in the occurrence of multicentric lymph-node positivity (9 patients), the survival rate after 5 years was found to amount to 64%; 5 patients deceased due to relapse. Out of 19 patients without pre-operative evidence of ovarian tumor as opposed to just 1 patient suspected of pelvic recurrence, after intra-operative surgical radicalization (45%), 1 patient was diagnosed fibrosis (suspicious lesion on CT) and 1 other patient peritoneal MTS (negative CT) by means of RIGS. RIGS has made it possible: to localize primary and/or metastatic lesions; to determine tumor-free margins, loco-regional disease spread; to differentiate suspicious foci on inspection and palpation (biotopic sampling); to detect invisible and impalpable tumor foci (occult sites); to verify radical exeresis; to evaluate lymphatic drainage stations; to enable guided exeresis of liver metastases.
Language of Publication
English
Unique Identifier
20091614

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Colorectal Neoplasms|MO/PA/RI/*SU; Ovarian Neoplasms|MO/PA/RI/*SU; Radioimmunodetection|*; Tomography, Emission-Computed, Single-Photon|*MT
MeSH Heading
Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal|DU; Antigens, Neoplasm|IM; Biopsy; Carcinoembryonic Antigen|IM; Colonoscopy; Comparative Study; Female; Glycoproteins|IM; Human; Iodine Radioisotopes|DU; Italy|EP; Lymphatic Metastasis|PA/RI; Male; Middle Age; Monitoring, Intraoperative; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Survival Rate; Tumor Markers, Biological

Publication Type
JOURNAL ARTICLE
ISSN
0172-6390
Country of Publication
GREECE

Record 27 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Passive movement of radioactive microspheres from bone and soft tissue in an extremity.
Author
Robertson WW Jr; Janssen HF; Walker RN
Address
 
Source
J Orthop Res, 1985, 3:4, 405-11
Abstract
Bone biopsy is the definitive method for bone tumor diagnosis. Unfortunately, the procedure is not without risk and may substantially increase the rate and extent of tumor cell metastasis. This study used radioactive microspheres (15 micron diameter) to explore the spread of cell-sized particles from the distal femur into the lymphatic system, venous drainage, and local tissue following a simulated biopsy in the canine model procedure. In the initial group of test animals the microspheres rapidly moved from the femur through the venous system to the lungs. There was no movement from the femur into the lymphatic system within 4 days. The lungs effectively filtered the 15 micron microspheres, thus preventing arterial dissemination. Additional groups were used to explore the movement of the cell-sized particles from the soft tissue surrounding the bone. At the end of the 4 day experimental period, microspheres were found in the iliac lymph nodes in two of nine animals. Microspheres were not detected in the lungs of any of these nine animals. These results suggest that tumor cell-sized particles can move rapidly from the bone venous system to the lungs following a bone biopsy. It appears that the lymphatic system does not contribute to this rapid dissemination. However, the role of lymphatics in a more chronic process remains unclear.
Language of Publication
English
Unique Identifier
86062025

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Biopsy|*AE; Bone and Bones|*PA; Neoplasm Metastasis|*ET
MeSH Heading
Animal; Contrast Media; Dogs; Injections; Lung; Lymph Nodes; Microspheres; Statistics; Thoracic Duct

Publication Type
JOURNAL ARTICLE
ISSN
0736-0266
Country of Publication
UNITED STATES

Record 28 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Pretherapeutic laparoscopic staging in advanced gastric carcinoma [see comments]
Author
Feussner H; Omote K; Fink U; Walker SJ; Siewert JR
Address
Dept. of Surgery and Surgical Oncology, Klinikum rechts der Isar, Technical University of Munich, Germany. feussner@nt1.chir.med.tu-muenchen.de
Source
Endoscopy, 1999 Jun, 31:5, 342-7
Abstract
BACKGROUND AND STUDY AIMS: Direct visualization of the abdominal cavity by laparoscopy prior to multimodal treatment may be capable of improving the diagnostic precision of gastric cancer staging. The aim of this study was to evaluate whether diagnostic laparoscopy can influence treatment strategies in gastric cancer staged T3 and T4 by preoperative diagnostic tests. PATIENTS AND METHODS: Extended diagnostic laparoscopy (EDL) was carried out in 111 patients with advanced gastric cancer staged T3 or T4 by computed tomography (CT) and endoluminal ultrasound (EUS). On Lauren's classification of gastric cancer, 46% of the lesions were of the intestinal type and 54% of the nonintestinal type. EDL was carried out with the patients under general anesthesia, and included visual inspection of the abdomen, with surgical exploration of initially inaccessible regions, laparoscopic ultrasound examination, peritoneal lavage, and biopsies. The information provided by laparoscopy was classified as 1) no additional information, 2) important additional findings independent of the tumor stage, 3) downgrading of the tumor to a more favorable stage, and 4) upgrading of the tumor to a less favorable stage. The results of EDL were then compared with those obtained by sonography, CT and EUS in combination. RESULTS: EDL was performed successfully in 107 patients. In 56 of the 111 patients (50.5%), no additional findings were obtained. In 5.4% of cases, additional unforeseen information was found, not connected with the tumor but altering the management. EDL altered the preoperative diagnosis in 51 of the 111 patients (46.0%), leading to changes in management in 45 of them (40.5%). EUS provided additional information in eight cases (7.2% of the whole group, or 15.7% of those in whom the diagnosis had to be changed). Four metastases were detected using EDL. It was possible to rule out peritoneal spread in four patients, but it was newly detected in 26. CONCLUSIONS: Additional information by EDL about the tumor stage in gastric cancer led to a modification of the therapeutic strategy in 40% of patients, in spite of earlier comprehensive diagnostic work-up using modern imaging procedures. EDL should therefore be mandatory if neoadjuvant treatment is planned, in order to avoid either undertreatment or overtreatment of this type of tumor.
Language of Publication
English
Unique Identifier
99360423

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Laparoscopy|*MT; Neoplasm Staging|*MT; Peritoneal Cavity|*PA/RA/US; Preoperative Care|*MT; Stomach Neoplasms|*PA/RA/SU/US
MeSH Heading
Adult; Aged; Aged, 80 and over; Biopsy; Comparative Study; Diagnosis, Differential; Endosonography|MT; Female; Gastrectomy; Human; Male; Middle Age; Neoplasm Metastasis|PA/RA/US; Reproducibility of Results; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
0013-726X
Country of Publication
GERMANY

Record 29 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Occult tonsillar carcinoma in the unknown primary.
Author
McQuone SJ; Eisele DW; Lee DJ; Westra WH; Koch WM
Address
Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
Source
Laryngoscope, 1998 Nov, 108:11 Pt 1, 1605-10
Abstract
OBJECTIVES: Evaluate effectiveness of routine tonsillectomy in the assessment of patients with squamous cell carcinoma of the neck of unknown primary, and evaluate outcomes of this group compared with patients without a primary identified initially. STUDY DESIGN: A retrospective review of the medical records of 37 patients presenting with an unknown primary tumor over a 10-year period. METHODS: Charts were reviewed for age and sex of patients, methods of evaluation and diagnosis, sites of tissues obtained on biopsy, N stage of disease, and presence of extracapsular spread. Recurrence and survival data were collected over a mean follow-up period of 34 months. RESULTS: All primary lesions discovered through pathologic evaluation arose from the tonsil (9/9), and all were detected in patients undergoing tonsillectomy in conjunction with direct laryngoscopy. None of the patients (0/9) with occult tonsillar carcinoma have had recurrence, in contrast to 60% (15/25) of remaining patients. Patients with tonsillar primary lesions demonstrated less extracapsular spread of disease (25%) than patients without tonsillar primaries (67%), despite similar N staging within the two groups. CONCLUSIONS: Occult tonsillar carcinoma accounts for the unknown primary more frequently than was previously recognized. Bilateral tonsillectomy is recommended to increase the detection yield and to capture the rare case of bilateral disease. A lower incidence of extracapsular spread and reduced recurrence rates in patients with unknown primary tumors presenting as occult tonsillar carcinoma may contribute to the improved prognosis observed in this group.
Language of Publication
English
Unique Identifier
99034122

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Carcinoma, Squamous Cell|PA/*SC/SU; Neoplasms, Unknown Primary|PA/*SU; Tonsillar Neoplasms|PA/*SC/SU; Tonsillectomy|*
MeSH Heading
Adult; Aged; Biopsy; Comparative Study; Evaluation Studies; Female; Follow-Up Studies; Head and Neck Neoplasms|PA/SC/SU; Human; Incidence; Lymphatic Metastasis|PA; Male; Middle Age; Neoplasm Recurrence, Local|PA; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome

Publication Type
JOURNAL ARTICLE
ISSN
0023-852X
Country of Publication
UNITED STATES

Record 30 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
The value of parasternal mediastinoscopy in staging bronchial carcinoma.
Author
Barendregt WB; Deleu HW; Joosten HJ; Berg W; Janssen JP
Address
Department of General Surgery, Canisius Wilhelmina Hospital, Nijmegen, Netherlands.
Source
Eur J Cardiothorac Surg, 1995, 9:11, 655-8
Abstract
Computed tomography (CT) is the non-invasive staging procedure of choice for assessment of metastasis to mediastinal lymph nodes in patients with bronchial carcinoma. Cervical mediastinoscopy can provide histologic evidence of mediastinal spread to the peritracheal, tracheobronchial and subcarinal lymph nodes. Sub-aortic and para-aortic nodes cannot be sampled via this route. The present study was performed to assess the staging value of the parasternal mediastinoscopy as a separate entity. Cervical and parasternal mediastinoscopy was performed in 37 patients with a proven diagnosis of non-small cell carcinoma of the left upper lobe. In 16 patients lymph node or tumor tissue could be biopsied via the parasternal route, in 21 patients no parasternal biopsy was taken. Of the 16 cases with biopsies, only one was positive (6%). Histologic examination of lymph node biopsy tissue was false negative in one other patient (6%). Of the 21 patients without biopsies taken during parasternal mediastinoscopy, three (14%) had proven lymphogenic spread to the subaortic and para-aortic nodes, detected at thoracotomy. The parasternal procedure changed treatment in only one patient (3%). Diagnostic sensitivity was 20%. It is concluded that parasternal mediastinoscopy should not be used as a routine staging procedure in patients with left upper lobe lung cancer.
Language of Publication
English
Unique Identifier
96307619

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Carcinoma, Bronchogenic|*PA/RA/SC; Lung Neoplasms|*PA/RA; Mediastinoscopy|*MT
MeSH Heading
Adenocarcinoma|PA; Biopsy; Carcinoma, Non-Small-Cell Lung|PA; Carcinoma, Squamous Cell|PA; Female; Human; Lymphatic Metastasis|PA; Male; Middle Age; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Thoracotomy; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
1010-7940
Country of Publication
NETHERLANDS

Record 31 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Correlation of high lactate levels in human cervical cancer with incidence of metastasis.
Author
Schwickert G; Walenta S; Sundf‡r K; Rofstad EK; Mueller Klieser W
Address
Institute of Physiology & Pathophysiology, University of Mainz, Germany.
Source
Cancer Res, 1995 Nov, 55:21, 4757-9
Abstract
Tissue concentrations of ATP, glucose, and lactate in cervical cancer biopsies that were taken before a conventional radiation treatment were imaged quantitatively with a bioluminescence technique. Concomitantly, a number of clinically relevant data, such as local tumor control, patient survival, metastatic spread, etc., were documented. There was no correlation between staging or grading and any of the metabolic parameters measured. Local correlations between ATP, glucose, and lactate on a pixel-to-pixel basis were generally positive, with respective Spearman's correlation coefficients being lower in patients without clinically documented metastasis compared to those with metastatic spread. Lactate concentrations were significantly higher and scattered over a wider range in tumors with metastatic spread in comparison to malignancies in patients without metastasis. Thus, high local lactate levels of > or = 20 mumole/g appear to be associated with a high risk of metastasis, at least in the ten human cervical tumors investigated to date.
Language of Publication
English
Unique Identifier
96046566

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Cervix Neoplasms|*CH/PA/*SC; Lactates|*ME
MeSH Heading
Adenosine Triphosphate|ME; Biopsy; Comparative Study; Female; Glucose|ME; Human; Luminescence; Necrosis|ME; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0008-5472
Country of Publication
UNITED STATES

Record 32 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Evaluation of T1N0M0 lung cancer with CT.
Author
Parker LA; Mauro MA; Delany DJ; King CW
Address
Department of Radiology, University of North Carolina School of Medicine, North Carolina Memorial Hospital, Chapel Hill.
Source
J Comput Assist Tomogr, 1991 Nov, 15:6, 943-7
Abstract
Medical records and radiologic studies of 238 patients with non-small cell lung cancer who had preoperative evaluation by chest radiography and CT were reviewed. Thirty-six patients were staged as T1N0M0 by chest radiograph. Of this group, 18 (50%) had abnormalities on CT requiring additional evaluation. Confirmation of abnormalities was by tissue sampling or clinical follow-up. Evidence for unresectable spread of disease was obtained in 12 (33%). We conclude that routine preoperative staging of T1N0M0 lung cancer with CT has a positive impact on patient management.
Language of Publication
English
Unique Identifier
92042951

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Carcinoma, Non-Small-Cell Lung|PA/*RA; Lung Neoplasms|PA/*RA; Tomography, X-Ray Computed|*
MeSH Heading
Adenocarcinoma|PA/RA; Adenocarcinoma, Bronchiolo-Alveolar|PA/RA; Adrenal Gland Neoplasms|SC; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell|PA/RA; Female; Human; Liver Neoplasms|SC; Lymphatic Metastasis; Male; Middle Age; Neoplasm Staging; Preoperative Care

Publication Type
JOURNAL ARTICLE
ISSN
0363-8715
Country of Publication
UNITED STATES

Record 33 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Mapping and quantification of biomolecules in tumor biopsies using bioluminescence.
Author
Schwickert G; Walenta S; Mueller Klieser W
Address
Institute of Physiology & Pathophysiology, University of Mainz, Germany.
Source
Experientia, 1996 May, 52:5, 460-3
Abstract
Quantitative bioluminescence and single-photon imaging have been applied for mapping concentration distributions of metabolites, such as adenosine triphosphate (ATP), glucose and lactate, in biopsies of cervical cancers in patients. Biopsies were taken before a conventional radiation treatment, and a number of clinically relevant data, such as local tumor control, patient survival, metastatic spread and so forth, were documented. There was no correlation between staging or grading and any of the metabolic parameters measured. Local correlations between ATP, glucose and lactate on a pixel-to-pixel basis were generally positive, with respective Spearman's correlation coefficients less in patients without clinically documented metastasis compared with those with metastatic spread. Lactate concentrations were significantly higher and scattered over a wider range in tumors with metastatic spread in comparison to malignancies in patients without metastasis. Thus, high local lactate levels of > or = 20 mumole/g appear to be associated with a high risk of metastasis, at least in human cervical tumors.
Language of Publication
English
Unique Identifier
96236447

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Energy Metabolism|*; Neoplasms|*ME/MO/PA
MeSH Heading
Adenosine Triphosphate|ME; Biopsy; Cervix Neoplasms|ME/PA; Female; Glucose|ME; Human; Lactates|ME; Luminescence; Necrosis; Neoplasm Metastasis; Neoplasm Staging; Statistics, Nonparametric; Support, Non-U.S. Gov't; Survival Rate

Publication Type
JOURNAL ARTICLE
ISSN
0014-4754
Country of Publication
SWITZERLAND

Record 34 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Preoperative evaluation of tumor ploidy in endometrial carcinoma: An accurate tool to identify patients at risk for extrauterine disease and recurrence.
Author
Susini T; Rapi S; Massi D; Savino L; Amunni G; Taddei GL; Massi G
Address
Obstetrics and Gynecology Department, University of Florence, Florence, Italy.
Source
Cancer, 1999 Sep, 86:6, 1005-12
Abstract
BACKGROUND: Tumor ploidy is a strong prognostic factor in patients with endometrial carcinoma, but generally is evaluated only after surgery. The availability of a simple and reliable method to determine tumor ploidy before any treatment is initiated could be helpful in the selection of patients at high risk for advanced primary disease and subsequent recurrence, with several possible benefits. The objectives of the current study were: 1) to test the accuracy of flow cytometric determination of tumor ploidy from preoperative outpatient endometrial biopsies compared with standard postoperative evaluation from the surgical specimen and 2) to correlate this preoperative parameter with the local recurrence and extrauterine tumor spread. METHODS: Tumor ploidy from both preoperative biopsy material and the macroscopic surgical specimens was evaluated prospectively in 50 consecutive patients with endometrial carcinoma. DNA analyses were performed in a blind fashion. Patients were followed for a median of 26 months (range, 16-46 months). RESULTS: In 9 of 50 cases (18%) an aneuploid tumor was found by the standard postoperative analysis. All 9 aneuploid tumors (100%) also were identified correctly by the preoperative test on biopsy material. Occult extrauterine tumor spread was found in 10 patients (20%). The incidence rate of aneuploidy among these tumors was 50% compared with 10% in surgical International Federation of Gynecology and Obstetrics Stage I tumors (P = 0.01). The recurrence rate was 55.5% (5 of 9 tumors) in the aneuploid group and 2.4% (1 of 41 tumors) in the diploid group (P < 0.001). The disease free survival rates of patients with diploid and aneuploid tumors were 97.5% and 44.4%, respectively (P < 0.0001). CONCLUSIONS: Preoperative tumor ploidy determination based on outpatient endometrial biopsy is as accurate as the standard postoperative evaluation in patients with endometrial carcinoma. Tumor aneuploidy confirms the usefulness of this method in selecting patients at risk for occult extrauterine tumor diffusion and recurrence. Copyright 1999 American Cancer Society.
Language of Publication
English
Unique Identifier
99423596

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Carcinoma|GE/*PA/SU; Endometrial Neoplasms|GE/*PA/SU; Ploidies|*
MeSH Heading
Adult; Aged; Aneuploidy; Biopsy; Comparative Study; Disease-Free Survival; Female; Flow Cytometry; Human; Middle Age; Neoplasm Metastasis; Neoplasm Recurrence, Local|GE; Preoperative Care; Prognosis; Risk Factors

Publication Type
JOURNAL ARTICLE
ISSN
0008-543X
Country of Publication
UNITED STATES

Record 35 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Accuracy of intraoperative staging of the NO neck in squamous cell carcinoma.
Author
Rassekh CH; Johnson JT; Myers EN
Address
Department of Otolaryngology, University of Texas Medical Branch Hospitals, Galveston 77555-0521, USA.
Source
Laryngoscope, 1995 Dec, 105:12 Pt 1, 1334-6
Abstract
Management of the neck in squamous cell carcinoma of the upper aerodigestive tract continues to be a topic of great debate. One major problem is that incorrect clinical staging is expected in approximately 20% of necks. This is true of both clinical stage NO and N+ necks, even when imaging studies are used. This prospective study of 108 necks in 79 patients examined the role of intraoperative palpation and inspection in improving the surgeon's ability to predict nodal stage. Of 62 patients with NO necks clinically on both sides, 26 were staged N+ by intraoperative node examination. Nineteen of the 26 were histologically negative (73% false-positive). Of the 36 patients staged intraoperatively as NO, 10 were histologically positive (28% false-negative). Of 108 necks judged clinically to be NO, 25 (23%) had occult metastases and 11 (10%) had extracapsular spread. Forty-one of 108 clinical NO necks were believed to have positive nodes at the time of neck dissection. Of these 41 necks, 30 (73%) were found to be histologically NO (false-positive). Of the 67 clinical NO necks that were also believed to be NO intraoperatively, occult metastases were found in 14 (21% false-negative). Therefore, intraoperative staging did not significantly improve the false-negative rate. Frozen-section biopsy obtained in the operating room was reliable in 24 (92.3%) of 26 patients. Although frozen-section biopsy was not performed in all patients, these data suggest that upstaging the neck without frozen-section biopsy is much less reliable. This study supports the use of frozen-section biopsy before converting the selective dissection to a radical or modified neck dissection in most instances.
Language of Publication
English
Unique Identifier
96101796

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Carcinoma, Squamous Cell|*PA/SC/*SU; Head and Neck Neoplasms|*PA/*SU; Intraoperative Care|*; Lymph Node Excision|*; Lymph Nodes|*PA
MeSH Heading
Biopsy; Decision Making; False Negative Reactions; False Positive Reactions; Forecasting; Frozen Sections; Human; Lymphatic Metastasis|PA; Neck; Neoplasm Staging; Palpation; Prospective Studies; Radical Neck Dissection; Reproducibility of Results; Sensitivity and Specificity

Publication Type
JOURNAL ARTICLE
ISSN
0023-852X
Country of Publication
UNITED STATES

Record 36 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Transcarinal needle aspiration biopsy in the staging of lung cancer.
Author
Vansteenkiste J; Lacquet LM; Demedts M; Deneffe G; Verbeken E
Address
Dept of Pneumology, University Hospitals, Catholic University, Leuven, Belgium.
Source
Eur Respir J, 1994 Feb, 7:2, 265-8
Abstract
Lung cancer without distant metastasis often requires an invasive surgical procedure to document inoperability. In order to determine how often puncture biopsy was a valid substitute for a surgical procedure, we investigated the performance of endoscopic staging by means of transcarinal needle aspiration biopsy during rigid bronchoscopy. Eighty lung cancer patients with subcarinal lymph nodes visible on computed tomography (CT) scan were studied. Specimens were of histological quality (i.e. lymph node tissue) in 59 out of 80 (74%) patients, and showed malignant invasion of this lymph node tissue in 43 cases. Specimens of cytological quality (i.e. lymph node cells) were obtained in 13 out of 80 (16%) patients, and showed malignancy in 7 cases. Therefore, adequate evaluation of the subcarinal lymph nodes was possible in 72 out of 80 (90%) patients. In 50 of these 72, malignant mediastinal spread was proven, and further invasive surgical staging could be avoided. Subgroup analysis showed that this outcome tended to be more likely in patients with abnormal endoscopic appearance of the main carina, with locally extensive tumours, and with nonsquamous histology. These results indicate that transbronchial needle aspiration biopsy of subcarinal lymph nodes can be a valuable alternative to more invasive surgical staging in patients selected by CT scan.
Language of Publication
English
Unique Identifier
94215664

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Carcinoma, Bronchogenic|*PA/SC; Lung|*PA; Lung Neoplasms|*PA
MeSH Heading
Adult; Aged; Biopsy, Needle|MT; Bronchoscopy; Female; Human; Lymph Nodes|PA; Lymphatic Metastasis; Male; Middle Age; Neoplasm Staging

Publication Type
JOURNAL ARTICLE
ISSN
0903-1936
Country of Publication
DENMARK

Record 37 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix.
Author
Kaspar HG; Dinh TV; Doherty MG; Hannigan EV; Kumar D
Address
Department of Pathology, University of Texas Medical Branch, Galveston.
Source
Obstet Gynecol, 1993 Feb, 81:2, 296-300
Abstract
OBJECTIVE: To evaluate the prognostic significance of three-dimensional determination of tumor size in stage I cervical adenocarcinoma. METHODS: Tumor volume was measured using hematoxylin and eosin-stained sections of cone biopsy and hysterectomy specimens from 36 patients with stage I adenocarcinoma of the cervix. The volume was then correlated with pelvic lymphatic spread and clinical outcome. RESULTS: The subjects were followed for a mean (+/- SEM) of 63 +/- 8 months. No recurrence or lymphatic seeding was encountered in the 22 tumors measuring no more than 500 mm3. Two of 25 tumors (8%) having up to 5 mm depth of stromal invasion had lymph node metastasis, one of which was 1.5 mm, compared with four of 11 (36%) in the group with deeper than 5 mm invasion (P < .02). The depth of stromal invasion predicted recurrence less significantly. Among the 25 tumors with up to 5 mm stromal invasion, two recurred, compared with three of 11 with more than 5 mm invasion (P < .1). Two women who had tumor volumes below 500 mm3 and depths of stromal invasion up to 8.5 mm were disease-free at 52 and 96 months of follow-up. On the other hand, tumors with 2.6 and 3.8 mm stromal invasion, but with volumes exceeding 500 mm3, recurred. CONCLUSION: Tumor volume is a better predictor of pelvic lymph node metastasis and recurrence than is the depth of stromal invasion in stage I cervical adenocarcinoma.
Language of Publication
English
Unique Identifier
93141184

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Adenocarcinoma|EP/*PA; Cervix Neoplasms|EP/*PA; Cervix Uteri|*PA
MeSH Heading
Biopsy; Female; Follow-Up Studies; Human; Lymphatic Metastasis; Middle Age; Neoplasm Invasiveness; Neoplasm Recurrence, Local|EP; Neoplasm Staging; Prognosis; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0029-7844
Country of Publication
UNITED STATES

Record 38 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Relationship of tumor thickness in punch biopsy and subsequent surgical specimens in stage I squamous cell carcinoma of the lower lip.
Author
de Visscher JG; Schaapveld M; Grond AJ; van der Waal I
Address
Department of Oral and Maxillofacial Surgery, Medisch Centrum Leeuwarden, The Netherlands.
Source
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1999 Aug, 88:2, 141-4
Abstract
OBJECTIVE: Among the histologic features of squamous cell carcinoma of the lower lip, maximum tumor thickness in particular is a predictor of regional nodal metastatic spread and thus an important parameter in treatment planning. The purpose of this study was to investigate the relationship between maximum tumor thickness in punch biopsies and maximum tumor thickness in subsequent surgical specimens. STUDY DESIGN: This retrospective study examined the relationship between maximum tumor thickness in punch biopsies with that in subsequent surgical specimens obtained in 72 patients with clinical stage I squamous cell carcinoma of the lower lip. RESULTS: A correlation between maximum tumor thickness in punch biopies and in subsequent surgical specimens was found only for tumors with a thickness less than 3 mm. CONCLUSIONS: Reliable predictive information could be obtained from punch biopsies with a maximum tumor thickness less than 3 mm. When the maximum tumor thickness exceeds 3 mm, better information may be obtained from either a large incisional biopsy or the surgical specimen.
Language of Publication
English
Unique Identifier
99396559

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Biopsy|*MT; Carcinoma, Squamous Cell|*PA/SC/SU; Lip Neoplasms|*PA/SU
MeSH Heading
Adult; Aged; Aged, 80 and over; Female; Forecasting; Human; Lymphatic Metastasis|PA; Male; Middle Age; Neoplasm Staging; Normal Distribution; Reproducibility of Results; Retrospective Studies

Publication Type
JOURNAL ARTICLE
ISSN
1079-2104
Country of Publication
UNITED STATES

Record 39 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas.
Author
Dommann SN; Dommann Scherrer CC; Ziegler T; Meyer J; Trüeb RM; Kündig T; Panizzon R; Burg G
Address
Department of Dermatology, University Hospital of Zurich, Switzerland.
Source
Am J Dermatopathol, 1997 Aug, 19:4, 391-5
Abstract
Advances in the molecular definition of surface proteins (adhesion molecules) involved in tumor metastasis may help to explain the invasive behavior of malignant tumors, that is, the migration of tumor cells involving reversible adhesive contacts, their release in the circulation, and their extravasation into distant sites. Intercellular adhesion molecule-3 (ICAM-3), the third receptor for the lymphocyte function-associated antigen molecule-1 (LFA-1) was recently characterized. We investigated fresh frozen skin biopsies from 10 patients with mycosis fungoides, four with pleomorphic T-cell lymphoma, six with Sézary syndrome, 10 with primary cutaneous B-cell lymphoma, and 10 with eczematous lesions as controls. The biopsies were compared with lymph node biopsies of five patients with known cutaneous T-cell lymphoma (CTCL), 10 with primary nodal B-cell lymphoma, and 11 with lymph-node specimens showing dermatopathic lymphadenopathy as controls. The specimens were stained with ICAM-3 antibody (Bender Medical Science) using the alkaline phosphatase antialkaline phosphatase method. Using cytomorphologic criteria, neoplastic lymphocytes could be differentiated from smaller reactive cells. Staining intensities were classified semiquantitatively as follows: 4, strong expression in 75 to 100% of the tumor cells; 3, 50 to 75%; 2, 25 to 50%; 1, 5 to 25%; and 0 fewer than 5% of the tumor cells. The endothelial cells in skin biopsies of seven of 30 primary cutaneous lymphomas expressed ICAM-3. In contrast, no expression of ICAM-3 could be demonstrated on endothelial cells in lymph nodes infiltrated with tumor cells of CTCL. Finally, endothelial cells of lymph nodes infiltrated with primary nodal B-cell lymphomas showed expression of ICAM-3 in three of 10 patients. The endothelial cells in the 11 control patients presenting with both eczematous lesions and dermatopathic lymphadenopathy showed no staining for ICAM-3. Every patient who expressed ICAM-3 on endothelial cells showed systemic spread of this disease. The findings suggest that ICAM-3 expression may be induced on endothelial cells in late-stage cutaneous lymphomas, probably by a cytokine-mediated mechanism.
Language of Publication
English
Unique Identifier
97404767

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Cell Adhesion Molecules|AN/*GE; Endothelium|*PA; Lymph Nodes|*PA; Lymphoma, T-Cell, Cutaneous|*PA; Skin Neoplasms|*PA
MeSH Heading
Adult; Aged; Aged, 80 and over; Alkaline Phosphatase|DU; Biopsy; Cell Movement; Comparative Study; Dyes|DU; Eczema|PA; Female; Gene Expression Regulation, Neoplastic; Human; Lymphatic Diseases|PA; Lymphatic Metastasis|PA; Lymphocyte Function-Associated Antigen-1|AN/GE; Lymphocytes|PA; Lymphoma, B-Cell|PA; Lymphoma, Lymphoblastic|PA; Male; Middle Age; Mycosis Fungoides|PA; Neoplasm Circulating Cells|PA; Sezary Syndrome|PA; Skin|PA

Publication Type
JOURNAL ARTICLE
ISSN
0193-1091
Country of Publication
UNITED STATES

Record 40 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma.
Author
Utz JP; Patel AM; Edell ES
Address
Division of Thoracic Diseases and Internal Medicine, Mayo Medical Center, Rochester, Minn. 55905.
Source
Chest, 1993 Oct, 104:4, 1012-6
Abstract
Metastatic spread to subcarinal lymph nodes in patients with bronchogenic carcinoma generally indicates unresectability. Transcarinal needle aspiration of the main carina (TCNA) has been used to obviate the need for more invasive procedures, particularly thoracic surgery. Of 510 transbronchial needle aspirations performed at our institution from 1983 to 1991, 88 (17 percent) were from the main carina in patients with bronchogenic carcinoma. We reviewed these 88 TCNA procedures to assess our experience with TCNA in the staging of lung cancer. The TCNA results were positive in 32 of 88 (36 percent) patients (20 non-small-cell cancers, 12 small-cell lung cancers). Following bronchoscopy, TCNA was the only evidence of unresectability in all 20 patients with non-small-cell lung cancer and was the only mode of diagnosis in 5 of 12 (42 percent) patients with small-cell lung cancer. Thirteen patients with non-small-cell lung cancer and positive TCNA also had positive bronchial secretion cytologic studies. Five of these patients had further subcarinal sampling and in all cases metastatic involvement was confirmed. TCNA was positive in 29 of 67 (43 percent) patients with radiographic evidence of mediastinal adenopathy. Of the remaining 38 patients with radiographic evidence of mediastinal adenopathy and negative TCNA results, 23 patients had further mediastinal sampling with mediastinoscopy or thoracotomy and in all cases mediastinal spread of cancer was established. Nineteen of 58 (33 percent) patients with an endoscopically normal-appearing main carina had a positive TCNA, while 13 of 30 (43 percent) patients with broadening or widening of the main carina had positive TCNA results. There were no complications. We conclude that TCNA is often a safe and useful staging modality in patients with bronchogenic carcinoma.
Language of Publication
English
Unique Identifier
94008088

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Carcinoma, Bronchogenic|EP/*PA/SC; Lung|*PA; Lung Neoplasms|EP/*PA
MeSH Heading
Biopsy, Needle|MT; Human; Lymphatic Metastasis; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies

Publication Type
JOURNAL ARTICLE
ISSN
0012-3692
Country of Publication
UNITED STATES

Record 41 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Inadvertent spread of cancer at surgery.
Author
Fortner JG
Address
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Source
J Surg Oncol, 1993 Jul, 53:3, 191-6
Abstract
Surgical cure requires that a given cancer be removed without inadvertent spillage of cancer cells by technical error. Potential mishaps include pressing a ligature, while tying, against a protruding tumor and cutting into it; inserting a hemostat into the tumor area to gain control of an escaped short pancreaticoduodenal artery stump which has retracted; grasping a lymph node with forceps which invariably fragments it spilling any cancer cells it may contain; and injecting local anesthesia into or adjacent to a lesion for biopsy. If the lesion is a cutaneous melanoma or other cancer the resulting pressure may force cancer cells into the lymphatic or bloodstream. Other misadventures include touching that portion of a biopsy needle which has been in the tumor and doing an intraoperative biopsy which allows blood or tissue fluid to flow out the opening from the tumor. Sensitivity to such dangers appears essential to avoiding spillage of cancer cells and obtaining maximal benefit from surgery.
Language of Publication
English
Unique Identifier
93323506

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Neoplasm Seeding|*; Neoplasms|*SU
MeSH Heading
Biopsy, Needle|AE; Hemostasis, Surgical; Hemostatic Techniques; Human; Intraoperative Care|MT; Lymph Node Excision|MT; Lymphatic Metastasis; Palpation|AE; Surgical Instruments; Suture Techniques

Publication Type
JOURNAL ARTICLE
ISSN
0022-4790
Country of Publication
UNITED STATES

Record 42 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Mobilization of tumour cells during biopsy in an infant with Ewing sarcoma.
Author
Zoubek A; Kovar H; Kronberger M; Amann G; Windhager R; Gruber B; Gadner H
Address
St. Anna Children's Hospital, Children's Cancer Research Institute, Kinderspitalgasse 6, Vienna, Austria.
Source
Eur J Pediatr, 1996 May, 155:5, 373-6
Abstract
Ewing sarcoma and the closely related peripheral primitive neuroectodermal tumour, recently referred to as Ewing tumour (ET), are characterised by unique gene rearrangements on chromosome 22. The breakpoints have been cloned and shown to fuse the Ewing sarcoma gene to one of two closely related ETS proto-oncogens, FLI-1 or ERG, which reside on chromosomes 11 and 21, respectively. The rearrangement results in the expression of specific hybrid transcripts which can be detected with high sensitivity by the reverse transcriptase polymerase chain reaction technique (RT-PCR) in primary tumours, blood and bone marrow. We report on a 7-month-old boy with a pelvic Ewing sarcoma in whom circulating tumour cells were identified in the peripheral blood during open tumour biopsy by RT-PCR. However, before and 6 days after surgery no tumour cells could be detected in the peripheral blood. CONCLUSION: The application of RT-PCR to monitor shedding of tumour cells during surgical intervention will help to evaluate if open biopsy potentially contributes to metastatic tumour cell spread.
Language of Publication
English
Unique Identifier
96302958

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Bone Neoplasms|*BL/GE/PA/SU; Neoplasm Circulating Cells|*; Sarcoma, Ewing's|*BL/GE/PA/SU
MeSH Heading
Base Sequence; Biopsy; Case Report; Human; Infant; Male; Molecular Sequence Data; Neoplasm Metastasis; Polymerase Chain Reaction; Support, Non-U.S. Gov't; Transcription, Genetic

Publication Type
JOURNAL ARTICLE
ISSN
0340-6199
Country of Publication
GERMANY

Record 43 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Occult papillary carcinoma of the thyroid with pulmonary lymphangitic spread diagnosed by lung biopsy.
Author
Fend F; Gruber U; Fritzsche H; Rothmund J; Breitfellner G; Mikuz G
Address
Institut fÂur Pathologische Anatomie, UniversitÂat Innsbruck.
Source
Klin Wochenschr, 1989 Jul, 67:13, 687-90
Abstract
Distant metastases from occult papillary carcinoma of the thyroid, which is defined as a tumor less than 15 mm in diameter, are extremely rare. A 21-year-old patient with miliary micronodular densities in both lungs is described, in whom pulmonary lymphangitic spread of occult papillary thyroid carcinoma was diagnosed by transthoracic lung biopsy.
Language of Publication
English
Unique Identifier
89329502

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Carcinoma, Papillary|PA/*SC; Lung Neoplasms|PA/*SC; Lymph Nodes|*PA; Thyroid Neoplasms|*PA
MeSH Heading
Adult; Biopsy; Case Report; Female; Human; Lung|PA; Lymphatic Metastasis; Neoplasm Circulating Cells

Publication Type
JOURNAL ARTICLE
ISSN
0023-2173
Country of Publication
GERMANY, WEST

Record 44 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography.
Author
Peters JH; Hoeft SF; Heimbucher J; Bremner RM; DeMeester TR; Bremner CG; Clark GW; Kiyabu M; Parisky Y
Address
Department of Surgery, University of Southern California School of Medicine, Los Angeles.
Source
Arch Surg, 1994 May, 129:5, 534-9
Abstract
OBJECTIVE: To assess the accuracy of pretreatment staging and the potential of using endosonographic findings to select patients for curative or palliative resection by comparing the preoperative endosonographic and computed tomographic (CT) findings with the histology of the surgical specimen. METHODS: Forty-two patients referred to our clinic with esophageal carcinoma underwent preoperative upper endoscopy with biopsy, endosonography, thoracic CT, and abdominal CT. Based on endoscopic ultrasonographic findings, patients with early-stage disease underwent en-bloc esophagogastrectomy, whereas those with advanced disease had a palliative transhiatal esophagectomy. Exceptions included patients with poor physiologic reserve who were treated by the transhiatal route. RESULTS: In eight patients, we were unable to pass the ultrasonographic endoscope. Seven of these eight had transmural tumors with nodal involvement on histologic study. Tumor length, based on endosonographic measurements, was correctly predicted in 34 patients (85%). Extent of wall penetration was accurately predicted in 26 (76%) of the 34, and regional lymph node status was accurately predicted in 28 (82%) of the 34. Of the patients with sonographic wall penetration, 80% had histologic evidence of one or more positive nodes. Using the WNM staging system, endoscopic ultrasonography correctly staged the cancer in 68% of the patients. Three patients were treated with an inappropriate procedure. CONCLUSION: Endosonography is a reliable method for the preoperative staging and selection of patients for curative or palliative resection. Endosonographic wall penetration appears to be a critical factor in determining tumor spread.
Language of Publication
English
Unique Identifier
94241880

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Esophageal Neoplasms|PA/RA/*SU/*US; Palliative Care|*
MeSH Heading
Adult; Aged; Aged, 80 and over; Biopsy; Comparative Study; Esophagectomy; Esophagoscopy; Esophagus|PA; Female; Human; Lymphatic Metastasis; Male; Middle Age; Neoplasm Invasiveness; Neoplasm Staging; Predictive Value of Tests; Preoperative Care|MT; Reproducibility of Results; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
0004-0010
Country of Publication
UNITED STATES

Record 45 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Metastatic tumours of the parotid gland.
Author
Malata CM; Camilleri IG; McLean NR; Piggott TA; Soames JV
Address
West of Scotland Plastic and Oral Surgery Unit, Canniesburn Hospital, Glasgow, UK.
Source
Br J Oral Maxillofac Surg, 1998 Jun, 36:3, 190-5
Abstract
Twenty patients (12 men and 8 women, median age 69 years) with metastatic tumours in the parotid gland who presented over a 12-year period were evaluated retrospectively. Preoperative investigations included fine needle aspiration cytology (n = 11) and computed tomography or magnetic resonance imaging (MRI) (n = 14). Most tumours originated from the head and neck region, the two main types being squamous cell carcinoma (n = 10) and malignant melanoma (n = 7). All 20 presented with a parotid mass and 11/20 (55%) had associated lymphadenopathy. Eleven patients (55%) underwent superficial, five total, and four radical, parotidectomy. Neck dissection was required in 16 patients (80%), and all 11 patients with clinically palpable lymph nodes had evidence of tumour in the neck dissection specimens. Half of all patients (n = 10) received adjuvant postoperative radiotherapy. Three-quarters of the patients (n = 15) were alive after a mean follow-up of 31 months and only one developed a marginal recurrence. The cumulative 5-year survival rate was 51%, and there was no significant difference (P = 0.48) in the 3-year survival rates of patients who had radical compared with those who had modified neck dissections. Patients who had superficial parotidectomy had a longer overall survival compared with those who had total or radical parotidectomy (P = 0.04) perhaps reflecting the advanced nature of tumours that required total or radical excision of the gland. We conclude that superficial parotidectomy is usually an adequate treatment for secondary parotid tumours (when disease is clinically limited to the superficial lobe), and we suggest that patients in whom metastatic disease of the parotid gland is suspected do not require neck dissection if they have no palpable lymph nodes and MRI shows no evidence of spread. There seems to be no survival advantage in radical over modified neck dissection.
Language of Publication
English
Unique Identifier
98342024

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Parotid Neoplasms|DI/*SC/TH
MeSH Heading
Adolescence; Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Squamous Cell|PA/SC; Comparative Study; Disease-Free Survival; Female; Follow-Up Studies; Head and Neck Neoplasms|PA; Human; Lymph Node Excision; Lymphatic Metastasis|PA; Magnetic Resonance Imaging; Male; Melanoma|PA/SC; Middle Age; Neoplasm Staging; Parotid Gland|SU; Radical Neck Dissection; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
0266-4356
Country of Publication
SCOTLAND

Record 46 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Penile cancer. Aspiration biopsy cytology for staging.
Author
Scappini P; Piscioli F; Pusiol T; Hofstetter A; Rothenberger K; Luciani L
Address
 
Source
Cancer, 1986 Oct, 58:7, 1526-33
Abstract
Appropriate management and prognosis of patients with penile carcinoma depends on an accurate knowledge of the regional node status. The usefulness of clinical and radiologic examinations in detecting the nodal spread of the disease is limited by the high rates of false-positive and false-negative results. On the other hand, routine or prophylactic lymphadenectomy is associated with 30% to 50% of the major morbidity and 3% of the mortality rate, so that caution is advisable for its use in patients with disease-free nodes. Even bilateral sentinel lymph node biopsy, as proposed by Cabanas, does not warrant an adequate selection of patients candidates to surgical treatment. The role of aspiration biopsy cytology in the management of penile carcinoma was evaluated in a study of 29 cases from the authors' institutions. Aspiration under fluoroscopic or computed tomographic guidance was performed using a 22-23-gauge Chiba needle. The accuracy of aspiration biopsy cytology in identifying the true stage of the disease was 100%. On histologic control, only one node contained malignant cells that were not detected by aspiration biopsy cytology, but this finding did not alter the stage of the patient. Positive cytology is conclusive of Stage III disease and, in this case, a curative lymphadenectomy may be attempted. Negative aspirations do not warrant the absence of metastatic nodal involvement as can be seen in two patients in this series. In such cases, however, a policy of "wait and watch" may be adopted, with repeated aspiration biopsies or surgical biopsy of the sentinel node area.
Language of Publication
English
Unique Identifier
86298118

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Biopsy, Needle|*; Carcinoma, Squamous Cell|MO/*PA/RA; Penile Neoplasms|MO/*PA/RA
MeSH Heading
Adult; Aged; Diagnostic Errors; Human; Lymphatic Metastasis; Male; Melanoma|MO/PA/RA; Middle Age; Neoplasm Staging; Prognosis; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
0008-543X
Country of Publication
UNITED STATES

Record 47 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Widespread lymph node metastases in a patient with microinvasive cervical carcinoma.
Author
Collins HS; Burke TW; Woodward JE; Spurlock JW; Heller PB
Address
Gynecologic Oncology Service, Walter Reed Army Medical Center, Washington, D.C. 20307-5001.
Source
Gynecol Oncol, 1989 Aug, 34:2, 219-21
Abstract
Lymph node metastasis is uncommon in patients with microinvasive squamous cell carcinoma of the cervix and is particularly unusual in tumors with early stromal invasion. We describe a patient with maximum stromal invasion of 0.8 mm who had extensive pelvic and para-aortic nodal metastases discovered at laparotomy. Despite combined modality therapy, she died with progressive disease. New clinical staging definitions for Stage IA cervical carcinoma incorporate measurement of both depth of invasion and lateral tumor spread and have resolved many of the descriptive controversies surrounding this entity. Our case illustrates that any degree of stromal invasion carries some risk of nodal metastasis. The management of patients with microinvasive carcinoma should be individualized. An abdominal approach should be considered for patients being treated by extrafascial hysterectomy to allow assessment of the regional lymph nodes. Whether more aggressive therapy will influence the outcome for the rare patient with lymph node metastasis is unknown.
Language of Publication
English
Unique Identifier
89326315

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Cervix Neoplasms|*PA
MeSH Heading
Adult; Basement Membrane|PA; Biopsy; Case Report; Female; Human; Lymph Nodes|PA; Lymphatic Metastasis; Neoplasm Invasiveness

Publication Type
JOURNAL ARTICLE
ISSN
0090-8258
Country of Publication
UNITED STATES

Record 48 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques.
Author
Kassis ES; Nguyen N; Shriver SP; Siegfried JM; Schauer PR; Luketich JD
Address
Department of Surgery, University of Pittsburgh Medical Center, PA 15213, USA.
Source
JSLS, 1998 Oct, 2:4, 331-6
Abstract
BACKGROUND AND OBJECTIVES: Lymph node metastases are the most important prognostic factor in patients with esophageal cancer. Histologic examination misses micrometastases in up to 20% of lymph nodes evaluated. In addition, non-invasive imaging modalities are not sensitive enough to detect small lymph nodes metastases. The objective of this study was to investigate the use of reverse transcriptase-polymerase chain reaction (RT-PCR) of messenger RNA (mRNA) for carcinoembryonic antigen (CEA) to increase the detection of micrometastases in lymph nodes from patients with esophageal cancer. METHODS: RT-PCR of CEA mRNA was performed in lymph nodes from patients with malignant and benign esophageal disease. Each specimen was examined histopathologically and by RT-PCR and the results were compared. RESULTS: Metastases were present in 29 of 60 (48%) lymph nodes sample by minimally invasive staging from 13 patients with esophageal cancer when examined histopathologically. RT-PCR identified nodal metastases in 46 of these 60 (77%) samples. RT-PCR detected CEA mRNA in all 29 histologically positive samples and in 17 histologically negative lymph nodes. All lymph nodes from patients with benign disease (n = 15) were negative both histopathologically and by RT-PCR. The stage of two patients was reclassified based on the RT-PCR results, which identified lymph node spread undetected histopathologically. Both of these patients developed recurrent disease after resection of the primary tumor. CONCLUSIONS: RT-PCR is more sensitive than histologic examination in the detection of lymph node metastases in esophageal cancer and can lead to diagnosis of a more advanced stage in some patients. The combination of minimally invasive surgical techniques in combination with new molecular diagnostic techniques may improve our ability to stage cancer patients.
Language of Publication
English
Unique Identifier
99154222

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Adenocarcinoma|*PA/*SC/SU; Carcinoembryonic Antigen|*AN; Esophageal Neoplasms|*PA/SU; RNA, Messenger|*AN; RNA, Neoplasm|*AN; Tumor Markers, Biological|*AN
MeSH Heading
Base Sequence; Biopsy, Needle; Comparative Study; Female; Human; Lymph Nodes|PA; Lymphatic Metastasis; Male; Molecular Sequence Data; Neoplasm Staging; Polymerase Chain Reaction; Reference Values; Sensitivity and Specificity; Surgical Procedures, Minimally Invasive

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE
Country of Publication
UNITED STATES

Record 49 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Small B cell NHL and their leukemic counterpart: differences in subtyping and assessment of leukemic spread.
Author
Criel A; Pittaluga S; Verhoef G; Wlodarska I; Meeus P; Mecucci C; Van Orshoven A; Van den Berghe H; Boogaerts M; De Wolf Peeters C
Address
Department of Hematology, KU, Leuven, Belgium.
Source
Leukemia, 1996 May, 10:5, 848-53
Abstract
Three subtypes of small lymphocytic lymphoma were studied, namely B cell chronic lymphocytic leukemia (B-CLL), mantle cell lymphoma (MCL) and follicle center lymphoma (FCL). Agreement between tissue diagnosis, based on the proposal for a revised European-American classification of lymphoid neoplasms from the International Lymphoma Study Group, and the cytomorphological diagnosis on peripheral blood and/or bone marrow smears, using the proposals for the classification of chronic (mature) B and T lymphoid leukemias of the French-American-British Cooperative Group, was studied. Full agreement was found in 90% of the CLL and 82% of the FCL cases. In MCL cases, agreement was 65% including all cases classified as intermediate/mantle zone lymphoma according to FAB criteria. The incidence of bone marrow involvement detection in trephines compared to smears was equal in CLL (both 100%) and slightly higher in MCL (56 vs 48.5%); in FCL, however, trephine biopsies provided more reliable material (71 vs 35%).
Language of Publication
English
Unique Identifier
96216625

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Leukemia, B-Cell, Chronic|BL/*CL/PA; Lymphoma, Small-Cell|BL/*CL/PA
MeSH Heading
Biopsy; Cell Division; Comparative Study; Human; Lymph Nodes|PA; Lymphoma, Follicular|CL/PA; Neoplasm Invasiveness; Neoplasm Metastasis; Spleen|PA; Terminology

Publication Type
JOURNAL ARTICLE
ISSN
0887-6924
Country of Publication
ENGLAND

Record 50 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Subtypes of renal cell carcinoma. Different onset and sites of metastatic disease.
Author
Renshaw AA; Richie JP
Address
 
Source
Am J Clin Pathol, 1999 Apr, 111:4, 539-43
Abstract
Different subtypes of renal cell carcinoma have different genetic features and prognoses. Whether the patterns of metastatic spread of different subtypes of renal cell carcinoma are different is unknown. To assess this, we reviewed the time course and sites of all pathologically confirmed metastatic disease in patients who underwent resection of the primary tumor at Brigham and Women's Hospital, Boston, MA, between 1973 and 1997. In 82 patients, 119 metastatic lesions were identified. Compared with clear cell tumors, papillary tumors were more likely to be Fuhrman grade 3 or 4, to have metastases present at the time of resection, and to involve lymph nodes but not lung. Metastases associated with chromophobe tumors developed in 3 patients, all of whom had Fuhrman grade 2 tumors, and were found only in the liver. We conclude that different subtypes of renal cell carcinoma develop pathologically confirmed metastases at different times and sites. The value of Fuhrman grading may depend on the subtype of renal cell carcinoma.
Language of Publication
English
Unique Identifier
99207500

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Carcinoma, Renal Cell|*CL/PA/SC; Kidney Neoplasms|*CL/PA; Neoplasm Metastasis|*
MeSH Heading
Aged; Biopsy; Female; Human; Liver Neoplasms|SC; Lung Neoplasms|SC; Lymphatic Metastasis; Male; Middle Age; Prognosis

Publication Type
JOURNAL ARTICLE
ISSN
0002-9173
Country of Publication
UNITED STATES

Record 51 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Aspiration cytology in the staging of urologic cancer.
Author
Piscioli F; Scappini P; Luciani L
Address
 
Source
Cancer, 1985 Sep, 56:5, 1173-80
Abstract
Knowledge of the status of the pelvic lymph nodes is vital for accurate staging and adequate treatment of patients with urologic cancer. Noninvasive techniques for assessing the lymphatic spread of urologic neoplasms have proved to be of limited value. Bipedal lymphangiography and percutaneous fine needle aspiration cytology under fluoroscopic guidance were performed for staging purposes in 71 patients with clinically localized bladder, prostatic and penile cancer from 257 nodal chains. The overall diagnostic accuracy was 93% and the correct aspiration of 186 lymph nodes was surgically confirmed. There were 11 (6%) false-negative biopsy results and no false-positive diagnoses. Aspiration cytology is a safe, well tolerated, accurate, and rapid method of determining the presence of metastatic disease in lymphangiographically visualized pelvic nodes. In the management of prostatic carcinoma, positive cytologic results are diagnostic of nodal metastatic involvement and spare the patients unnecessary surgical staging. Negative cytologic findings may be considered diagnostic of localized disease in the patients with well differentiated prostatic carcinoma (2-4 Gleason's sum). Since most surgeons are reluctant to perform a staging lymphadenectomy in the management of invasive bladder carcinoma, aspiration cytology can provide accurate staging, thus permitting an appropriate treatment plan. In patients with carcinoma of the penis, a positive aspirate permits an early and even curative lymphadenectomy in cases with clinically negative but pathologically positive nodes.
Language of Publication
English
Unique Identifier
85254334

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Biopsy, Needle|*; Lymph Nodes|*PA; Urologic Neoplasms|*PA/RA
MeSH Heading
Bladder Neoplasms|PA/RA; Cytodiagnosis; Diagnostic Errors; Human; Lymphatic Metastasis; Lymphography; Male; Neoplasm Staging|MT; Pelvis; Penile Neoplasms|PA/RA; Prostatic Neoplasms|PA/RA; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0008-543X
Country of Publication
UNITED STATES

Record 52 from database: MEDLINE
Return To Top
Return To Menu Position #40
Return To Menu Position #50

Title
Role of thoracoscopic lymph node staging for lung and esophageal cancer.
Author
Krasna MJ
Address
Division of Thoracic and Cardiovascular Surgery, University of Maryland, School of Medicine, Baltimore, USA.
Source
Oncology (Huntingt), 1996 Jun, 10:6, 793-802; discussion 804, 813-4
Abstract
Staging is extremely important in determining the proper treatment of patients with thoracic malignancies. Staging groups can be used to predict outcome after cancer treatment and allocate patients to appropriate treatment regimens. Thoracoscopy is an excellent means of staging intrathoracic malignancies. It is a good tool for biopsy of mediastinal lymph nodes and evaluation of the pleural cavity. Routine thoracoscopic and laparoscopic lymph node staging have been used in patients with esophageal carcinoma with excellent results. For patients with lung cancer, thoracoscopy augments other noninvasive and minimally invasive staging procedures. It is used as a complement to standard cervical mediastinoscopy in assessing mediastinal and hilar lymph nodes. It can thus help avoid an unnecessary thoracotomy for attempted resection in a patient who is found to have gross spread of locoregional disease.
Language of Publication
English
Unique Identifier
96421098

Return To Top
Return To Menu Position #40
Return To Menu Position #50


MeSH Heading (Major)
Esophageal Neoplasms|*PA; Lung Neoplasms|*PA; Lymph Nodes|*PA; Neoplasm Staging|*; Thoracoscopy|*MT
MeSH Heading
Biopsy; Human; Laparoscopy|MT; Lymphatic Metastasis; Mediastinum|PA; Prognosis

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0890-9091
Country of Publication
UNITED STATES

Record 53 from database: MEDLINE
Return To Top
Return To Menu Position #50

Title
Minimally invasive staging for esophageal cancer.
Author
Krasna MJ
Address
Division of Thoracic and Cardiovascular Surgery, University of Maryland School of Medicine, Baltimore, USA.
Source
Chest, 1997 Oct, 112:4 Suppl, 191S-194S
Abstract
Thoracoscopy is an excellent means for staging esophageal cancer. Staging of esophageal carcinoma facilitates prognostication and allocation of patients to appropriate treatment regimens. Thoracoscopy is also useful in biopsies of direct mediastinal invasion. Routine thoracoscopic and laparoscopic lymph node staging has been used in patients with esophageal carcinoma with excellent results. Thoracoscopy can allocate patients for neoadjuvant therapy and help avoid an unnecessary thoracotomy in patients found to have gross spread of locoregional disease.
Language of Publication
English
Unique Identifier
97477223

Return To Top
Return To Menu Position #50


MeSH Heading (Major)
Adenocarcinoma|*PA/TH; Carcinoma, Squamous Cell|*PA/TH; Esophageal Neoplasms|*PA/TH; Neoplasm Staging|*MT; Thoracoscopy|*
MeSH Heading
Biopsy; Combined Modality Therapy; Human; Laparoscopy; Lymph Nodes|PA; Lymphatic Metastasis; Retrospective Studies

Publication Type
JOURNAL ARTICLE
ISSN
0012-3692
Country of Publication
UNITED STATES

Record 54 from database: MEDLINE
Return To Top
Return To Menu Position #50

Title
Malignant epithelioid hemangioendothelioma of the liver in young women. Relationship to oral contraceptive use.
Author
Dean PJ; Haggitt RC; OHara CJ
Address
 
Source
Am J Surg Pathol, 1985 Oct, 9:10, 695-704
Abstract
Epithelioid hemangioendothelioma (EH) is a vascular neoplasm that occurs predominantly in soft tissue and is not infrequently misdiagnosed as an epithelial neoplasm or angiosarcoma. Only a few cases of hepatic EH have been described, and a relationship to oral contraceptive (OC) use in patients with the hepatic lesions has not generally been recognized. We present a series of five patients with malignant epithelioid hemangioendothelioma of the liver. Confirmation of the endothelial origin of these tumors was provided by positive immunoperoxidase staining for Factor-VIII-related antigen in the four cases studied by that technique, and by the demonstration of Weibel-Palade bodies in two tumors examined by electron microscopy. All five patients were young women (mean age 33 years) and all five gave a history of OC use of 4-7 years' duration. The clinical course varied from indolent but progressive to rapid death. One patient who underwent resection of the primary tumor has survived 3 years without evidence of disease, and one patient with metastatic disease who was treated with radiation and chemotherapy has survived for 8 years with disease. Three patients with extrahepatic spread have died of the tumor. Early diagnosis of this distinctive tumor might offer the hope of salvage by resection or liver transplantation.
Language of Publication
English
Unique Identifier
86048321

Return To Top
Return To Menu Position #50


MeSH Heading (Major)
Contraceptives, Oral, Hormonal|*AE; Hemangioendothelioma|*CI/ME/PA; Liver Diseases|*CI/ME/PA
MeSH Heading
Adult; Biopsy; Female; Histocytochemistry; Human; Immunoenzyme Techniques; Liver|ME/PA; Lymph Nodes|ME/PA; Lymphatic Metastasis; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0147-5185
Country of Publication
UNITED STATES

Record 55 from database: MEDLINE
Return To Top
Return To Menu Position #50

Title
Sentinel node dissection in the treatment of melanoma. Report of three cases and review of the literature.
Author
Cottingham T; Larson J; Delaney JP; Zachary C
Address
Department of Dermatology, University of Minnesota, Minneapolis 55455-0392, USA.
Source
Dermatol Surg, 1997 Feb, 23:2, 113-8; discussion 118-9
Abstract
BACKGROUND: Elective lymph node dissection for treatment of cutaneous malignant melanoma is controversial. Sentinel node dissection involves removing the primary lymph node in a nodal basin that drains a particular cutaneous lesion. Theoretically, this node would collect regional metastases first. Therefore, if this node is negative, the chances are low that the melanoma would have spread either systemically or to other nodes within this basin. Removing one node would decrease the morbidity associated with radical lymph node dissection. However, the actual risk of widespread metastases in sentinel node-negative patients is yet to be determined, pending results of large, multicenter studies currently under investigation. OBJECTIVE: To present three cases of intermediate thickness cutaneous melanoma treated with selective lymph node dissection and to review the techniques of selective lymphadenectomy and lymphoscintigraphy. METHODS: In a nonrandomized prospective evaluation, patients with intermediate depth melanomas or in transit metastases without signs of systemic disease were given the opportunity for further investigation by sentinel node dissection to determine if additional lymph node dissection or adjunctive therapies would be advantageous. RESULTS: All three patients had negative sentinel node examinations. Two are without visceral or nodal metastases 1 year after the procedure. The third had in-transit metastases from the outset, had in-transit metastases on sentinel node/lymphatic examination, and now has systemic cutaneous metastases. Complications of sentinel node dissection were limited to transient postoperative lymphedema of the extremities and transient seroma formation. No postoperative wound infections or permanent nerve damage were noted. CONCLUSIONS: Our preliminary findings in this limited series suggests that sentinel node dissection appears to be a procedure of low morbidity and relatively high predictive value.
Language of Publication
English
Unique Identifier
97261331

Return To Top
Return To Menu Position #50


MeSH Heading (Major)
Lymph Node Excision|*; Melanoma|RI/*SC/*SU; Skin Neoplasms|RI/*SU
MeSH Heading
Aged; Aged, 80 and over; Biopsy; Case Report; Female; Human; Lymph Nodes|PA/RI; Lymphatic Metastasis; Male; Middle Age; Neoplasm Staging; Prospective Studies

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
1076-0512
Country of Publication
UNITED STATES

Record 56 from database: MEDLINE
Return To Top
Return To Menu Position #50

Title
Determining the extent of the cancer and clinical planning for cure.
Author
Karnofsky DA
Address
 
Source
Cancer, 1968 Oct, 22:4, 730-4
Abstract
The patient with presumed localized cancer should be carefully surveyed both for evidence of spread of the disease, and in order to obtain baseline data which may be relevant to interpret any later clinical changes. The procedures used--a careful medical history, complete physical examination, laboratory tests, biopsy and cytology preparations, radiographic procedures and radioactive isotope scans of selected organ system--are listed. The recommended procedures in the individual patient are related to the primary site and apparent local extent of the cancer, a knowledge of the natural history of the particular cancer, and the practicalities of the situation. Proper study will direct an attempt at optimal curative therapy or spare the patient with metastatic disease unrewarding and possibly disabling therapeutic efforts.
Language of Publication
English
Unique Identifier
85151532

Return To Top
Return To Menu Position #50


MeSH Heading (Major)
Neoplasms|DI/*TH
MeSH Heading
Human; Neoplasm Metastasis

Publication Type
JOURNAL ARTICLE
ISSN
0008-543X
Country of Publication
UNITED STATES

Record 57 from database: MEDLINE
Return To Top
Return To Menu Position #50

Title
An analysis of 38 malignant fibrous histiocytomas in the extremities.
Author
Ekfors TO; Rantakokko V
Address
 
Source
Acta Pathol Microbiol Scand [A], 1978 Jan, 86:1, 25-35
Abstract
All the malignant soft tissue tumours in the extremities and limb girdles reported to the Finnish Cancer Registry between 1960-1969 were reviewed. From a total of 246 sarcomas, 38 were diagnosed as malignant fibrous histiocytoma. There was an equal number of male and female patients with the median age of 67 years. The thigh was the most frequent site, and the majority of the tumours originated in the deep soft tissues. The predominant treatment was excision followed by radiation therapy. In 17 patients there were one or more recurrences and in 21 patients there was a metastatic spread ascertained by biopsy, autopsy or clinical or radiographic evidence. There were 11 survivors with a minimum of 5 years' follow-up; seven patients died of an intercurrent disease and the remaining 20 patients were considered victims of their tumour. The findings that seemed to favour a poor prognosis were higher age and female sex of the patient as well as deep location, large size, necrotic areas, and high mitotic activity of the tumour.
Language of Publication
English
Unique Identifier
78141577

Return To Top
Return To Menu Position #50


MeSH Heading (Major)
Dermatofibroma|*/MO/PA/TH; Soft Tissue Neoplasms|*/MO/PA/TH
MeSH Heading
Adult; Age Factors; Aged; Arm; Female; Finland; Human; Leg; Male; Middle Age; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Sex Factors; Thigh

Publication Type
JOURNAL ARTICLE
ISSN
0365-4184
Country of Publication
DENMARK

Record 58 from database: MEDLINE
Return To Top
Return To Menu Position #50
Return To Menu Position #60

Title
Serum immunoglobulins in breast cancer.
Author
Alsabti EA
Address
 
Source
J Surg Oncol, 1979, 11:2, 129-33
Abstract
Eighty-one women admitted for breast tumor biopsy have been followed sequentially for 12 months. Thirty-one women had clinical stage I and II breast cancer and 50 had benign breast disease. All these women had serum immunoglobulin IgA, IgG, IgM and IgE levels measured by immunodiffusion and radioimmunoassay preoperatively, two weeks postoperatively, then three months, six months, nine months and twelve months postoperatively. Significant differences were found in IgA and IgG levels preoperatively in the cancer group while no differences were found in IgM or IgE levels at any time. There was positive correlation between the extent of metastatic breast cancer and IgA level. There was negative correlation between the extent of metastatic breast cancer and IgM levels. These findings raise the value of measuring the levels of immunoglobulins in patients with breast cancer as a guide to subclinical spread of the disease. The results may also support the hypothesis of the role of early immune defect in immunoglobulin metabolism in the pathogenesis of breast cancer.
Language of Publication
English
Unique Identifier
79176719

Return To Top
Return To Menu Position #50
Return To Menu Position #60


MeSH Heading (Major)
Breast Neoplasms|*IM/SU; Immunoglobulins|*AN
MeSH Heading
Aged; Breast Diseases|IM; Female; Human; IgA|AN; IgE|AN; IgG|AN; IgM|AN; Middle Age; Neoplasm Metastasis; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0022-4790
Country of Publication
UNITED STATES

Record 59 from database: MEDLINE
Return To Top
Return To Menu Position #50
Return To Menu Position #60

Title
Parameningeal rhabdomyosarcoma.
Author
Chan RC; Sutow WW; Lindberg RD
Address
 
Source
Radiology, 1979 Apr, 131:1, 211-4
Abstract
The records of 27 patients with rhabdomyosarcoma involving the parameningeal area (nasopharynx, paranasal sinus, and middle ear) treated from 1961 to 1976 were reviewed. Due to the location of the primary tumor, radiation and chemotherapy were used but surgery was limited to simple biopsy. In the literature, spread of tumor from these primary sites to the meninges has been as high as 26-35%. In this series, meningeal disease developed in only 2 of the 27 patients (7%).
Language of Publication
English
Unique Identifier
79137815

Return To Top
Return To Menu Position #50
Return To Menu Position #60


MeSH Heading (Major)
Ear Neoplasms|*RA/TH; Ear, Middle|*/RA; Nasopharyngeal Neoplasms|*RA/TH; Paranasal Sinus Neoplasms|*RA/TH; Rhabdomyosarcoma|*RA/TH
MeSH Heading
Adolescence; Human; Infant; Meningeal Neoplasms|RA; Neoplasm Metastasis; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0033-8419
Country of Publication
UNITED STATES

Record 60 from database: MEDLINE
Return To Top
Return To Menu Position #50
Return To Menu Position #60

Title
Zosteriform inflammatory metastatic carcinoma.
Author
Hodge SJ; Mackel S; Owen LG
Address
 
Source
Int J Dermatol, 1979 Mar, 18:2, 142-5
Abstract
A 57-year-old man presented with chest wall lesions and swelling of his left arm. The rapid onset of vesicular lesions in a dermatomal distribution resulted in an initial diagnosis of herpes zoster. Cutaneous biopsy revealed adenocarcinoma and further evaluation revealed a primary source of pulmonary adenocarcinoma. Lymphatic spread of tumor cells is the most likely source of the zosteriform skin lesions, but other possibilities are discussed.
Language of Publication
English
Unique Identifier
79129699

Return To Top
Return To Menu Position #50
Return To Menu Position #60


MeSH Heading (Major)
Adenocarcinoma|*PA; Lung Neoplasms|*PA; Skin|*PA; Skin Neoplasms|*PA
MeSH Heading
Case Report; Diagnosis, Differential; Herpes Zoster|PA; Human; Male; Middle Age; Neoplasm Metastasis

Publication Type
JOURNAL ARTICLE
ISSN
0011-9059
Country of Publication
UNITED STATES

Record 61 from database: MEDLINE
Return To Top
Return To Menu Position #60

Title
Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination.
Author
Bunn PA Jr; Huberman MS; Whang Peng J; Schechter GP; Guccion JG; Matthews MJ; Gazdar AF; Dunnick NR; Fischmann AB; Ihde DC; Cohen MH; Fossieck B; Minna JD
Address
 
Source
Ann Intern Med, 1980 Aug, 93:2, 223-30
Abstract
A prospective pretreatment staging evaluation was done on 49 consecutive patients with mycosis fungoides or the Sézary syndrome to study patterns of disease spread and prognostic factors. Routine staging procedures included complete blood count, blood chemistries, chest roentgenogram, lymphangiogram, radionuclide scans, bone marrow aspiration and biopsy, liver biopsy, and lymph node biopsy. Special evaluations included cytogenetic analysis, electron microscopy, and T-cell cytology. Extracutaneous lymphoma was documented by light microscopy in 51% of patients and by the three special procedures in 88%. Extracutaneous lymphoma was most frequent in blood and lymph nodes; 18% of patients had visceral involvement. Patients with generalized erythroderma had a higher frequency of extracutaneous disease than did patients with cutaneous plaques and tumors by both light microscopy and special studies. Survival was directly related to the type of skin involvement and the presence or absence of extracutaneous disease. Systemic dissemination of cutaneous T-cell lymphoma is frequent, generally asymptomatic, and develops early via the circulation. These findings may explain why cutaneous therapies are associated with a high frequency of relapse.
Language of Publication
English
Unique Identifier
80263798

Return To Top
Return To Menu Position #60


MeSH Heading (Major)
Lymphoma|MO/*PA/SC; Neoplasm Circulating Cells|*; Skin Neoplasms|MO/*PA; T-Lymphocytes|*
MeSH Heading
Adult; Aged; Female; Human; Intestinal Neoplasms|SC; Lymphatic Metastasis; Male; Middle Age; Mycosis Fungoides|PA; Neoplasm Staging; Prospective Studies; Sezary Syndrome|PA

Publication Type
JOURNAL ARTICLE
ISSN
0003-4819
Country of Publication
UNITED STATES

Record 62 from database: MEDLINE
Return To Top
Return To Menu Position #60

Title
Malignant mesothelioma of the pleura: review of 123 patients.
Author
Brenner J; Sordillo PP; Magill GB; Golbey RB
Address
 
Source
Cancer, 1982 Jun, 49:11, 2431-5
Abstract
One-hundred-twenty-three cases of malignant pleural mesothelioma were reviewed. Exposure to asbestos or to other industrial dusts or chemicals was an important etiologic factor with 24% of patients relating such a history. A history of prior irradiation or previous lung disease was also occasionally noted. Diagnosis was most often made by exploratory thoracotomy, with pleural biopsy or cytology rarely helpful. Except for nine patients, tumor was confined to the chest at the time of diagnosis, but in 33 of the remaining 114 patients, spread to the abdomen or distant metastasis was seen during the course of disease. Surgery and radiotherapy were ineffective in preventing local recurrence. There were only three major responses to chemotherapy in 111 trials. Median survival was 12 months, and only seven patients (5.6%) lived more than five years. Patients with epithelial mesothelioma and Stage I disease had the most favorable prognosis.
Language of Publication
English
Unique Identifier
82184108

Return To Top
Return To Menu Position #60


MeSH Heading (Major)
Mesothelioma|*DI/PA/SU; Pleural Neoplasms|*DI/PA/SU
MeSH Heading
Adolescence; Female; Human; Lymphatic Metastasis; Male; Middle Age; Neoplasm Metastasis

Publication Type
JOURNAL ARTICLE
ISSN
0008-543X
Country of Publication
UNITED STATES

Record 63 from database: MEDLINE
Return To Top
Return To Menu Position #60

Title
Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.
Author
Horenblas S; van Tinteren H; Delemarre JF; Moonen LM; Lustig V; van Waardenburg EW
Address
Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoekhuis, Amsterdam.
Source
J Urol, 1993 Mar, 149:3, 492-7
Abstract
We analyzed the management of regional lymph nodes in 110 patients with squamous cell carcinoma of the penis treated at the Netherlands Cancer Institute between 1956 and 1989 with curative intent. Of 66 patients who presented with unsuspected nodes 57 were placed on a surveillance program, while lymph node dissection was performed in 5 (with adjuvant external radiation therapy in 1) and 4 were treated with external radiation therapy only. The management of 40 patients with clinically suspected nodes included surveillance in 5, lymph node dissection in 27 (with adjuvant radiotherapy in 11), biopsy in 4 and external radiation therapy in 4. Postoperative radiotherapy had been given if more than 2 nodes were involved or when extracapsular growth was observed. Overall, 25 patients had a regional recurrence, 5 of whom could be cured subsequently. All regional recurrences developed within 2 years after primary treatment. Analysis showed 100% survival in histologically proved node negative patients (stage pN0). The success of lymph node dissection was related to the extent of the metastatic spread and to the number of involved nodes. Patients with 1 positive node and unilateral inguinal involvement showed a statistically significant survival advantage compared to patients with more extensive spread. Considering the indications for node dissection we found a clear relationship among T category, grade and the probability of lymph node invasion. Patients with stage T1 tumors and stage T2, grades 1 and 2 tumors presented significantly less often with lymphatic invasion than those with other categories of disease and were less likely to have a regional recurrence after treatment of the primary tumor only. In these categories we recommend surveillance of the regional lymph nodes in patients who present with unsuspected nodes. However, patients with stage T2 grade 3, stage T3 and operable stage T4 tumors should undergo an immediate inguinal node dissection because of the high probability of clinically occult lymph node invasion (in our material more than 50%). With respect to the extent of the node dissection, we found that the likelihood of spread to the contralateral and/or pelvic regions was related to the number of invaded nodes in the inguinal region. We recommend contralateral node dissection and unilateral pelvic node dissection when 2 or more positive nodes are found in the dissected groin specimen. Primary pelvic node dissection should be performed in patients who present initially with cytologically or biopsy proved positive inguinal nodes.(ABSTRACT TRUNCATED AT 400 WORDS)
Language of Publication
English
Unique Identifier
93172416

Return To Top
Return To Menu Position #60


MeSH Heading (Major)
Carcinoma, Squamous Cell|MO/PA/*SC/*TH; Penile Neoplasms|MO/PA/*TH
MeSH Heading
Adult; Aged; Aged, 80 and over; Clinical Protocols; Combined Modality Therapy; Follow-Up Studies; Human; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Age; Neoplasm Recurrence, Local|EP; Neoplasm Staging; Remission Induction; Survival Rate

Publication Type
JOURNAL ARTICLE
ISSN
0022-5347
Country of Publication
UNITED STATES

Record 64 from database: MEDLINE
Return To Top
Return To Menu Position #60

Title
Staging of cancer of the breast as a guide to therapy.
Author
Beahrs OH
Address
 
Source
Cancer, 1984 Feb, 53:3 Suppl, 592-4
Abstract
Staging of a cancer of the breast reflects the anatomic extent of the tumor either at the time of diagnosis prior to treatment based on clinical, diagnostic, and biopsy information or at the time of postsurgical resection when all pathologic information obtained or studied of the resected specimen is used. In the future, chemical or biological markers may add another dimension to staging. There have been several schemes suggested for staging breast cancer, but the current recommendation of the American Joint Committee on Cancer (AJCC) jointly with the TNM Committee of the International Union against Cancer (UICC) should be universally used. More complete definitions of staging of the primary tumor (T), nodes (N), and distant spread (M), are discussed in this report. It is stressed that, obviously, the smaller a cancer and the earlier it is diagnosed has a greater influence on therapy.
Language of Publication
English
Unique Identifier
84106261

Return To Top
Return To Menu Position #60


MeSH Heading (Major)
Breast Neoplasms|*PA
MeSH Heading
Breast|PA; Human; Lymph Nodes|PA; Lymphatic Metastasis|PA; Neoplasm Staging

Publication Type
JOURNAL ARTICLE
ISSN
0008-543X
Country of Publication
UNITED STATES

Record 65 from database: MEDLINE
Return To Top
Return To Menu Position #60

Title
Merkel cell carcinoma of the eyelid and periocular tissues.
Author
Rubsamen PE; Tanenbaum M; Grove AS; Gould E
Address
Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida 33101.
Source
Am J Ophthalmol, 1992 Jun, 113:6, 674-80
Abstract
Five patients had eyelid and periocular Merkel cell carcinoma. The tumor was located on the left lower eyelid in two patients, the left upper eyelid in one patient, the right upper eyelid in one patient, and was metastatic to the right outer canthus in one patient. The mean duration of symptoms was approximately four months. The diagnosis of Merkel cell carcinoma was not suspected clinically in any of the four primary eyelid cases, but was only established on histopathologic examination of biopsy specimens. Light microscopy disclosed carcinoma with small primitive cells in all five tumor biopsy specimens. Immunohistochemical studies showed neuron-specific enolase and keratin and transmission electron microscopy demonstrated neurosecretory granules typical for Merkel cell carcinoma. All five patients in this study were treated with wide surgical excision of the eyelid tumors with intraoperative frozen-section monitoring of the margins of resection. The left lower eyelid Merkel cell carcinoma spread to the preauricular lymph node in one patient. This patient subsequently died of metastatic Merkel cell carcinoma. One patient with metastatic right outer canthus Merkel cell carcinoma received radiotherapy (6,550 cGy). Eyelid Merkel cell carcinoma has the potential for recurrence and metastatic spread. We recommend lifetime follow-up for patients treated for eyelid Merkel cell carcinoma.
Language of Publication
English
Unique Identifier
92286335

Return To Top
Return To Menu Position #60


MeSH Heading (Major)
Carcinoma, Merkel Cell|*PA/RT/SU; Eyelid Neoplasms|*PA/RT/SU; Facial Neoplasms|*PA/RT/SU
MeSH Heading
Aged; Aged, 80 and over; Case Report; Female; Human; Lymph Nodes|PA; Lymphatic Metastasis|PA; Male; Middle Age; Neoplasm Recurrence, Local

Publication Type
JOURNAL ARTICLE
ISSN
0002-9394
Country of Publication
UNITED STATES

Record 66 from database: MEDLINE
Return To Top
Return To Menu Position #60

Title
Computed tomography in carcinoma of the rectum.
Author
Zaunbauer W; Haertel M; Fuchs WA
Address
 
Source
Gastrointest Radiol, 1981 Jan, 6:1, 79-84
Abstract
A total of 11 cases of untreated carcinoma of the rectosigmoid colon and 56 cases of recurrent rectosigmoid carcinoma have been investigated by computed tomography. A tumor size of more than 2 cm in diameter is easily demonstrated within the rectosigmoid wall. Invasion of the pararectal fatty planes and the neighboring structures and organs is conclusively diagnosed when obliteration of the demarcating fat planes is demonstrated. Enlargement of the regional lymph nodes of more than 15 mm diameter indicates malignant metastatic spread. Local malignant recurrence following complete resection of the rectum is recognized when the tumor size has reached 2 cm or more. Fine-needle aspiration biopsy may be necessary to conclusively identify malignant tissue within the postoperative cavity.
Language of Publication
English
Unique Identifier
81261785

Return To Top
Return To Menu Position #60


MeSH Heading (Major)
Rectal Neoplasms|*RA; Tomography, X-Ray Computed|*
MeSH Heading
Adult; Aged; Female; Human; Lymphatic Metastasis; Male; Middle Age; Neoplasm Recurrence, Local|RA; Neoplasm Staging|MT

Publication Type
JOURNAL ARTICLE
ISSN
0364-2356
Country of Publication
UNITED STATES

Record 67 from database: MEDLINE
Return To Top
Return To Menu Position #60

Title
Sebaceous carcinoma of meibomian gland origin. The diagnostic importance of pagetoid spread of neoplastic cells.
Author
Russell WG; Page DL; Hough AJ; Rogers LW
Address
 
Source
Am J Clin Pathol, 1980 Apr, 73:4, 504-11
Abstract
The clinical and pathologic features of four sebaceous carcinomas primary located in the eyelids were studied in detail. The neoplasms occurred in four patients of ages 62 to 76 years, were often misdiagnosed at initial excision, and recurred in all four cases. Three of the four cases required orbital exenteration, and preauricular lymph node metastases developed in two. The tumors were characterized by variable histologic growth patterns and evidence of sebaceous differentiation. Pagetoid spread of the neoplastic cells in the overlying epithelium was found in all four cases. Recognition of the pagetoid growth pattern in biopsy material was essential in correctly diagnosing two of the four cases. It is one of the important features enabling sebaceous carcinoma to be distinguished from basal cell carcinomas showing sebaceous differentiation.
Language of Publication
English
Unique Identifier
80172509

Return To Top
Return To Menu Position #60


MeSH Heading (Major)
Carcinoma|*PA/SU; Eyelid Neoplasms|*PA/SU; Eyelids|*PA; Meibomian Glands|*PA; Sebaceous Gland Neoplasms|*PA/SU
MeSH Heading
Aged; Case Report; Diagnostic Errors; Epithelium|PA; Female; Human; Lymphatic Metastasis; Male; Middle Age; Neoplasm Recurrence, Local|PA; Orbit|SU; Support, U.S. Gov't, Non-P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0002-9173
Country of Publication
UNITED STATES

Record 68 from database: MEDLINE
Return To Top
Return To Menu Position #60

Title
Prognostic significance of morphology of tumor and retroperitoneal lymph nodes in epithelial carcinoma of the ovary. I. Correlation with lymph node metastasis.
Author
Chen SS; Lee L
Address
 
Source
Gynecol Oncol, 1984 May, 18:1, 87-93
Abstract
The prognostic indices based on a morphologic study of tumor and retroperitoneal lymph nodes in 63 patients with epithelial carcinoma of the ovary are reported. The purpose of the study was to identify those variables most frequently related to nodal involvement. The cases in the series consisted of 11 Stage I, 10 Stage II, 34 Stage III, and 8 Stage IV. Histologic distribution was 60.4% serous type, 11.1% mucinous, 6.3% endometrioid, 6.3% clear cell, and 15.9% unclassified. All patients had maximal surgery and selective biopsy of para-aortic and pelvic lymph nodes. The results showed statistically significant variables associated with nodal metastasis in both primary tumor and regional lymph nodes. The indices in primary tumor were grade of tumor, vascular invasion, lymphocytic infiltration, and stromal fibrosis; those in lymph node were type of lymph node reaction, sinus histiocytosis, and fibroblastic proliferation. The nodes with lymphocyte depletion were associated with nodal spread in 81.3% of cases. It is concluded that morphologic study of tumor and lymph node could identify prognostic factors predicting regional nodal metastasis in ovarian carcinoma.
Language of Publication
English
Unique Identifier
84183805

Return To Top
Return To Menu Position #60


MeSH Heading (Major)
Lymph Nodes|IM/*PA; Ovarian Neoplasms|BS/*PA/SU; Retroperitoneal Neoplasms|*SC
MeSH Heading
Female; Human; Lymphatic Metastasis; Lymphocyte Depletion; Neoplasm Staging; Prognosis

Publication Type
JOURNAL ARTICLE
ISSN
0090-8258
Country of Publication
UNITED STATES

Record 69 from database: MEDLINE
Return To Top
Return To Menu Position #60
Return To Menu Position #70

Title
Post-thoracotomy diagnostic and staging conversion rates of clinically staged I lung cancer.
Author
Valente M; Pastorino U; Piva L; Guzzon A; Ravasi G
Address
 
Source
Tumori, 1981 May, 67:3, 239-43
Abstract
The accuracy of stage I lung cancer assessment achieved by traditional clinico-diagnostic staging was retrospectively evaluated in 164 consecutive patients who underwent thoracotomy. The diagnostic conversion rate was 6.7% (1 carcinoid and 10 innocent pulmonary lesions) and occurred only in the subset of patients lacking preoperative pathologic confirmation (15%). The conversion rate to unresectable tumor extent was 8% (11/153), and local spread was the main cause of unresectability (5.5%). The staging conversion rate was 29% (43/153): the conversion rate for nodal evaluation was double that of primary tumor evaluation (24% versus 12%), but conversion to anatomically unresectable nodal diffusion occurred in only one patient (0.6%). The ability of the surgeon to convert the wrong diagnosis was scanty without extemporary biopsy, and 7 patients with innocent lesions underwent standard resection for primary cancer. Surgical staging was a precise as pathological staging in primary tumor evaluation, but was faulty in nodal evaluation (15% error in sN- and sN1-2 assessment). It is concluded that following stage I lung cancer assessment by traditional means, supplementary examinations are requested for a better sensitivity of pathological confirmation and a better refinement of local spread. Better nodal evaluation has less value until a biologic limit to surgery for anatomically resectable nodal diffusion is universally accepted.
Language of Publication
English
Unique Identifier
82018500

Return To Top
Return To Menu Position #60
Return To Menu Position #70


MeSH Heading (Major)
Lung Neoplasms|DI/*PA
MeSH Heading
Adult; Aged; Diagnostic Techniques, Surgical; Female; Human; Lymphatic Metastasis; Male; Middle Age; Neoplasm Staging; Retrospective Studies

Publication Type
JOURNAL ARTICLE
ISSN
0300-8916
Country of Publication
ITALY

Record 70 from database: MEDLINE
Return To Top
Return To Menu Position #60
Return To Menu Position #70

Title
Preoperative prediction of nodal state in gastric cancer by nuclear DNA content.
Author
Hashizume T; Nakajima T; Nagamachi Y
Address
First Department of Surgery, Gumma University School of Medicine, Japan.
Source
Eur J Surg, 1991 Apr, 157:4, 267-9
Abstract
To see if there was an association between the number of lymph node metastases and the macroscopic findings of the tumour (such as size, location, and gross appearance), the nuclear DNA content was cytophotometrically analysed in biopsy specimens taken at preoperative endoscopy from 84 cases of gastric cancer. The DNA ploidy patterns were classified into type D, type A1, and type A2, according to the stem lines and the degree of scatter of the cells. Lymph nodes were positive in 2 of 20 (10%) in type D and 10 of 30 (33%) in type A1; these were both significantly lower than that in type A2 (24 of 34, 71%). Knowing the degree of nodes metastases or the microscopic lymphatic spread before the operation is almost impossible at present; the nuclear DNA content is closely associated with metastatic content of the nodes, so the cytophotometric determination of the DNA ploidy patterns from biopsy specimens may be useful in predicting the nodal state.
Language of Publication
English
Unique Identifier
91308501

Return To Top
Return To Menu Position #60
Return To Menu Position #70


MeSH Heading (Major)
DNA, Neoplasm|*AN; Lymphatic Metastasis|*DI; Stomach Neoplasms|*PA/SU
MeSH Heading
Aged; Female; Human; Male; Middle Age; Ploidies

Publication Type
JOURNAL ARTICLE
ISSN
1102-4151
Country of Publication
SWEDEN

Record 71 from database: MEDLINE
Return To Top
Return To Menu Position #60
Return To Menu Position #70

Title
Infratentorial glioblastoma: the role of neuraxis irradiation.
Author
Kopelson G; Linggood R
Address
 
Source
Int J Radiat Oncol Biol Phys, 1982 Jun, 8:6, 999-1003
Abstract
The patterns of clinical-and autopsy-documented tumor spread were evaluated for 15 patients with biopsy-proven infratentorial (8 cerebellar, 2 brainstem, 5 intramedullary spinal cord) glioblastoma. No patient developed clinical nor autopsy evidence of subarachnoid dissemination, even though no patient had received craniospinal axis irradiation. Fully 14 of the 21 previously reported patients with subarachnoid dissemination from infratentorial glioblastoma had this diagnosis made only at autopsy. The overall poor prognosis at present (8% 3-year survival from the present series and recent literature) along with the demonstrated pattern of local-regional aggressiveness as the major form of initial spread and post-irradiation recurrence, suggests that routine craniospinal axis irradiation may not be indicated for most patients with infratentorial glioblastoma.
Language of Publication
English
Unique Identifier
82265210

Return To Top
Return To Menu Position #60
Return To Menu Position #70


MeSH Heading (Major)
Astrocytoma|*RT; Brain Neoplasms|*RT; Cerebellar Neoplasms|*RT; Glioma|*RT; Spinal Cord Neoplasms|*RT
MeSH Heading
Adolescence; Adult; Aged; Brain Stem; Child; Female; Follow-Up Studies; Human; Male; Middle Age; Neoplasm Metastasis; Prognosis

Publication Type
JOURNAL ARTICLE
ISSN
0360-3016
Country of Publication
UNITED STATES

Record 72 from database: MEDLINE
Return To Top
Return To Menu Position #60
Return To Menu Position #70

Title
Adenocarcinoma of the gastric cardia. The choice of gastrectomy.
Author
Papachristou DN; Fortner JG
Address
 
Source
Ann Surg, 1980 Jul, 192:1, 58-64
Abstract
A retrospective study of 101 patients with adenocarcinoma of the gastric cardia treated with proximal subtotal, extended proximal subtotal, total, and extended total gastrectomy demonstrated the following: 1) There were no five year survivors among patients with TNM stage III and IV disease. 2) Surgical treatment was curative only in the presence of stage I and II disease, where extended total gastrectomy resulted in a significantly higher survival rate than proximal subtotal gastrectomy (p less than 0.03). 3) Proximal subtotal gastrectomy resulted in a high incidence of local recurrence, particularly when it was applied in patients with stage I and II neoplasms. 4) There were no significant differences in operative mortality between the four procedures. Since the choice of operative procedure makes a difference only in patients with TNM stage I and II disease, intraoperative classification should be considered in the management of adenocarcinoma of the cardia. Classification should be based on lymph node biopsy unless the neoplasm has spread beyond the confines of gastrectomy.
Language of Publication
English
Unique Identifier
80264331

Return To Top
Return To Menu Position #60
Return To Menu Position #70


MeSH Heading (Major)
Adenocarcinoma|MO/PA/*SU; Cardia|*; Gastrectomy|*MT; Stomach Neoplasms|MO/PA/*SU
MeSH Heading
Adult; Aged; Comparative Study; Esophageal Neoplasms|SC/SU; Esophagogastric Junction|SU; Female; Follow-Up Studies; Human; Lymphatic Metastasis; Male; Middle Age; Neoplasm Staging; Retrospective Studies; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0003-4932
Country of Publication
UNITED STATES

Record 73 from database: MEDLINE
Return To Top
Return To Menu Position #60
Return To Menu Position #70

Title
Bone marrow evaluation in small cell lung cancer.
Author
Muss HB; Jackson DV Jr; Richards F 2d; White DR; Cooper MR; Stuart JJ; Spurr CL; Lawhon K; Watson NE; Shore A
Address
 
Source
Am J Clin Oncol, 1984 Feb, 7:1, 59-63
Abstract
The records of 87 patients with small cell lung cancer were reviewed. Patients were clinically staged with bone marrow aspirate and biopsy as well as radionuclide scans of bone, liver, and brain. Extrathoracic spread was noted in 54% (47/87) and limited disease in 46% (40/87). The bone marrow evaluation was positive in 13/62 patients (21%) and seven of these thirteen patients had normal bone scans (54%). Of these seven patients, five had no other evidence of distant metastases and their survival was 7-10 months, considerably shorter than patients found to have limited disease. Bone marrow examination appears to complement radionuclide scanning in the initial staging of patients with small cell carcinoma of the lung and provides important prognostic information.
Language of Publication
English
Unique Identifier
84125193

Return To Top
Return To Menu Position #60
Return To Menu Position #70


MeSH Heading (Major)
Bone Marrow Examination|*; Carcinoma, Small Cell|MO/*TH; Lung Neoplasms|MO/*TH
MeSH Heading
Bone and Bones|RI; Bone Neoplasms|SC; Brain|RI; Combined Modality Therapy; Evaluation Studies; Human; Liver|RI; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Retrospective Studies; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0277-3732
Country of Publication
UNITED STATES

Record 74 from database: MEDLINE
Return To Top
Return To Menu Position #60
Return To Menu Position #70

Title
Current imaging strategies for colorectal cancer.
Author
Collier BD; Foley WD
Address
Department of Nuclear Medicine, Medical College of Wisconsin, Milwaukee 53226.
Source
J Nucl Med, 1993 Mar, 34:3 Suppl, 537-40
Abstract
Endoscopy and barium enema examinations are used to identify the primary site of disease in patients with clinical suspicion of colorectal cancer. Once colorectal cancer has been confirmed by imaging studies and biopsy, preoperative evaluation is directed toward accurate disease staging. Most currently available imaging techniques are inaccurate for detecting transmural extension, perienteric spread of tumors and distant lymph node involvement. Although both computed tomography (CT) and magnetic resonance imaging (MRI) have an unacceptably low sensitivity for accurate staging, CT is clearly superior to MRI for detecting extrahepatic metastases. Transrectal ultrasonography, however, is a promising new method for detecting perirectal spread of disease. The diagnostic efficacy of MRI and intravenous dynamic hepatic CT for detecting liver metastases is approximately equal. CT during arterial portography is recommended before resection of solitary liver metastases. Chest radiography is also part of the routine preoperative evaluation. Bone scans are rarely performed in patients without the skeletal pain suggestive of bone metastases. During the years following surgery for colorectal cancer, many patients undergo special imaging studies to identify local tumor recurrence, secondary tumor growth elsewhere within the large bowel and both regional and distant spread of disease. Thus, for the patient with a sharply increasing carcinoembryonic antigen level, CT of the abdomen and liver is the current recommendation. Immunoscintigraphy is a new imaging modality that addresses some of the limitations of current diagnostic procedures for colorectal cancer. This procedure gives whole body information on disease extent, especially in the extrahepatic abdomen and pelvis, and can therefore contribute to patient management decisions.
Language of Publication
English
Unique Identifier
93179987

Return To Top
Return To Menu Position #60
Return To Menu Position #70


MeSH Heading (Major)
Colorectal Neoplasms|*DI/PA
MeSH Heading
Human; Liver Neoplasms|SC; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
0161-5505
Country of Publication
UNITED STATES

Record 75 from database: MEDLINE
Return To Top
Return To Menu Position #60
Return To Menu Position #70

Title
Thoracic metastases from carcinoma of the nasopharynx: high frequency of hilar and mediastinal lymphadenopathy.
Author
Daly BD; Leung SF; Cheung H; Metreweli C
Address
Department of Diagnostic Radiology and Organ Imaging, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin.
Source
AJR Am J Roentgenol, 1993 Feb, 160:2, 241-4
Abstract
OBJECTIVE. Nasopharyngeal carcinoma is a malignant tumor commonly encountered in Chinese patients living in or originating from Hong Kong or southern China. This article describes the previously unreported radiologic appearances of thoracic metastases from nasopharyngeal carcinoma. MATERIALS AND METHODS. The radiographic (33 patients) and CT (eight patients) appearances of thoracic metastases from nasopharyngeal carcinoma were studied retrospectively. All 33 patients had biopsy-proved primary nasopharyngeal carcinoma, and seven patients had biopsy-proved thoracic metastases. Radiologic and clinical evidence of metastases was unequivocal in 26 others, 16 of whom had synchronous spread to cervical lymph nodes, bone, or liver. RESULTS. Twenty-one patients (64%) had evidence of thoracic lymphadenopathy, most frequently hilar (n = 18, 55%), on chest radiographs or CT scans. Seventeen patients (52%) had evidence of multiple parenchymal pulmonary metastases. Enlargement of lymph nodes without multiple pulmonary deposits was seen in 12 patients (36%), seven of whom had radiologic signs of bronchial obstruction, hemoptysis, or a single pulmonary lesion simulating a synchronous bronchial neoplasm. Pleural effusions or deposits (n = 6), lymphangitis carcinomatosa (n = 5), and rib metastases (n = 4) also were seen. CONCLUSION. Metastases from nasopharyngeal carcinoma may be detected in a wide range of thoracic sites. This disease appears to be as likely to disseminate to the mediastinal or hilar lymph nodes as to the pulmonary parenchyma, and it can simulate a primary bronchial tumor or lymphoma.
Language of Publication
English
Unique Identifier
93142635

Return To Top
Return To Menu Position #60
Return To Menu Position #70


MeSH Heading (Major)
Carcinoma, Squamous Cell|RA/*SC; Lymph Nodes|*RA; Nasopharyngeal Neoplasms|*PA; Thoracic Neoplasms|RA/*SC
MeSH Heading
Adult; Female; Human; Lung Neoplasms|RA/SC; Lymphatic Metastasis|RA; Male; Mediastinal Neoplasms|RA/SC; Middle Age; Retrospective Studies; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
0361-803X
Country of Publication
UNITED STATES

Record 76 from database: MEDLINE
Return To Top
Return To Menu Position #60
Return To Menu Position #70

Title
Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis [see comments]
Author
Yamamura K; Kibbey MC; Jun SH; Kleinman HK
Address
Laboratory of Developmental Biology, National Institute of Dental Research, NIH, Bethesda, MD 20892.
Source
Semin Cancer Biol, 1993 Aug, 4:4, 259-65
Abstract
Basement membrane has a variety of effects on tumor cells and promotes malignant behavior. Tumor cell growth is enhanced both in vitro and in vivo in mice in the presence of basement membrane. This has led to the ability to grow various tumors including human biopsy specimens in nude mice. Furthermore, low cell numbers can be used when coinjected with Matrigel, a basement membrane extract. The basement membrane glycoprotein laminin is important in promoting invasive behavior and the level of a 32/67 kDa laminin receptor has been shown to correlate with malignancy. A sequence of five amino acids, tyrosine-isoleucine-glycine-serine-arginine (YIGSR) has been shown to recognize this receptor and to reduce experimental metastases (tail vein injection resulting in colonization of the lung) and subcutaneous tumor growth. This peptide is active in both models either when coinjected or when daily intraperitoneal injections are given after tumor growth has initiated. YIGSR does not effect cell arrest but does inhibit angiogenesis which is necessary for tumor growth. YIGSR also appears to have an additional antitumor effect via its interaction with a specific receptor. YIGSR-adherent cells established after 30 successive selections on YIGSR-coated dishes in vitro formed more lung colonies after intravenous injection and larger tumors after subcutaneous injection than the parent B16F10 melanoma cells. The YIGSR-non-adherent cells formed fewer lung colonies and smaller subcutaneous tumors. These data demonstrate the importance of laminin-tumor cell interactions in malignancies and suggest that a short sequence from laminin has multiple effects in reducing tumor growth and spread.(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
94003091

Return To Top
Return To Menu Position #60
Return To Menu Position #70


MeSH Heading (Major)
Collagen|CH/*PH; Laminin|CH/*PH; Neoplasms, Experimental|*PA; Oligopeptides|CH/*PH; Proteoglycans|CH/*PH
MeSH Heading
Amino Acid Sequence; Animal; Basement Membrane|PH; Cell Division|DE; Drug Combinations; Human; Mice; Molecular Sequence Data; Neoplasm Metastasis; Receptors, Laminin|PH; Tumor Cells, Cultured

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
1044-579X
Country of Publication
UNITED STATES

Record 77 from database: MEDLINE
Return To Top
Return To Menu Position #70

Title
Thoracoscopic lymph node staging for esophageal cancer.
Author
Krasna MJ; McLaughlin JS
Address
Division of Thoracic and Cardiovascular Surgery, University of Maryland School of Medicine, Baltimore 21201.
Source
Ann Thorac Surg, 1993 Sep, 56:3, 671-4
Abstract
Thoracoscopy allows evaluation of the mediastinum and assessment of the local spread of malignancy. Adjuvant therapy trials have shown some increased survival for esophageal cancer although morbidity is high. Preoperative staging may allow appropriate allocation of adjuvant therapy. Patients with esophageal cancer underwent computed tomographic scan, magnetic resonance imaging, and endoesophageal ultrasonography. Thoracoscopic staging was performed through the left chest with biopsy of American Thoracic Society level 5 and 6 and 8 and 9 lymph nodes. Resection at a separate sitting with complete intraoperative lymph node sampling was done. Fourteen patients underwent thoracoscopic lymph node staging. One procedure could not be completed because of adhesions. Of the 13 patients undergoing successful staging, all had correct thoracic lymph node staging confirmed at surgical exploration. Two patients with adenocarcinoma of the distal third/gastroesophageal junction were found at laparotomy to have positive celiac lymph nodes. Two patients who had lymph nodes positive at computed tomographic scan and magnetic resonance imaging were found to have negative lymph nodes at thoracoscopy and subsequent resection. Two patients were found to have pulmonary metastasis at thoracoscopy. Lymph node stage in esophageal carcinoma is an important prognostic indicator. Thoracoscopic lymph node staging provides accurate pre-resection staging information.
Language of Publication
English
Unique Identifier
93393316

Return To Top
Return To Menu Position #70


MeSH Heading (Major)
Adenocarcinoma|PA/*SC; Carcinoma, Squamous Cell|PA/*SC; Esophageal Neoplasms|*PA; Thoracoscopy|*
MeSH Heading
Comparative Study; Diagnostic Imaging; Female; Human; Lymphatic Metastasis; Male; Neoplasm Staging

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE
ISSN
0003-4975
Country of Publication
UNITED STATES

Record 78 from database: MEDLINE
Return To Top
Return To Menu Position #70

Title
Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.
Author
Kanda S; Cochran AJ; Lee WR; Morton DL; Irie RF
Address
Department of Surgery, Jonsson Comprehensive Cancer Center, UCLA School of Medicine 90024.
Source
Int J Cancer, 1992 Nov, 52:5, 682-7
Abstract
Gangliosides may play an important role in the proliferation and spread of human malignant melanoma. Because the frequency of metastases in uveal and cutaneous melanoma differs, it is possible that they may express different gangliosides. We analyzed the ganglioside profiles of primary uveal melanoma in 14 cases and of cutaneous melanoma metastasis in 19 cases. In cutaneous melanoma, GM3 ranged from 4.2% to 74.6% and GD3 from 22.1% to 91.8% of total lipid-bound sialic acid. GM2 (found in 13 of 19 cases, ranging from 0.5% to 11.7%), GD2 (11/19, 0.5%-22.0%) and 9-O-acetyl-GD3 (13/19, 0.5%-12.6%) were also frequently observed. By contrast, in 11 cases of uveal melanoma, GM3 was > 90%, GD3 was < 10%, GM2 was < 1.1%; neither GD2 nor 9-O-acetyl-GD3 were detected. The ganglioside profiles of these uveal melanomas were virtually identical to those of normal melanocytes obtained from foreskins. Histological examination of these 11 biopsies showed a monomorphous cell composition, but neither infiltration of lymphocytes or melanophages nor cell necrosis was observed. In 3 other cases, GD3 was increased to 19.5%-46.0%. Histological examination of these 3 biopsy specimens showed at least 2 populations of tumor cells that were separable based on morphological grounds, and mononuclear inflammatory cells interspersed among the tumor cells. An increase in GD3 appears to be related to tumor polyclonality and infiltration of the tumor by lymphocytes and macrophages. These results suggest that ganglioside expression of uveal melanoma is associated with host immune responses to the tumor. Furthermore, the low metastatic capacity of uveal melanoma, in contrast to the high metastatic rate of cutaneous melanoma, may be a result of its differentiated ganglioside expression, which is strikingly similar to that of normal melanocytes.
Language of Publication
English
Unique Identifier
93052851

Return To Top
Return To Menu Position #70


MeSH Heading (Major)
Gangliosides|*CH; Melanoma|*CH/PA; Uveal Neoplasms|*CH/PA
MeSH Heading
Human; Neoplasm Metastasis; Skin Neoplasms|CH; Support, U.S. Gov't, P.H.S.

Publication Type
JOURNAL ARTICLE
ISSN
0020-7136
Country of Publication
UNITED STATES

Record 79 from database: MEDLINE
Return To Top
Return To Menu Position #70

Title
Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma [published erratum appears in Cancer Res 1987 Nov 15;47(22):6161]
Author
Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
Address
 
Source
Cancer Res, 1987 Aug, 47:15, 4218-24
Abstract
Monoclonal antibody (MAb) B72.3 has been shown to have selective reactivity for a wide range of carcinomas (colorectal, ovarian, breast, lung, gastric, and endometrial) versus normal adult tissues. 131I-Labeled B72.3 IgG has recently been shown to selectively bind carcinoma lesions when administered i.v. in patients with metastatic colorectal cancer. We report here the first direct comparison of i.p. administered [131I]B72.3 IgG to specifically localize metastatic carcinoma. Three of 10 patients studied were negative for tumor detection by both CAT scan and X-ray but were positive for tumor localization via gamma scanning i.p. administered 131I-labeled MAb B72.3 IgG. Direct analyses of biopsy specimens of carcinoma and normal tissues demonstrated ratios of greater than 70:1 (based on percentage of injected dose/mg) for tumor MAb localization versus normal tissues. Specificity of [131I]B72.3 tumor targeting was demonstrated by the concomitant administration of an equal dose of an 125I-labeled isotype identical (IgG1) control MAb. Simultaneous i.p. administration of [131I]B72.3, and i.v. administration of [125I]B72.3 in individual patients demonstrated: peritoneal implants are targeted more efficiently via i.p. MAb administration, and hematogenously spread and lymph node metastases as well as local recurrences are targeted more efficiently by i.v. administered MAb. No antibody toxicity was observed in any patients. Pharmacokinetics of MAb clearance demonstrated that only 10 to 30% of the i.p. administered MAb was found in plasma. These studies thus demonstrate the efficacy of intracavitary MAb administration as well as the advantage of the concomitant use of intracavitary and i.v. administered MAbs for tumor targeting and for potential MAb guided therapy of metastatic carcinoma.
Language of Publication
English
Unique Identifier
87273209

Return To Top
Return To Menu Position #70


MeSH Heading (Major)
Antibodies, Monoclonal|AD/*DU/ME; Antibodies, Neoplasm|AD/*DU/ME; Colonic Neoplasms|IM/*PA; Neoplasm Metastasis|IM/*RI; Rectal Neoplasms|IM/*PA
MeSH Heading
Adolescence; Adult; Antibody Specificity; Human; Injections, Intraperitoneal; Injections, Intravenous; Iodine Radioisotopes|AD/DU; Metabolic Clearance Rate; Middle Age

Publication Type
JOURNAL ARTICLE
ISSN
0008-5472
Country of Publication
UNITED STATES

Record 80 from database: MEDLINE
Return To Top
Return To Menu Position #70
Return To Menu Position #80

Title
Progress in the recognition and treatment of soft tissue sarcomas.
Author
Eilber FR; Huth JF; Mirra J; Rosen G
Address
Department of Surgery/Oncology, University of California, Los Angeles 90024.
Source
Cancer, 1990 Feb, 65:3 Suppl, 660-6
Abstract
Over the past 10 years there has been significant progress made in the recognition and treatment of soft tissue sarcomas. With the advent of CAT scans and MRI, preoperative delineation of soft tissue tumors has become readily available. The diagnostic use of these modalities in patients presenting with an ill-defined asymptomatic mass has been extremely helpful in terms of screening patients to decide whether or not a biopsy is indicated. These techniques have also provided a much clearer delineation of the anatomic extent of the primary tumor, which has been of great assistance both in radiation therapy treatment calculations as well as in preoperative surgical planning. The recognition that tumor grade is the dominant prognostic variable has resulted in the more common use of a grading system, and a more uniform reporting and stratification of end results. Recent studies with immunohistochemical staining have proven of value in determining the histogenesis of many tumors that in the past were difficult to classify accurately. Most recently the use of flow cytometry suggests that this will also be a valuable adjunct in determining tumor grade and thereby prognosis. The most recent investigations of molecular biologic evaluation of genetic DNA and RNA sequences, as well as of oncogenes are extremely interesting from a diagnostic standpoint and in demonstrating the potential of molecular biologic evaluation for understanding the origin of these tumors. Multimodality therapy with surgery, radiation, chemotherapy, or all three has resulted in a marked improvement in local tumor control for patients with soft tissue sarcomas. The combination of modalities has allowed smaller surgical excisions of the tumor and thereby preservation of the extremity and much of its function. There are currently several different methods of multimodality therapy used including neoadjuvant therapy and postoperative therapy, both of which have been proven efficacious. Chemotherapy is now playing an increased role in clinical investigation and treatment. The availability of Adriamycin, DTIC, cisplatin, and most recently ifosfamide has added several chemotherapeutic agents for use by the clinician. Combination chemotherapy and radiation is of value in the neoadjuvant setting, and several studies are now underway to determine whether postoperative adjuvant chemotherapy is of similar value in reducing systemic spread of disease. Finally, surgical resection of pulmonary metastases has been proven of value in 20% to 25% of patients who subsequently develop metastatic disease. As a result of these advances in several different treatment disciplines, the overall survival rate and quality of life of patients with soft tissue sarcoma have improved markedly over the past 10 years.(ABSTRACT TRUNCATED AT 400 WORDS)
Language of Publication
English
Unique Identifier
90149988

Return To Top
Return To Menu Position #70
Return To Menu Position #80


MeSH Heading (Major)
Sarcoma|*/DI/PA/TH; Soft Tissue Neoplasms|*/DI/PA/TH
MeSH Heading
Antineoplastic Agents, Combined|TU; Brachytherapy; Clinical Trials; Combined Modality Therapy; Human; Immunohistochemistry; Magnetic Resonance Imaging; Neoplasm Metastasis; Tomography, X-Ray Computed

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE; REVIEW; REVIEW LITERATURE
ISSN
0008-543X
Country of Publication
UNITED STATES

Record 81 from database: MEDLINE
Return To Top
Return To Menu Position #70
Return To Menu Position #80

Title
Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.
Author
Horenblas S; van Tinteren H; Delemarre JF; Moonen LM; Lustig V; van Waardenburg EW
Address
Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoekhuis, Amsterdam.
Source
J Urol, 1993 Mar, 149:3, 492-7
Abstract
We analyzed the management of regional lymph nodes in 110 patients with squamous cell carcinoma of the penis treated at the Netherlands Cancer Institute between 1956 and 1989 with curative intent. Of 66 patients who presented with unsuspected nodes 57 were placed on a surveillance program, while lymph node dissection was performed in 5 (with adjuvant external radiation therapy in 1) and 4 were treated with external radiation therapy only. The management of 40 patients with clinically suspected nodes included surveillance in 5, lymph node dissection in 27 (with adjuvant radiotherapy in 11), biopsy in 4 and external radiation therapy in 4. Postoperative radiotherapy had been given if more than 2 nodes were involved or when extracapsular growth was observed. Overall, 25 patients had a regional recurrence, 5 of whom could be cured subsequently. All regional recurrences developed within 2 years after primary treatment. Analysis showed 100% survival in histologically proved node negative patients (stage pN0). The success of lymph node dissection was related to the extent of the metastatic spread and to the number of involved nodes. Patients with 1 positive node and unilateral inguinal involvement showed a statistically significant survival advantage compared to patients with more extensive spread. Considering the indications for node dissection we found a clear relationship among T category, grade and the probability of lymph node invasion. Patients with stage T1 tumors and stage T2, grades 1 and 2 tumors presented significantly less often with lymphatic invasion than those with other categories of disease and were less likely to have a regional recurrence after treatment of the primary tumor only. In these categories we recommend surveillance of the regional lymph nodes in patients who present with unsuspected nodes. However, patients with stage T2 grade 3, stage T3 and operable stage T4 tumors should undergo an immediate inguinal node dissection because of the high probability of clinically occult lymph node invasion (in our material more than 50%). With respect to the extent of the node dissection, we found that the likelihood of spread to the contralateral and/or pelvic regions was related to the number of invaded nodes in the inguinal region. We recommend contralateral node dissection and unilateral pelvic node dissection when 2 or more positive nodes are found in the dissected groin specimen. Primary pelvic node dissection should be performed in patients who present initially with cytologically or biopsy proved positive inguinal nodes.(ABSTRACT TRUNCATED AT 400 WORDS)
Language of Publication
English
Unique Identifier
93172416

Return To Top
Return To Menu Position #70
Return To Menu Position #80


MeSH Heading (Major)
Carcinoma, Squamous Cell|MO/PA/*SC/*TH; Penile Neoplasms|MO/PA/*TH
MeSH Heading
Adult; Aged; Aged, 80 and over; Clinical Protocols; Combined Modality Therapy; Follow-Up Studies; Human; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Age; Neoplasm Recurrence, Local|EP; Neoplasm Staging; Remission Induction; Survival Rate

Publication Type
JOURNAL ARTICLE
ISSN
0022-5347
Country of Publication
UNITED STATES

Record 82 from database: MEDLINE
Return To Top
Return To Menu Position #70
Return To Menu Position #80

Title
Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma.
Author
Sian KU; Wagner JD; Sood R; Park HM; Havlik R; Coleman JJ
Address
Department of Surgery, Indiana University Medical Center, Indianapolis, USA.
Source
Ann Plast Surg, 1999 Jun, 42:6, 679-82
Abstract
Merkel cell carcinoma (MCC) is a rare cutaneous malignancy characterized by an aggressive clinical behavior with high rates of locoregional and systemic recurrence. Regional disease and distant metastases are associated with poor prognosis. Despite a predisposition of MCC to spread via the lymphatics, prophylactic lymph node dissection in the absence of clinically apparent lymph node involvement is controversial. The value of lymphoscintigraphy in cutaneous melanoma is established in lesions with ambiguous lymphatic drainage patterns. When used with sentinel lymph node biopsy (SLNB), it can identify subjects with occult regional node metastasis. The authors present 2 patients with MCC who underwent regional node staging with lymphoscintigraphy-directed SLNB. Both patients had sentinel nodes that were positive for metastatic disease. In patients with MCC, minimally invasive regional node staging SLNB may be useful in limiting the sequelae of routine lymphadenectomies. Whether early identification and treatment of patients with occult regional node disease can influence survival in MCC is not known.
Language of Publication
English
Unique Identifier
99310181

Return To Top
Return To Menu Position #70
Return To Menu Position #80


MeSH Heading (Major)
Carcinoma, Merkel Cell|PA/*RI/SU; Lymph Nodes|PA/*RI; Skin Neoplasms|PA/*RI/SU
MeSH Heading
Aged; Case Report; Female; Human; Lymph Node Excision; Lymphatic Metastasis|RI; Neoplasm Staging; Radiopharmaceuticals|DU; Technetium Tc 99m Sulfur Colloid|DU

Publication Type
JOURNAL ARTICLE
ISSN
0148-7043
Country of Publication
UNITED STATES

Record 83 from database: MEDLINE
Return To Top
Return To Menu Position #70
Return To Menu Position #80

Title
Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer.
Author
Chariyalertsak S; Sugano K; Ohkura H; Mori Y
Address
Division of Clinical Laboratory, National Cancer Center Hospital, Thailand.
Source
Tumour Biol, 1994, 15:5, 294-303
Abstract
Resected specimens of 288 primary stomach cancers (175 early cases and 113 advanced cases) and recurrent tumors or biopsy specimens of 21 recurrent or inoperable metastatic stomach cancers were examined immunohistochemically for expression of c-erbB-2 oncogene product. c-erbB-2 protein-positive staining was detected in 6.9, 15.9 and 28.6% of early, advanced and recurrent or inoperable metastatic stomach cancers, respectively, the difference being significant (p < 0.005). Four patients with advanced cancer showed positive staining in metastatic lymph nodes but not in the primary tumors. The results of tissue immunostaining were compared with c-erbB-2 protein levels in sera of the patients measured by an enzyme-linked immunosorbent assay. The levels of this oncogene product were consistently low in the sera of most of the patients with primary stomach cancers, regardless of whether or not c-erbB-2 protein was expressed in the tumor. However, in the recurrent or inoperable metastatic stomach cancers, 5 of 6 patients with c-erbB-2 protein-positive tumors showed elevated levels of c-erbB-2 protein in the serum. After following up c-erbB-2 protein levels in the sera of 3 patients during the period of chemotherapy against recurrent or inoperable metastatic disease, we found that the levels increased only in the late stage. These results suggest that, in stomach cancer, c-erbB-2 protein is likely to be excreted into the serum at a relatively late stage, reflecting systemic spread of the disease.
Language of Publication
English
Unique Identifier
95084089

Return To Top
Return To Menu Position #70
Return To Menu Position #80


MeSH Heading (Major)
Adenocarcinoma|*ME/PA; Carcinoma, Signet Ring Cell|*ME/PA; Proto-Oncogene Proteins c-erbB-2|*BI/BL; Stomach Neoplasms|BL/DT/*ME/PA; Tumor Markers, Biological|*AN/BL
MeSH Heading
Antineoplastic Agents, Combined|TU; Cell Membrane|PA; Comparative Study; Enzyme-Linked Immunosorbent Assay; Human; Immunohistochemistry; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Recurrence; Support, Non-U.S. Gov't

Publication Type
CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; JOURNAL ARTICLE
ISSN
1010-4283
Country of Publication
SWITZERLAND

Record 84 from database: MEDLINE
Return To Top
Return To Menu Position #80

Title
Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.
Author
Visonneau S; Cesano A; Torosian MH; Miller EJ; Santoli D
Address
The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104, USA.
Source
Am J Pathol, 1998 May, 152:5, 1299-311
Abstract
We evaluated the growth and metastatic potential of two human breast cancer cell lines and 16 patient-derived biopsy specimens, representing the most common histological types of breast carcinomas, upon subcutaneous implantation into severe combined immunodeficient (SCID) mice. The method of engraftment we used, based on implantation of intact tissue specimens and complete immunosuppression of the host, provided an easier system to grow human breast carcinoma specimens in mouse models and resulted in a 50% success rate of tumor take. No correlation was found between growth in SCID mice and pathological diagnosis, grading, or estrogen/progesterone receptor expression by the tumor biopsy specimen. Serial passage of the tumor fragments in SCID mice resulted in increased metastasis rates and more rapid emergence of a palpable tumor mass. A tumor from a patient with infiltrating ductal carcinoma, which grew aggressively and metastasized in 100% of the female SCID mice, was also successfully engrafted in 100% of nonobese diabetic (NOD)/SCID female mice, but systemic spread was minimal. Fragments of the same tumor grew in only 33% of male SCID mice with very limited metastases. A strong correlation (r = 0.997) was observed between tumor burden and the presence of soluble (serum) interleukin-2 receptor, a marker associated with a subset of human breast tumors. All together, these data indicate the usefulness of SCID/human breast tumor xenografts for measuring tumor progression and evaluating novel therapeutic approaches to breast cancer.
Language of Publication
English
Unique Identifier
98248312

Return To Top
Return To Menu Position #80


MeSH Heading (Major)
Breast Neoplasms|BL/GE/*PA; Carcinoma, Infiltrating Duct|BL/GE/*PA; Carcinoma, Lobular|BL/GE/*PA; Severe Combined Immunodeficiency|*PA
MeSH Heading
Adenocarcinoma|PA; Aged; Animal; Etoposide|AD; Female; Human; Injections, Intravenous; Injections, Subcutaneous; Lymphatic Metastasis|PA; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Age; Neoplasm Transplantation; Polymerase Chain Reaction; Support, Non-U.S. Gov't; Transplantation, Heterologous; Tumor Cells, Cultured|PA/TR; Tumor Markers, Biological|BL

Publication Type
JOURNAL ARTICLE
ISSN
0002-9440
Country of Publication
UNITED STATES

Record 85 from database: MEDLINE
Return To Top
Return To Menu Position #80

Title
Laparoscopic lymph node assessment in pretherapeutic staging of gastric and esophageal cancer.
Author
Rau B; Hünerbein M; Reingruber B; Hohenberger P; Schlag PM
Address
Virchow Klinikum, Medical Faculty of the Humboldt University, Robert-RÂossle Cancer Hospital, Max DelbrÂuck Center of Molecular Medicine, Berlin, Germany.
Source
Recent Results Cancer Res, 1996, 142:, 209-15
Abstract
In gastric cancer lymph node metastases at the hepatoduodenal ligament and in esophageal cancer, metastases at the celiac axis are classified as distant metastases (M1 LYMPH) and implying a poor prognosis. In pretherapeutic staging, imaging procedures such as computed tomography of the abdomen or transcutaneous ultrasonic examination are of limited value in the assessment of enlarged or metastatic lymph nodes. Conversely, laparoscopic staging with subsequent biopsy of suspicious lymph nodes provides essential diagnostic information. After exclusion of distant metastases (liver, lung, bone) in 73 patients with esophageal-(n = 21) and gastric cancer (n = 52), staging laparoscopy, including laparoscopic ultrasound, were performed during an 18-month-period (July/ 93-December/94). After laparoscopic exclusion of peritoneal seedings, the hepatoduodenal ligament was examined and enlarged lymph nodes were biopsied. In a total of 73 patients, laparoscopy revealed previously undiagnosed liver metastases in 14 and peritoneal carcinosis in 19 patients. Additionally, in eight (esophageal cancer; n = 3, gastric cancer; n = 5) of the remaining 40 patients, lymph nodes in the M1-position were regarded suspicious and biopsied. In six of these, malignant spread was observed. Thus, in a further six of 40 patients, surgically incurable situations could be detected. In esophageal and gastric cancer, staging laparoscopy, including laparoscopic ultrasound and biopsy, is a sensitive technique to assess local tumor spread and distant metastases. The detection of M1- lymph node metastases is facilitated by the use of laparoscopic ultrasound. Tumor spread, which limits surgical curability, can be properly assessed and exploratory laparotomy avoided.
Language of Publication
English
Unique Identifier
97048507

Return To Top
Return To Menu Position #80


MeSH Heading (Major)
Esophageal Neoplasms|*PA/TH; Stomach Neoplasms|*PA/TH
MeSH Heading
Human; Laparoscopy; Lymphatic Metastasis; Neoplasm Staging

Publication Type
JOURNAL ARTICLE
ISSN
0080-0015
Country of Publication
GERMANY

Record 86 from database: MEDLINE
Return To Top
Return To Menu Position #80

Title
Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes.
Author
Chuang L; Burke TW; Tornos C; Marino BD; Mitchell MF; Tortolero Luna G; Levenback C; Morris M; Gershenson DM
Address
Department of Gynecologic Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Source
Gynecol Oncol, 1995 Aug, 58:2, 189-93
Abstract
The surgical staging scheme for uterine corpus cancer adopted in 1988 by the International Federation of Gynecology and Obstetrics assigns patients with tumor spread to retroperitoneal lymph nodes to stage IIIC. However, a recommended approach to the detection of lymph node metastasis is not delineated. As part of an ongoing project to assess the value of surgical staging procedures, we reviewed the techniques of lymph node evaluation in 295 at-risk patients. Cases included clinical stage I patients whose preoperative biopsies demonstrated grade 2 or 3 adenocarcinoma or papillary serous, clear cell, or mixed carcinoma. We arbitrarily divided the retroperitoneal space into 10 lymphatic zones: left and right para-aortic, common iliac, external iliac, hypogastric, and obturator. Eighty-two percent of patients had some type of node sampling that involved a mean of three zones. Thirty-three of 244 sampled cases (13.5%) had nodal metastases: 20 had gross involvement and 13 had microscopic. We stratified patients into three groups: (1) those who had no node sampling (n = 51), (2) those with some nodes biopsied (n = 193), and (3) those whose node sampling included a minimum of one para-aortic plus at least one right and left pelvic specimen (n = 51). Retroperitoneal recurrences thought to originate from lymph node sites were identified for the "node-negative" patients in each group: Group 1, 4/51 (8%); Group 2, 9/173 (5%); and Group 3, 0/38 (0%). Lymphatic site failures were seen in 8 of 33 (24%) patients with biopsy-proven metastases. We found that failure to systematically sample pelvic and para-aortic nodes results in a small, but real, risk of undetected extrauterine metastasis. A selective approach to sampling that includes biopsy from both para-aortic and bilateral pelvic lymphatic zones appears to provide an accurate estimate of true node negativity. Further evaluation of this approach is warranted.
Language of Publication
English
Unique Identifier
95347655

Return To Top
Return To Menu Position #80


MeSH Heading (Major)
Endometrial Neoplasms|*PA/*SU; Lymph Nodes|*PA
MeSH Heading
Adult; Aged; Aged, 80 and over; Fallopian Tubes|SU; Female; Follow-Up Studies; Human; Hysterectomy; Lymphatic Metastasis; Middle Age; Neoplasm Staging|MT; Ovariectomy; Retroperitoneal Space

Publication Type
JOURNAL ARTICLE
ISSN
0090-8258
Country of Publication
UNITED STATES

Record 87 from database: MEDLINE
Return To Top
Return To Menu Position #80
Return To Menu Position #90

Title
Mortality in prostatic carcinoma.
Author
Kuban DA; el Mahdi AM; Schellhammer PF
Address
Department of Radiation Oncology and Biophysics, Eastern Virginia Medical School, Norfolk.
Source
Urology, 1989 Jan, 33:1, 1-5
Abstract
One hundred forty-seven patients definitively irradiated for biopsy-proved adenocarcinoma of the prostate from December, 1975, to March, 1979, have either died after a median survival of forty-five months or have been followed up for a minimum of seven years. Seventy-six patients (52%) are currently alive, 62 of them with no evidence of disease. Seventy-one patients (48%) have died, 28 without disease. In addition, 12 patients died with prostatic carcinoma but of other causes. In assessing the characteristics of those patients who remain disease-free following treatment, a significant difference in disease control was seen based on tumor stage, histologic differentiation, pelvic lymph node status, and whether or not tumor was present microscopically at rebiopsy. Of those deceased patients with recurrent prostate cancer, more than one-half had distant metastasis only. In all, 61 percent of patients had no further evidence of prostatic carcinoma after definitive irradiation, 20 percent had distant metastasis alone, and only 18 percent had locally recurrent disease along with distant disease spread.
Language of Publication
English
Unique Identifier
89101361

Return To Top
Return To Menu Position #80
Return To Menu Position #90


MeSH Heading (Major)
Prostatic Neoplasms|*MO/PA/RT
MeSH Heading
Aged; Aged, 80 and over; Cause of Death; Follow-Up Studies; Human; Lymph Nodes|PA; Male; Middle Age; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvis; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0090-4295
Country of Publication
UNITED STATES

Record 88 from database: MEDLINE
Return To Top
Return To Menu Position #80
Return To Menu Position #90

Title
Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus.
Author
Chen SS
Address
Department of Obstetrics and Gynecology, Long Island Jewish Medical Center, New Hyde Park, New York 11042.
Source
Gynecol Oncol, 1989 Feb, 32:2, 215-7
Abstract
Information in the literature about the incidence of nodal spread and its clinical implication in stage I sarcoma of the uterus is limited. The purpose of this study is to provide additional information derived from surgical staging of 20 patients who were treated by primary surgery to include total abdominal hysterectomy, bilateral salpingo-oophorectomy, and selective biopsy of paraaortic and pelvic nodes. Nine out of 20 patients (45%) of this small series had lymph node metastases either to both pelvic and paraaortic nodes (6) or pelvic nodes alone (3). This high rate of nodal involvement was associated with deep myometrial invasion, uteri sounding larger than 8 cm, patients older than 65 years, and leiomyosarcoma. In 12 of 20 patients, clinical staging was an underestimate. In a follow-up from 2 to 12 years, all 9 patients with positive nodes succumbed to their diseases. This result indicates that incidence of nodal spread in stage I sarcoma of the uterus is a frequent occurrence and is related to ultimate survival. Furthermore, it suggests that lymphatic permeation might precede hematogenous spread in early sarcoma of the uterus.
Language of Publication
English
Unique Identifier
89092136

Return To Top
Return To Menu Position #80
Return To Menu Position #90


MeSH Heading (Major)
Sarcoma|MO/*PA; Uterine Neoplasms|MO/*PA
MeSH Heading
Aged; Aged, 80 and over; Female; Human; Lymphatic Metastasis; Middle Age; Neoplasm Staging; Retroperitoneal Space

Publication Type
JOURNAL ARTICLE
ISSN
0090-8258
Country of Publication
UNITED STATES

Record 89 from database: MEDLINE
Return To Top
Return To Menu Position #80
Return To Menu Position #90

Title
Preoperative diagnostics in pancreatic carcinoma: would less be better?
Author
Böttger T; Engelman R; Seifert JK; Löw R; Junginger T
Address
Klinik und Poliklinik fÂur Allgemein- und Abdominalchirurgie, Johannes-Gutenberg-UniversitÂat Mainz, Germany.
Source
Langenbecks Arch Surg, 1998 Aug, 383:3-4, 243-8
Abstract
OBJECTIVE: The objective of this study was to investigate the value of preoperative diagnostics in patients with pancreatic carcinoma in terms of tumor diagnosis and evaluation of resectability. PATIENTS/METHODS: From 1 September 1985 to 31 December 1997, 408 patients shown by histology to have a ductal (n=330) or periampullary carcinoma (n=78) were treated at our hospital. RESULTS: In determining the presence of tumor, ultrasonography and computed tomography (CT) had a sensitivity of 88.3% and 94.0%, respectively; combined, they had a sensitivity of 96.2%. Endoscopic retrograde cholangiopancreatography (ERCP) had a sensitivity of 96.2%. Preoperative aspiration biopsy cytology had a sensitivity of 71.4%. No correlation was found in the patients undergoing surgery between the preoperative level of serum CA 19-9 and the presence of distant metastases. Tumor infiltration of the portal vein was shown with a sensitivity of 33.3%, 24.3%, and 76.5% and a specificity of 93.9%, 98.9%, and 65.6% by ultrasonography, CT, and angiography, respectively. Ultrasonography and CT detected liver metastases or peritoneal carcinomatosis with a sensitivity of 35.9% each and a specificity of 91.9% and 91.7%, respectively. CONCLUSION: This study shows that, in 96% of patients with pancreatic carcinoma, ultrasonography and CT are adequate for diagnosis and for the evaluation of resectability. ERCP is not the method of choice in the diagnosis of pancreatic carcinoma due to its invasiveness and to the fact that it fails to demonstrate the pathological anatomical location of the tumor; it should only be used if a tumor is suspected despite negative results on ultrasonography and CT or as an additional diagnostic method to differentiate between chronic pancreatitis and carcinoma. On account of the low sensitivity of percutaneous aspiration biopsy cytology, this method is not necessary preoperatively and may even lead to the spread of tumor cells. In 7% of patients, routine laparoscopy would additionally show liver metastases or peritoneal carcinomatosis not demonstrated using the imaging techniques.
Language of Publication
English
Unique Identifier
98447345

Return To Top
Return To Menu Position #80
Return To Menu Position #90


MeSH Heading (Major)
Carcinoma|*DI/SU/US; Carcinoma, Infiltrating Duct|*DI/SU/US; Pancreatic Neoplasms|*DI/SU/US
MeSH Heading
Adult; Aged; Aged, 80 and over; Cholangiopancreatography, Endoscopic Retrograde; CA-19-9 Antigen|AN; Female; Human; Male; Middle Age; Neoplasm Invasiveness; Neoplasm Metastasis; Sensitivity and Specificity; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
1435-2443
Country of Publication
GERMANY

Record 90 from database: MEDLINE
Return To Top
Return To Menu Position #80
Return To Menu Position #90

Title
A case of malignant pleural mesothelioma with metastasis to the orbit.
Author
Kubota K; Furuse K; Kawahara M; Ogawara M; Ryu S; Yamamoto S
Address
Department of Internal Medicine, National Kinki Central Hospital for Chest Diseases, Sakai, Osaka.
Source
Jpn J Clin Oncol, 1996 Dec, 26:6, 469-71
Abstract
A 58-year-old woman with malignant mesothelioma metastatic to the orbit is reported. Malignant pleural mesothelioma was diagnosed by pleural biopsy. Marked reduction of pleural effusion was obtained with intrapleural interleukin-2 therapy. Systemic chemotherapy failed to elicit a response after the first recurrence of the tumor. Multiple systemic metastasis, including metastasis to the orbit, developed and the patient died one year and 4 months after the initial diagnosis. Although malignant mesothelioma is known to spread hematogenously, sometimes producing brain metastasis, there have been few reports of orbital metastasis, and in fact the present report may be the first clinically documented account of its kind.
Language of Publication
English
Unique Identifier
97154636

Return To Top
Return To Menu Position #80
Return To Menu Position #90


MeSH Heading (Major)
Mesothelioma|*SC/TH; Neoplasm Circulating Cells|*; Orbital Neoplasms|*SC; Pleural Neoplasms|*PA/TH
MeSH Heading
Case Report; Female; Heart Neoplasms|SC; Human; Interleukin-2|TU; Lung Neoplasms|SC; Lymphatic Metastasis; Middle Age; Pleural Effusion, Malignant|ET/TH; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE
ISSN
0368-2811
Country of Publication
JAPAN

Record 91 from database: MEDLINE
Return To Top
Return To Menu Position #80
Return To Menu Position #90

Title
Spread of ovarian cancer after laparoscopic surgery: report of eight cases.
Author
Leminen A; Lehtovirta P
Address
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, HYKS, 00029, Finland.
Source
Gynecol Oncol, 1999 Dec, 75:3, 387-90
Abstract
OBJECTIVE: The aim of this study was to describe early occurrences of metastases after laparoscopy of ovarian masses later found to be malignant. METHODS: The hospital charts of eight women having undergone laparoscopic surgery for ovarian mass were reviewed and analyzed. RESULTS: The mean age of the patients was 40 years (range 25 to 66). Size of the tumor ranged from 2 to 15 cm. In four patients the ovarian mass was suspected to be malignant in the laparoscopy. Diagnostic procedure (biopsy of the tumor) was performed in two and salpingo-oophorectomy in six patients. Staging laparotomy was performed within the mean of 17 days (range 7-29). In four patients (50%) the cancer had spread from a localized to an advanced stage during the delay. Ascites was present in the laparoscopy in two of the four patients with port site or abdominal wall metastases. CONCLUSIONS: Laparoscopic surgery of ovarian mass later found to be malignant can cause considerable and early spread of the cancer. Copyright 1999 Academic Press.
Language of Publication
English
Unique Identifier
20069529

Return To Top
Return To Menu Position #80
Return To Menu Position #90


MeSH Heading (Major)
Laparoscopy|*AE; Ovarian Neoplasms|PA/*SU
MeSH Heading
Adult; Aged; Female; Human; Middle Age; Neoplasm Metastasis

Publication Type
JOURNAL ARTICLE
ISSN
0090-8258
Country of Publication
UNITED STATES

Record 92 from database: MEDLINE
Return To Top
Return To Menu Position #90

Title
Routine CT scan in cystectomy patients: does it change management? [published erratum appears in Urology 1996 May;47(5):785]
Author
Herr HW
Address
Urology Service, Department of Surgery Memorial Sloan, Kettering Cancer Center, New York, USA.
Source
Urology, 1996 Mar, 47:3, 324-5
Abstract
OBJECTIVES: To evaluate the practical use of routine computed tomography (CT) scan in changing management of patients with muscle-invasive bladder cancer who are candidates for cystectomy. METHODS: One hundred five patients (52 with tumors confined to the bladder and 53 with extravesical spread) were evaluated for cystectomy. The presence of nodal metastasis at surgery or biopsy was correlated with preoperative CT findings. RESULTS: The CT scan was abnormal (nodes > 1.5 cm in size) in 32% and normal (nodes < 1.5 cm) in 68% of 28 patients with positive nodes. Of 52 cases with T2 tumors, CT scan was abnormal in 6, 14% (1 of 7) with positive and 11% (5 of 45) with negative nodes, whereas of 53 with T3-4 tumors, 15 had abnormal scans, 38% (8 of 21) with positive and 22% (7 of 32) with negative nodes. CT scan changed management (a biopsy deferred surgery) in 2 (2%) of the 105 cases. CONCLUSIONS: A routine CT scan was not helpful in management of operable T2 tumors but might change therapy in selected patients with T3-4 tumors who are considered for cystectomy.
Language of Publication
English
Unique Identifier
96217855

Return To Top
Return To Menu Position #90


MeSH Heading (Major)
Bladder Neoplasms|PA/*RA/*SU; Cystectomy|*; Tomography, X-Ray Computed|*
MeSH Heading
Bladder|PA; Human; Lymph Nodes|PA/RA; Lymphatic Metastasis; Muscle Neoplasms|PA; Neoplasm Invasiveness

Publication Type
JOURNAL ARTICLE
ISSN
0090-4295
Country of Publication
UNITED STATES

Record 93 from database: MEDLINE
Return To Top
Return To Menu Position #90

Title
Absence of epidermal growth factor receptor expression in squamous cell carcinoma of the uterine cervix is an indicator of limited tumor disease.
Author
Biesterfeld S; Schuh S; Muys L; Rath W; Mittermayer C; Schröder W
Address
Institute of Pathology, University of Aachen, D-52057 Aachen, Germany.
Source
Oncol Rep, 1999 Jan, 6:1, 205-9
Abstract
The expression of growth factors is considered as an important diagnostic and prognostic feature in tumor pathology. We investigated the value of the immunohistochemical EGF-receptor expression (EGF-R) in 30 squamous cell carcinomas of the uterine cervix, treated by radical hysterectomy and lymphadenectomy according to the Wertheim-Meigs-Okabayashi technique. Immunohistochemical reactions were performed on 4 microm sections from paraffin-embedded tissue, using an indirect peroxidase method. The staining results were evaluated semiquantitatively as negative (n=9; 30%) or as slightly, moderately or severely positive (n=21; 70%). The EGF-R-negative tumors were found in less advanced tumor stages. None had invaded into the parametrium (100%), eight were staged as T1 (89%), seven as N0 (78%), and seven showed no evidence for lymphangiosis carcinomatosa (78%). The respective values for the EGF-R-positive tumors ranged from 52% to 67%. However, only the difference in parametral invasion (EGF-R-negative: 0%, EGF-R-positive: 38%) was statistically significant (p=0.0306), probably due to the small number of cases. The EGF-R-expression was not correlated to histomorphological tumor grading. The results of this study indicate an inverse correlation between EGF-R expression and tumor spread. Assuming that this trend could be confirmed by a larger group of patients, immunostaining for EGF-R in a tumor biopsy could be useful to adapt surgical strategies and adjuvant therapy in the individual patient. Moreover, the EGF-R is an interesting target for immunotherapeutic approaches in squamous cell cervical carcinoma.
Language of Publication
English
Unique Identifier
99085140

Return To Top
Return To Menu Position #90


MeSH Heading (Major)
Carcinoma, Squamous Cell|*CH/PA; Cervix Neoplasms|*CH/PA; Neoplasm Proteins|*AN; Receptor, Epidermal Growth Factor|*AN; Tumor Markers, Biological|*AN
MeSH Heading
Adult; Aged; Aged, 80 and over; Comparative Study; Evaluation Studies; Female; Human; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Age; Neoplasm Invasiveness; Neoplasm Staging; Pregnancy

Publication Type
JOURNAL ARTICLE
ISSN
1021-335X
Country of Publication
GREECE

Record 94 from database: MEDLINE
Return To Top
Return To Menu Position #90

Title
Prognostic value of p53 protein accumulation in cancer cell nuclei in adenocarcinoma of the uterine cervix.
Author
Tsuda H; Jiko K; Tsugane S; Yajima M; Yamada T; Tanemura K; Tsunematsu R; Ohmi K; Sonoda T; Hirohashi S
Address
Pathology Division, National Cancer Center Research Institute and Hospital, Tokyo.
Source
Jpn J Cancer Res, 1995 Nov, 86:11, 1049-53
Abstract
Adenocarcinoma of the uterine cervix (CxAd) is one of the most distressing malignancies of the female reproductive system because of its tendency to spread aggressively and to be resistant to radiation and systemic therapies. To clarify the prognostic significance of p53 alteration in CxAd, we immunohistochemically examined the incidence of p53 nuclear accumulation, which is considered to be mostly parallel with p53 gene mutation, and its association with clinicopathological parameters in 26 patients with CxAd. The overall incidence of p53 nuclear accumulation was 46% (12 of 26), being higher in groups with clinically advanced disease, higher degrees of cellular atypia, and deeper myometrial invasion, but significantly lower in patients with integration of human papillomavirus (HPV) type 16 or 18 DNA. Nuclear p53 immunoreactivity as well as lymph node status, depth of invasion and the absence of HPV-DNA integration were significant indicators of a poor prognosis. Examination of p53 nuclear accumulation could be applied to biopsy material, and would be of practical assistance in predicting the prognosis of CxAd both preoperatively and postoperatively.
Language of Publication
English
Unique Identifier
96159041

Return To Top
Return To Menu Position #90


MeSH Heading (Major)
Adenocarcinoma|*CH/MO/PA/VI; Cell Nucleus|*CH; Cervix Neoplasms|*CH/MO/PA/VI; Neoplasm Proteins|*AN; Protein p53|*AN; Tumor Markers, Biological|*AN
MeSH Heading
Comorbidity; DNA Probes, HPV; DNA, Neoplasm|AN; DNA, Viral|AN; Female; Genes, p53; Human; Neoplasm Metastasis; Neoplasm Staging; Papillomavirus, Human|IP; Papovaviridae Infections|EP; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Prognosis; Support, Non-U.S. Gov't; Survival Rate; Tumor Virus Infections|EP

Publication Type
JOURNAL ARTICLE
ISSN
0910-5050
Country of Publication
JAPAN

Record 95 from database: MEDLINE
Return To Top
Return To Menu Position #90

Title
Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study.
Author
Barbu V; Bonnand AM; Hillaire S; Coste T; Chazouilleres O; Gugenheim J; Boucher E; Poupon R; Poupon RE
Address
Laboratoire de Biologie MolÆeculaire, HÈopital Saint-Antoine, and INSERM Unit 402 Paris, France.
Source
Hepatology, 1997 Nov, 26:5, 1171-5
Abstract
The presence of circulating tumor cells might be an indicator of hematogenous spread of tumor cells leading to extrahepatic metastasis. Messenger RNA (mRNA) expression of human albumin, as a liver specific cell marker, has been proposed for this purpose in hepatocellular carcinoma. We conducted a multicenter prospective study in 101 patients with biopsy-proven hepatocellular carcinoma followed-up every 3 months for 1 year or until death. At entry into the study, albumin mRNA was detected in the blood by reverse transcription-polymerase chain reaction (RT-PCR). At entry into the study, 45% of the patients had a positive albumin mRNA test, 53% a single tumor, 16% a portal or venous hepatic thrombosis, and 16% had proven metastasis. After 1 year, there was no significant difference in survival of patients with positive or negative albumin mRNA at entry (P = .16, log-rank test). When patients with metastasis at entry were excluded, again survival did not differ between the two groups (P = .20). Independent prognostic factors of survival were radical therapeutic procedures, metastasis, number of tumors, Child-Pugh score, and thrombosis, but not the albumin mRNA test. Taking the presence of metastasis as a reference, the specificity of the test was 56%, its sensitivity 50%, and its negative predictive value 85%. The present study shows that circulating albumin mRNA detected by means of RT-PCR fails to provide significant information in the diagnosis and prognosis of hepatocellular carcinoma. Further studies are needed to determine whether the use of specific tumor markers could have clinical relevance in this setting.
Language of Publication
English
Unique Identifier
98026681

Return To Top
Return To Menu Position #90


MeSH Heading (Major)
Carcinoma, Hepatocellular|*ME; Liver Neoplasms|*ME; RNA, Messenger|*ME; Serum Albumin|*GE
MeSH Heading
Adult; Aged; Aged, 80 and over; Female; Human; Male; Middle Age; Neoplasm Metastasis; Polymerase Chain Reaction; Prognosis; Prospective Studies; Sensitivity and Specificity; Support, Non-U.S. Gov't; Survival Analysis; Transcription, Genetic

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE; MULTICENTER STUDY
ISSN
0270-9139
Country of Publication
UNITED STATES

Record 96 from database: MEDLINE
Return To Top
Return To Menu Position #90

Title
Current imaging strategies for colorectal cancer.
Author
Collier BD; Foley WD
Address
Department of Nuclear Medicine, Medical College of Wisconsin, Milwaukee 53226.
Source
J Nucl Med, 1993 Mar, 34:3 Suppl, 537-40
Abstract
Endoscopy and barium enema examinations are used to identify the primary site of disease in patients with clinical suspicion of colorectal cancer. Once colorectal cancer has been confirmed by imaging studies and biopsy, preoperative evaluation is directed toward accurate disease staging. Most currently available imaging techniques are inaccurate for detecting transmural extension, perienteric spread of tumors and distant lymph node involvement. Although both computed tomography (CT) and magnetic resonance imaging (MRI) have an unacceptably low sensitivity for accurate staging, CT is clearly superior to MRI for detecting extrahepatic metastases. Transrectal ultrasonography, however, is a promising new method for detecting perirectal spread of disease. The diagnostic efficacy of MRI and intravenous dynamic hepatic CT for detecting liver metastases is approximately equal. CT during arterial portography is recommended before resection of solitary liver metastases. Chest radiography is also part of the routine preoperative evaluation. Bone scans are rarely performed in patients without the skeletal pain suggestive of bone metastases. During the years following surgery for colorectal cancer, many patients undergo special imaging studies to identify local tumor recurrence, secondary tumor growth elsewhere within the large bowel and both regional and distant spread of disease. Thus, for the patient with a sharply increasing carcinoembryonic antigen level, CT of the abdomen and liver is the current recommendation. Immunoscintigraphy is a new imaging modality that addresses some of the limitations of current diagnostic procedures for colorectal cancer. This procedure gives whole body information on disease extent, especially in the extrahepatic abdomen and pelvis, and can therefore contribute to patient management decisions.
Language of Publication
English
Unique Identifier
93179987

Return To Top
Return To Menu Position #90


MeSH Heading (Major)
Colorectal Neoplasms|*DI/PA
MeSH Heading
Human; Liver Neoplasms|SC; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
0161-5505
Country of Publication
UNITED STATES

Record 97 from database: MEDLINE
Return To Top
Return To Menu Position #90

Title
Thoracic metastases from carcinoma of the nasopharynx: high frequency of hilar and mediastinal lymphadenopathy.
Author
Daly BD; Leung SF; Cheung H; Metreweli C
Address
Department of Diagnostic Radiology and Organ Imaging, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin.
Source
AJR Am J Roentgenol, 1993 Feb, 160:2, 241-4
Abstract
OBJECTIVE. Nasopharyngeal carcinoma is a malignant tumor commonly encountered in Chinese patients living in or originating from Hong Kong or southern China. This article describes the previously unreported radiologic appearances of thoracic metastases from nasopharyngeal carcinoma. MATERIALS AND METHODS. The radiographic (33 patients) and CT (eight patients) appearances of thoracic metastases from nasopharyngeal carcinoma were studied retrospectively. All 33 patients had biopsy-proved primary nasopharyngeal carcinoma, and seven patients had biopsy-proved thoracic metastases. Radiologic and clinical evidence of metastases was unequivocal in 26 others, 16 of whom had synchronous spread to cervical lymph nodes, bone, or liver. RESULTS. Twenty-one patients (64%) had evidence of thoracic lymphadenopathy, most frequently hilar (n = 18, 55%), on chest radiographs or CT scans. Seventeen patients (52%) had evidence of multiple parenchymal pulmonary metastases. Enlargement of lymph nodes without multiple pulmonary deposits was seen in 12 patients (36%), seven of whom had radiologic signs of bronchial obstruction, hemoptysis, or a single pulmonary lesion simulating a synchronous bronchial neoplasm. Pleural effusions or deposits (n = 6), lymphangitis carcinomatosa (n = 5), and rib metastases (n = 4) also were seen. CONCLUSION. Metastases from nasopharyngeal carcinoma may be detected in a wide range of thoracic sites. This disease appears to be as likely to disseminate to the mediastinal or hilar lymph nodes as to the pulmonary parenchyma, and it can simulate a primary bronchial tumor or lymphoma.
Language of Publication
English
Unique Identifier
93142635

Return To Top
Return To Menu Position #90


MeSH Heading (Major)
Carcinoma, Squamous Cell|RA/*SC; Lymph Nodes|*RA; Nasopharyngeal Neoplasms|*PA; Thoracic Neoplasms|RA/*SC
MeSH Heading
Adult; Female; Human; Lung Neoplasms|RA/SC; Lymphatic Metastasis|RA; Male; Mediastinal Neoplasms|RA/SC; Middle Age; Retrospective Studies; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
0361-803X
Country of Publication
UNITED STATES

Record 98 from database: MEDLINE
Return To Top
Return To Menu Position #90

Title
Surgery in the management of mediastinal carcinoid.
Author
Best LA; Westbrook BM; Trastek VF; Payne WS; Pairolero PC
Address
Mayo Clinic, Rochester, Minnesota, USA.
Source
J Cardiovasc Surg (Torino), 1994 Dec, 35:6 Suppl 1, 133-5
Abstract
Primary carcinoid tumors of the mediastinum were described for the first time in 1972 as thymic carcinoids. Our experience with 16 patients who underwent diagnostic and surgical procedures at the Mayo Clinic is presented. All of these patients had mediastinal carcinoid. The surgical procedures included node biopsy, anterior mediastinotomy (Chamberlain), median sternotomy and posterior lateral thoracotomy. Complete resection was possible in 9 (56.3%) patients, 3 (18.7%) had partial removal (debulking), and 4 (25%) had diagnostic biopsies only. The operative morbidity was 25%. There were no postoperative deaths. In resectable patients, the average disease free interval was 45.7 months. Five year and ten year survival was 47% and 22%, respectively. Local or distant metastatic spread developed in all patients (100%). Mediastinal carcinoids are a separate entity from other thymic and mediastinal neoplasms. (We suggest that) Surgical excision may be possible earlier in the disease and radiation and chemotherapy are of doubtful value.
Language of Publication
English
Unique Identifier
95294077

Return To Top
Return To Menu Position #90


MeSH Heading (Major)
Carcinoid Tumor|MO/SC/*SU; Mediastinal Neoplasms|MO/*SU
MeSH Heading
Adult; Aged; Comparative Study; Disease-Free Survival; Female; Follow-Up Studies; Human; Male; Middle Age; Neoplasm Metastasis; Neoplasm Recurrence, Local|SU; Postoperative Complications; Radical Neck Dissection; Reoperation; Survival Analysis; Time Factors

Publication Type
JOURNAL ARTICLE
ISSN
0021-9509
Country of Publication
ITALY

Record 99 from database: MEDLINE
Return To Top
Return To Menu Position #90

Title
Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
Author
Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
Address
University Clinic of Nuclear Medicine, Department of Biomedical Engineering and Physics, Vienna, Austria.
Source
J Nucl Med, 1998 Jul, 39:7, 1166-71
Abstract
We prospectively investigated 200 patients with the clinical suspicion for head and neck tumors. The final diagnoses were 94 primary and 56 (37 confirmed, 19 excluded) recurrent squamous cell carcinomas (SCCs), 3 primary and 7 (4 confirmed, 3 excluded) recurrent adenoid cystic carcinomas (ACCs), 6 non-Hodgkin's lymphomas, 10 distant metastases, 6 other malignancies, 10 inflammatory and 8 other nonmalignant conditions. METHODS: Bone (600 MBq 99mTc-3,3-diphosphono-1,2-propane dicarboxylic acid tetrasodium salt) and hexakis-2-methoxyisobutyl isonitrile (MIBI) (600 MBq 99mTc-MIBI) SPECT were both performed under identical conditions (triple-head gamma camera; ultra-high-resolution, parallel-hole collimators; three-dimensional postfiltering) and judged independently and after superimposition. The results were compared to the results of biopsy, surgery and CT. RESULTS: The overall sensitivity/specificity of MIBI was 90%/78% for tumor detection and 90%/95% for the identification of malignant lymph node involvement (CT: 79%/66%, respectively 90%/79%). In the subgroup of recurrent SCC and ACC the sensitivity/specificity for tumor detection was 95%/71% for MIBI versus 78%/68% for CT. The isolated assessment of bone SPECT had a sensitivity/specificity of 100%/17% for osseous tumor spread. Image fusion of MIBI and bone SPECT differentiated between regio-local bone involvement and inflammatory changes and increased the specificity of bone SPECT to 100% in primary staging. Tumor size, stage, histology and pretreatment had no statistically significant effect on tracer uptake or diagnostic utility of scintigraphy. CONCLUSION: We propose the combined 99mTc-MIBI and bone ultra-high resolution SPECT as a highly useful imaging approach in the primary and secondary staging in patients with suspected malignancies in the head and neck region. The high specificity for malignancies in the head and neck region may be used in the differential diagnosis between head and neck malignancies and inflammatory disease in patients with the accidental finding of enlarged lymph nodes and no clinical signs of a primary tumor. Image fusion with bone scanning is mandatory for the topographical orientation and increases the specificity of bone scanning to differentiate between inflammatory or malignant causes of increased bone metabolism.
Language of Publication
English
Unique Identifier
98332051

Return To Top
Return To Menu Position #90


MeSH Heading (Major)
Bone Neoplasms|PA/*RI; Head and Neck Neoplasms|PA/*RI; Neoplasm Recurrence, Local|*RI; Radiopharmaceuticals|*DU; Technetium Tc 99m Sestamibi|*DU; Tomography, Emission-Computed, Single-Photon|*
MeSH Heading
Carcinoma, Adenoid Cystic|PA/RI; Carcinoma, Squamous Cell|PA/RI; Comparative Study; Diphosphonates|DU; Female; Human; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Age; Neoplasm Staging; Organotechnetium Compounds|DU; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE
ISSN
0161-5505
Country of Publication
UNITED STATES

Record 100 from database: MEDLINE
Return To Top
Return To Menu Position #90

Title
Spinal ependymomas--the value of postoperative radiotherapy for residual disease control.
Author
Sgouros S; Malluci CL; Jackowski A
Address
Department of Neurosurgery, Birmingham Neurosciences Centre, Queen Elizabeth Hospital, UK.
Source
Br J Neurosurg, 1996 Dec, 10:6, 559-66
Abstract
Spinal ependymomas are rare intramedullary tumours, usually with a benign biological nature. They have, however, a known potential for recurrence and metastatic spread through the CSF pathways. Traditionally, radiotherapy has been employed as an adjuvant to surgery. Recently, however, this view has been increasingly questioned. Thirty-eight adult patients operated in the West Midlands between 1956 and 1994 were reviewed. Mean age at presentation was 37.8 years. Of all tumours 45% (17) were situated in the conus/cauda equina region, 26% (10) in the thoracic and 29% (11) in the cervical region. All patients underwent surgery as primary treatment. Postoperative mortality was 2.6% (one patient). Complete macroscopic excision of their tumours was performed in 14 patients; of these three received postoperative radiotherapy. Subtotal excision was performed in 18 patients, seven receiving adjuvant radiotherapy. Decompressive laminectomy and biopsy was performed in five patients with either no radiotherapy in one, radiotherapy in three or radiotherapy and chemotherapy in one. The overall survival rate was 87% at 5 years and 73% at 10 years for the whole series. In patients treated after the 1970s, the cumulative 10-year survival was 95%. Patients over the age of 40 years at diagnosis had a 10-year survival of 61% compared to 78% of those under the age of 40. Intramedullary tumours had a worse outcome with 68% survival at 10 years, compared to 89% of tumours at the cauda equina. Total excision carried 86% survival, subtotal excision 80% and biopsy only 25% at 10 years. In those patients treated by administration of postoperative radiotherapy the 10-year survival was 48%, compared to 96% in those in whom radiotherapy was not given postoperatively. Analysis of the recurrence and survival rates demonstrated that radiotherapy did not confer any significant protection against recurrence or disease progression. Whilst complete excision offers the maximal potential for cure, an expectant policy with possible repeat surgery may be appropriate when total excision is not achieved. The main conclusion to be drawn is that a randomized controlled trial of the value of adjuvant radiotherapy is greatly needed.
Language of Publication
English
Unique Identifier
97165193

Return To Top
Return To Menu Position #90


MeSH Heading (Major)
Cauda Equina|*PA/SU; Ependymoma|PA/*RT/SU
MeSH Heading
Adolescence; Adult; Age Factors; Aged; Human; Laminectomy; Magnetic Resonance Imaging; Middle Age; Neoplasm Metastasis; Radiation Dosage; Retrospective Studies; Spinal Cord Neoplasms|PA/RT/SU; Survival Rate

Publication Type
JOURNAL ARTICLE
ISSN
0268-8697
Country of Publication
ENGLAND
Return To Top
Return To Menu Position #90
Home Page -- Karl Loren Web Site Navigation Bar
Karl Loren Diet Cancer & Biopsies Oral Chelation High Cholesterol Risk Factor
Karl Loren's Personal
Diet Diary
Ultrasound Technology Karl Loren Personal Plaque Isn't Where They Say It Is
Aajonus Vonderplanitz Arthritis Karl's Adventure
 With The IRS
Bones Are Alive
Diabetes Table Of Contents Jean Ross Witch Doctors & Ethnobotany
Sugar Shopping Cart Order Karl Loren's Book
On Heart Disease
AIDS
Raw Milk Search  This Web Write To Karl Loren Right To Die
Why You Should Drink More Water Transfer Factor & The Immune System What Is A Free Radical? Methyl Sulfonyl Methane
Taheebo Tea Germanium Corruption In The American Heart Association James Coburn's Use Of MSM To Handle Arthritis
Floaters Rather Than Sinkers Toxic Metals Heart Disease Jimmy Keller -- Forbidden Medicine
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Karl Loren's Catalog Store Central Page For All 12 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 


SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.